fluorodeoxyglucose f18 has been researched along with Neoplasm Metastasis in 914 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.22) | 18.7374 |
| 1990's | 41 (4.49) | 18.2507 |
| 2000's | 317 (34.68) | 29.6817 |
| 2010's | 496 (54.27) | 24.3611 |
| 2020's | 58 (6.35) | 2.80 |
| Authors | Studies |
|---|---|
| Alavi, A; Baun, C; Duvnjak, S; Falch, K; Gerke, O; Hansen, JA; Hildebrandt, MG; Høilund-Carlsen, PF; Naghavi-Behzad, M | 1 |
| Goksel, S; Ozcelik, N | 1 |
| Dimitriou, F; Ensle, F; Huellner, MW; Maurer, A; Schaab, JA | 1 |
| Sauvanet, A; Wartski, M | 1 |
| Chapiro, J; Pucar, D; Saperstein, L; Savic, LJ; Schobert, I | 1 |
| Burger, IA; Ghafoor, S; Vargas, AH | 1 |
| Barker, CA; Mahajan, S; Mauguen, A; Pandit-Taskar, N; Singh, B | 1 |
| Chen, Z; Dong, H; Lian, Z; Liu, C; Liu, E; Wang, S | 1 |
| Chen, Y; Huang, Z; Sun, R | 1 |
| Albert, NL; Bartenstein, P; Brendel, M; Cyran, CC; Herms, J; Ruf, V; Schüller, U; Thon, N; Tonn, JC; Unterrainer, M | 1 |
| Aarntzen, EHJG; Gerritsen, WR; van Willigen, WW | 1 |
| George, T; Joshi, PV; Joshi, S; Kulkarni, M; Sahasrabudhe, S; Shewalkar, B | 1 |
| Byun, BH; Cho, WH; Kim, W; Kong, CB; Lim, I; Lim, SM; Sheen, H; Song, WS; Woo, SK | 1 |
| Higashi, T; Ishizu, K; Kagawa, S; Kusano, K; Nakamoto, R; Okuyama, C; Saga, T; Takahashi, M; Yamauchi, H | 1 |
| Guo, X; Yang, M; Yang, Z; Zhou, N; Zhu, H | 1 |
| Avci, N; Sengoz, T | 1 |
| Kay, MD; Kuo, PH; Pariury, HE; Perry, A; Winegar, BA | 1 |
| Boers, J; de Vries, EFJ; Elias, SG; Glaudemans, AWJM; Hospers, GAP; Kwee, TC; Martens, JWM; Schröder, CP; Schuuring, E; Venema, CM | 1 |
| Al-Ubaedi, A; Flygare, L; Mo, SJ; Öhman, W | 1 |
| Annovazzi, A; Carpano, S; Cognetti, F; Ferraresi, V; Giannarelli, D; Pasqualoni, R; Sciuto, R; Vari, S | 1 |
| He, L; He, R; Li, G; Li, X; Qiao, Y; Ren, YW; Song, YQ; Wang, CY; Wang, N; Wang, RZ; Wang, TL; Yang, QK; Zhang, XF | 1 |
| Acosta, O; Castelli, J; Creff, G; Depeursinge, A; Devillers, A; Jegoux, F; Palard-Novello, X | 1 |
| Aoki, S; Araya, M; Komiyama, T; Kuriyama, K; Maehata, Y; Marino, K; Matsumoto, Y; Miyakawa, A; Miyawaki, D; Nishimura, Y; Nonaka, H; Onishi, H; Saito, M; Saito, R; Sano, N; Sasaki, R; Shibamoto, Y; Shioyama, Y; Suzuki, G; Tominaga, L; Yamada, S | 1 |
| Li, J; Pang, X; Song, F; Wei, Z; Zhang, X; Zhou, H | 1 |
| Di, G; He, M; Liu, C; Liu, G; Liu, Y; Shao, Z; Shi, Q; Sun, Y; Wang, Z; Xu, X; Yang, Z; Yuan, H; Zhang, Y | 1 |
| Guo-Qiang, S; Jian, W; Jun, Z; Long-Bao, X; Ming-Ya, P | 1 |
| Caroli, P; Colletti, PM; Maffione, AM; Matteucci, F; Rubello, D | 1 |
| Bagnardi, V; Corso, G; De Scalzi, AM; Gilardi, L; Girardi, A; Grana, CM; Montagna, G; Pagan, E; Pagani, G; Rossi, EMC; Veronesi, P | 1 |
| Ch'ng, S; Chakera, AH; Emmett, L; Fung, S; Gonzalez, M; Holtkamp, LHJ; Lee, K; Nieweg, OE; Saw, RPM; Stretch, JR; Thompson, JF | 1 |
| Abgral, R; Amrane, K; le Pennec, R; Metges, JP; Schick, U | 1 |
| Bendifallah, S; Body, G; Bricou, A; Collinet, P; Delvallée, J; Huchon, C; Lavoue, V; Ouldamer, L; Rossard, L; Touboul, C | 1 |
| Cui, XW; Gu, L; Li, YS; Sun, J; Wang, SY; Wang, XN; Yin, Q | 1 |
| Beg, M; De Blanche, L; Kandathil, A; Kazmi, S; Subramaniam, RM; You, H | 1 |
| Bensch, F; Brouwers, AH; de Vries, EGE; Elias, SG; Glaudemans, AWJM; Iersel, MW; Kwee, TC; Maduro, JH; Oosting, SF; Schröder, CP; van Es, SC; Velleman, T | 1 |
| Gao, Q; Guo, X; He, H; Jin, Y | 1 |
| Gao, J; Lin, M; Liu, Y; Wang, G; Wu, Y; Xu, B; Yu, H | 1 |
| Cadiot, G; de Mestier, L; Do Cao, C; Hentic, O; Perrier, M; Walter, T | 1 |
| Houdek, MT; Johnson, JD; Rainer, WG; Rose, PS | 1 |
| Can, C; Gündoğan, C; Kömek, H | 1 |
| Chen, QY; Guo, SS; Jia, GD; Liu, LT; Liu, SL; Luo, DH; Mai, HQ; Sun, R; Sun, XS; Tang, LQ; Xie, HJ; Yu, YF | 1 |
| Au-Yeung, G; Balachander, S; Bhave, P; Callahan, J; Chua, M; De Ieso, P; Gill, AJ; Hatzimihalis, A; Hicks, RJ; McArthur, GA; Pattison, A; Raleigh, J; Sandhu, S; Tothill, RW; Weppler, AM | 1 |
| Civan, C; Isik, EG; Simsek, DH | 1 |
| Bozec, L; Champion, L; Nascimento-Leite, C; Seban, RD | 1 |
| Bartel, T; Chen, C; Duan, F; Lowe, VJ; Romanoff, J; Sicks, JD; Stack, BC; Subramaniam, RM | 1 |
| Choi, JY; Hahn, SY; Kim, JH; Lim, Y; Park, KW; Shin, JH | 1 |
| Amano, Y; Omori, Y; Takagi, R; Tang, X; Yanagisawa, F | 1 |
| ArunRaj, ST; Bal, C; Gupta, S; Kp, H; Kumar, A; Mohan, N; Tripathi, M | 1 |
| Bartenstein, P; Di Gioia, D; Fabritius, MP; Holzgreve, A; Knösel, T; Lindner, LH; Renz, BW; Rübenthaler, J; Tiling, R | 1 |
| Han, J; Li, F; Li, X; Li, Y; Qu, L | 1 |
| Danilenko, VV; Kmetyuk, YV; Solodyannikova, OI; Sukach, GG | 1 |
| Bloise, I; Gowdy, C; Martineau, P; Worsley, D | 1 |
| In, GK; Jadvar, H | 1 |
| Chen, W; Hong, X; Lu, L; Peng, L; Wang, Q; Yuan, Q | 1 |
| Boye, K; Cesari, M; Guren, T; Hompland, I; Lobmaier, I; Longhi, A; Lorenz, S; Løndalen, AM; Meza-Zepeda, LA; Næss, S; Paioli, A; Palmerini, E; Pierini, M; Setola, E; Sundby Hall, K; Taksdal, I | 1 |
| Aryal, A; Gamanagatti, S; Khan, SA; Kumar, VS; Shamim, SA | 1 |
| Bjerring, OS; Fristrup, CW; Hess, S; Lundell, L; Mortensen, MB; Petersen, H | 1 |
| Civan, C; Erdem, S; Has Simsek, D; Sanli, Y | 1 |
| Creytens, D; Kruse, V; Ost, P; Spaas, M; Van den Broeck, B | 1 |
| Dong, C; Hao, J; Li, X; Ma, X; Wang, Y | 1 |
| Buck, A; Fassnacht, M; Fröhling, S; Fuss, CT; Germer, CT; Hübschmann, D; Kickuth, R; Kircher, S; Kroiss, M; Lenschow, C; Reibetanz, J; Schlegel, N; Stenzinger, A; Wiegering, A | 1 |
| Barshack, I; Ben-Haim, S; Chikman, B; Davidson, T; Halevy, A; Nissan, E; Shehade, N; Sklair-Levy, M; Zippel, D | 1 |
| Avril, N; Avril, S; Jones, RS; Kikano, EG; Marshall, H; Montero, AJ | 1 |
| Johnson, A; Manners, D; Norman, R; Piccolo, F | 1 |
| Bisogno, G; Cameron, A; Chisholm, J; Coppadoro, B; Corradini, N; Gallego, S; Jehanno, N; Mercolini, F; Merks, JH; Minard-Colin, V; Rogers, T; Scarzello, G; Van Rijn, RR; Zucchetta, P | 1 |
| Gu, J; Lu, Y; Xu, G | 1 |
| Hasumi, H; Hattori, Y; Hayashi, N; Inoue, T; Ito, H; Kaneta, T; Kawahara, T; Kobayashi, K; Kondo, K; Makiyama, K; Miyoshi, Y; Nakaigawa, N; Namura, K; Osaka, K; Tateishi, U; Teranishi, JI; Uemura, H; Ueno, D; Yao, M; Yokomizo, Y; Yumura, Y | 1 |
| Chan, ATC; Chan, CML; Ho, WM; King, AD; Leung, L; Ma, B; Mo, F; Poon, A; Wang, K; Wong, SCC | 1 |
| Huang, T; Jin, Z; Li, XF; Shen, B; Sun, Y | 1 |
| Bremicker, K; Exner, M; Höhn, AK; Meyer, HJ; Purz, S; Schob, S; Stumpp, P; Surov, A | 1 |
| Baltzer, P; Dickler, M; Gönen, M; Jochelson, MS; McArthur, HL; Ong, LT; Pinker, K; Riedl, CC; Ulaner, GA; Weber, WA | 1 |
| Dong, Y; Hu, G; Huang, P; Xiao, W; Zhao, X | 1 |
| Bible, KC; Jasim, S; Nathan, MA | 1 |
| Higashi, M; Jinguji, M; Nagano, H; Nakajo, M; Yoshiura, T | 1 |
| Griffin, A | 1 |
| Almquist, H; Bläckberg, M; Cwikiel, M; Gudjonsson, S; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
| Borrego-Dorado, I; de Bonilla-Damiá, A; Fernández-López, R; Márquez-Vega, C; Pachón-Garrudo, VM | 1 |
| Cook, G; Goh, V; Kelly-Morland, C; Mallett, S; Montana, G; Nathan, P; Rudman, S | 1 |
| Apte, AP; Deasy, JO; Folkert, MR; Grkovski, M; Lee, NY; Oh, JH; Schöder, H; Setton, J; Thorstad, WL; Young, RJ | 1 |
| Hwang, JP | 1 |
| Cheng, ZB; Jin, YN; Ma, J; Mo, HY; Sun, Y; Wang, SY; Yao, JJ; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Ahn, SJ; Marcus, C; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Young, B | 1 |
| Goel, R; Khan, S; Moore, W; Sher, D; Subramaniam, RM; Sumer, B | 1 |
| Avigdor, A; Ben-Haim, S; Chikman, B; Davidson, T; Goshen, E; Kedmi, M; Komisar, O; Lidar, M; Tzila Zwas, S | 1 |
| Beauregard, JM; Bergeron, M; Fradet, V; Fradet, Y; Lacombe, L; Morin, F; Nguile Makao, M; Pouliot, F | 1 |
| Argon, AM; Avci, NC; Yararbas, U; Yeniay, L | 1 |
| Ashwathanarayana, AG; Biswal, CK; Kapoor, R; Mittal, BR; Parihar, AS; Sood, A | 1 |
| Brennan, I; Johnston, C; Murphy, J | 1 |
| Bailly, C; Bodet-Milin, C; Campion, L; Carlier, T; Kraeber-Bodere, F; Leforestier, R; Moreau, A; Thebaud, E | 1 |
| Derlin, T; Hueper, K; Soudah, B | 1 |
| Al-Muqbel, KM | 1 |
| Agrawal, A; Gupta, T; Jalali, R; Moiyadi, A; Purandare, NC; Puranik, A; Rangarajan, V; Shah, S; Shetty, P; Shridhar, E | 1 |
| Hou, S; Jiao, B; Lin, C; Sa, R; Xu, S; Zhao, H | 1 |
| Beattie, B; Blanc-Autran, E; Fine, SW; Fox, JJ; Gavane, SC; Gönen, M; Humm, JL; Larson, SM; Lewis, JS; Morris, MJ; Nehmeh, S; Osborne, JR; Sawyers, CL; Scher, HI; Schöder, H; Solomon, SB; Vargas, HA; Veach, D; Weber, WA | 1 |
| Betancourt Cuellar, SL; Carter, BW; Correa, AM; Hofstetter, WL; Marom, EM; Palacio, DP; Wu, CC | 1 |
| Ege Aktas, G; Sarikaya, A; Taştekin, E | 1 |
| Asamoah, P; Gross, M; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
| Court, LE; Fried, DV; Gomez, DR; Jensen, GL; Mackin, DS; Yost, CM; Zhou, S | 1 |
| Apter, S; Ben-Haim, S; Davidson, T; Felder, S; Komisar, O; Korach, J; Perri, T | 1 |
| Eshghi, N; Kuo, PH; Lundeen, TF | 1 |
| Amano, K; Fukuchi, M; Ishida, H; Ishiguro, T; Ito, T; Kumakura, M; Mochiki, E; Muta, Y; Ogura, T; Yamamoto, A | 1 |
| Sharma, P | 1 |
| Cha, J; Cho, YU; Kim, D; Kim, HJ; Kim, MJ; Park, HS; Yun, M | 1 |
| Fukuda, A; Kimura, T; Matsumura, T; Nagao, M; Seno, H | 1 |
| Bradbury, P; Cho, J; de Perrot, M; Elliott, HS; Hussey, D; Metser, U; Noam, T; Veit-Haibach, P | 1 |
| Buchpiguel, CA; de Carvalho, JWA; Duarte, PS; Marin, JFG; Sapienza, MT | 1 |
| Beatty, GL; Chen, F; Gladney, WL; June, CH; Kulikovskaya, IM; Lacey, SF; Levine, BL; McGarvey, M; Melenhorst, JJ; Nazimuddin, F; Nelson, AM; O'Hara, MH; Plesa, G; Soulen, MC; Torigian, DA | 1 |
| Attinà, G; Giordano, A; Lanni, V; Librizzi, A; Mastrangelo, S; Maurizi, P; Riccardi, R; Ruggiero, A | 1 |
| Antunovic, L; Chiti, A; Cozzi, L; Fogliata, A; Kirienko, M; Rossi, A; Sollini, M; Voulaz, E | 1 |
| Liang, X; Liu, Y; Ran, P; Tang, M; Xu, C; Zhu, Y | 1 |
| Allkemper, T; Auf der Springe, K; Huss, S; Noto, B; Stegger, L | 1 |
| Bronsert, P; Reichel, K; Ruf, J | 1 |
| Anconina, R; Ezroh Kazap, D; Hod, N; Lantsberg, S; Levin, D; Shaco-Levy, R | 1 |
| Laila, H; Leila, A; Mohamed, R; Mustapha, E; Soumia, F | 1 |
| Alavi, A; Baun, C; Falch, K; Gerke, O; Hansen, J; Hildebrandt, MG; Høilund-Carlsen, PF; Nguyen, T | 1 |
| Cho, YS; Kim, BT; Lee, KH; Moon, SH; Park, JM; Park, SB; Sun, JM | 1 |
| Chin, AL; Diehn, M; Gensheimer, MF; Guo, HH; Kumar, KA; Loo, BW; Maxim, PG; Neal, JW; Wakelee, H | 1 |
| Fan, W; He, Q; Zhang, L; Zhang, R; Zhang, X | 1 |
| Besutti, G; Cecinato, P; Coiro, S; Di Grezia, G; Falco, G; Ferrari, G; Gatta, G; Mele, S; Vacondio, R; Zizzo, M | 1 |
| Abadi-Korek, I; Bernstine, H; Domachevsky, L; Goldberg, N; Groshar, D; Guindy, M; Nidam, M; Sosna, J; Stein, D | 1 |
| Goel, R; Mahajan, S; Riedl, C; Ulaner, GA | 1 |
| Diaz-Bode, A; Kuker, R; Manov, JJ | 1 |
| Koizumi, M; Koyama, M; Sato, Y; Tanaka, H; Terauchi, T | 1 |
| de Keizer, B; Goense, L; Kroese, TE; Mook, S; Ruurda, JP; van Hillegersberg, R; van Rossum, PSN | 1 |
| Abgral, R; Crouzeix, G; Descourt, R; Salaun, PY; Thuillier, P | 1 |
| Berriolo-Riedinger, A; Bertaut, A; Brunotte, F; Cochet, A; Depardon, E; Dygai-Cochet, I; Fumoleau, P; Humbert, O; Kanoun, S; Lasserre, M; Riedinger, JM; Tal, I; Toubeau, M; Vrigneaud, JM | 1 |
| Avram, AM; Beesley, LJ; Bellile, EL; Manohar, PM; Worden, FP | 1 |
| Adkins, DR; Chin, RI; Dehdashti, F; DeWees, TA; Floberg, JM; Garsa, AA; Gay, HA; Nussenbaum, B; Oppelt, PJ; Thorstad, WL | 1 |
| Attal, M; Bailly, C; Bodet-Milin, C; Caillot, D; Carlier, T; Eugene, T; Facon, T; Garderet, L; Hulin, C; Jamet, B; Kraeber-Bodéré, F; Leleu, X; Macro, M; Moreau, P; Perrot, A; Touzeau, C | 1 |
| Boellaard, R; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Vacher, YJL; van Helden, EJ; van Velden, FHP; van Wieringen, WN; Verheul, HMW | 1 |
| Borm, KJ; Combs, SE; Duma, MN; Düsberg, M; Oechsner, M; Vag, T; Voppichler, J; Weber, W | 1 |
| Fraum, TJ; Hope, TA; Ippolito, JE; Kim, EH; Ludwig, DR; Schroeder, P | 1 |
| Chen, G; Liao, JQ; Liu, ET; Wang, SX; Wang, SY; Xie, L | 1 |
| Basu, S; Parghane, R | 1 |
| Li, Q; Li, Y; Liao, S; Liao, X; Liu, Z; Wei, C; Wei, J; Zhong, J | 1 |
| Han, S; Lee, JJ; Suh, CH; Woo, S | 1 |
| Guermazi, A; Jamar, F; Lecouvet, FE; Lhommel, R; Pasoglou, VP; Van Nieuwenhove, S | 1 |
| Bignardi, S; Comelli, A; Ippolito, M; Petrucci, G; Russo, G; Sabini, MG; Stefano, A; Yezzi, A | 1 |
| Chen, C; Cui, F; Su, M; Tian, R | 1 |
| Choudhury, PS; Gupta, M | 1 |
| Gong, C; Li, Y; Liu, C; Wang, B; Wu, B; Xie, Y; Yang, Z; Zhang, Y; Zhao, Y | 1 |
| Chang, JH; Keam, B; Kim, DW; Kim, E; Kim, HJ; Kim, TM; Paeng, JC; Wu, HG | 1 |
| Ankrah, AO; Kaoma, CA; Lawal, IO; Maes, A; Mokgoro, NP; Mokoala, KMG; Popoola, GO; Sathekge, MM; Van de Wiele, C | 1 |
| Axelrod, D; Kim, E; Melsaether, AN; Pujara, AC | 1 |
| Acar, E; Kaya, GÇ | 1 |
| Cao, L; Chen, F; Li, S; Lin, S; Yang, F | 1 |
| Tamam, C; Tamam, M | 1 |
| Gross, MD; Singh, H; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
| Liu, Y | 3 |
| Dimitrakopoulou-Strauss, A; Hassel, JC; Kopp-Schneider, A; Larribère, L; Sachpekidis, C | 1 |
| Cortés-Romera, M; Cos-Domingo, M; Gámez Cenzano, C; Moreno-Llorente, P; Pérez-Maraver, M; Reynés-Llompart, G; Rodríguez-Bel, L; Rossi-Seoane, S; Sabaté-Llobera, A; Vercher Conejero, JL | 1 |
| Hwang, HK; Kang, CM; Lee, SH; Lee, WJ; Yun, M | 1 |
| Chen, S; Cheng, KC; Ho, CL; Leung, YL; Wong, YH | 1 |
| Huang, D; Ou, X; Ye, Y; Zhang, W | 1 |
| Cheng, MF; Ho, BY; Hsin, LW; Huang, YY; Jeng, YM; Kuo, HC; Kuo, TC; Shiue, CY; Tien, YW; Yen, RF | 1 |
| Calcagni, ML; Cardillo, G; Carleo, F; De Massimi, AR; Di Martino, M; Ricciardi, S; Scolozzi, V; Taralli, S; Triumbari, EK | 1 |
| Bantilan, K; Horwitz, SM; Ito, K; Mehta-Shah, N; Moskowitz, AJ; Sauter, C; Schöder, H | 1 |
| Doroudinia, A; Dorudinia, A; Kaghazchi, F; Mehrian, P | 1 |
| Chen, X; Fu, Z; Li, Q; Yang, X | 1 |
| Byun, JH; Choi, SH; Hong, SB; Kim, KW; Kim, SY; Lee, MG; Lee, SJ; Lee, SS; Park, SH | 1 |
| Chantalat, E; Courbon, F; Ducassou, A; Ferron, G; Gabiache, E; Lusque, A; Martinez, A; Motton, S; Querleu, D; Voglimacci, M | 1 |
| Dehdashti, F; Grigsby, P; Lin, A; Ma, S; Markovina, S; Powell, M; Schwarz, J; Siegel, B | 1 |
| Bates, BM; Beck, S; Bell, AH; Bowtell, DD; Browning, J; Byrne, DJ; Choong, DY; Desai, J; Etemadmoghadam, D; Fellowes, AP; Fox, SB; Iravani, A; Khoo, C; McEvoy, CR; Mileshkin, L; Nastevski, V; Prall, OW; San Leong, H; Smith, K; Tothill, RW; Xu, H | 1 |
| Bone, TM; Byrd, JK; Groves, MW; Leto, CJ; Liebman, RM; Sharbel, D; Wang, CW | 1 |
| Arslan, M; Dag, Y; Simsek, FS | 1 |
| Ankrah, AO; Janse van Rensburg, C; Lawal, IO; Lengana, T; Popoola, GO; Reyneke, F; Sathekge, MM | 1 |
| Kairemo, K; Subbiah, V; Wang, WL | 1 |
| Cheng, Z; Song, S; Zhu, X; Zou, S | 1 |
| Dick, J; Dimitrakopoulou-Strauss, A; Enk, AH; Hassel, JC; Lang, N; Sachpekidis, C; Schulz, C; Slynko, A | 1 |
| Cao, Z; Chen, L; Fan, F; Gao, S; Li, D; Li, H; Li, Q; Liu, S; Ma, J; Wang, X; Wang, Y; Xu, W; Yan, T; Yang, H; Yu, Y; Yue, Y; Zhang, Y; Zhao, H; Zhao, Z | 1 |
| Asmussen, JT; Bjørndal, K; Diaz, A; Eriksen, JG; Gerke, O; Godballe, C; Høilund-Carlsen, PF; Larsen, SR; Nguyen, N; Nielsen, AL; Nielsen, MK; Rohde, M; Thomassen, A; Westergaard-Nielsen, M | 1 |
| Abgral, R; Amrane, K; Metges, JP; Ollivier, L; Salaun, PY | 1 |
| Ali, Z; Koppula, V; Mandava, A; Yalamanchili, R | 1 |
| Bang, JI; Chung, JK; Kang, KW; Kang, SY; Lee, HY | 1 |
| Choi, HJ; Chun, YJ; Jeon, TJ; Jeung, HC; Lee, JH; Park, HS; Park, JS; Rha, SY | 1 |
| Ammari, S; Barker, L; Bigorgne, AE; Dercle, L; Deutsch, E; Finkel, G; Gartrell, RD; Marabelle, A; Mokrane, FZ; Moya-Plana, A; Nemer, JS; Robert, C; Saenger, Y; Schwartz, LH; Seban, RD; Yeh, R | 1 |
| Gambhir, S; Ora, M; Parashar, A; Rangan B K, K; Suraj, AS | 1 |
| Bosco, A; Dhiantravan, N; Hovey, E; Wegner, EA | 1 |
| Khoo, ACH; Yeoh, KW | 1 |
| Aliyev, A; Asa, S; Halac, M; Ozhan, M; Ylmaz, S | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| di Lenardo, F; Epstude, M; Hug, U; Riklin, C; Strobel, K; Tornquist, K; Winterhalder, R | 1 |
| Ceriani, L; Foppiani, L; Giovanella, L; Piccardo, A; Treglia, G; Trimboli, P; Verburg, FA | 1 |
| Abe, S; Ikeda, M; Itoh, S; Iwano, S; Kato, K; Naganawa, S; Nihashi, T; Shimamoto, K | 1 |
| Giaccari, A; Petrone, G; Rindi, G; Rufini, V; Salomone, E; Treglia, G | 1 |
| Bhattacharya, A; Manohar, K; Mittal, BR | 1 |
| Meinel, FG; Morelli, JN; Reiser, MF; Rist, C; Rominger, A; Schmid-Tannwald, C; Schmidt, C; Schramm, N | 1 |
| Halac, M; Kabasakal, L; Kanmaz, B; Maecke, H; Önsel, Ç; Sager, S; Uslu, L | 1 |
| Bhattacharya, A; Bhoil, A; Manohar, K; Mittal, BR; Singh, G | 1 |
| Hong, S; Li, J; Wang, S | 1 |
| Berney, D; Bex, A; Blank, C; Boleti, E; Chowdhury, S; Haanen, J; Jones, R; Kayani, I; Lim, L; Peters, J; Powles, T; Reynolds, AR; Sahdev, A; Shamash, J; Sharpe, K; Stewart, GD | 1 |
| Arcaini, L; Biasoli, I; Boccomini, C; Carella, AM; D'Arco, AM; Di Raimondo, F; Federico, M; Ferreri, AJ; Gaidano, G; Gallamini, A; Luminari, S; Mastronardi, S; Merli, F; Musto, P; Rusconi, C; Santoro, A; Spina, M; Versari, A; Zinzani, PL | 1 |
| Bishop, WD; Bonyadlou, S; Henderson, R; Kim, A; Sheth, S | 1 |
| Ali, Z; Aurangabadkar, H | 1 |
| Guo, W; Hu, S; Li, J; Wang, C; Yao, Z; Zhang, Y; Zhou, M | 1 |
| Bagrosky, BM; Gonzalez, R; Klingensmith, WC; Koo, PJ; Lewis, KD | 1 |
| Kong, F; Li, J; Sun, X; Xu, W; Zuo, X | 1 |
| Bjerkehagen, B; Bruland, OS; Hole, KH; Julsrud, L; Reitan, E; Revheim, ME; Seierstad, T | 1 |
| Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI | 1 |
| Fu, L; Fu, Z; Han, DL; Kong, L; Li, J; Yu, JM; Yu, YH; Zhang, Y; Zhu, SH | 1 |
| Califano, I; Califano, L; Coduti, M; Otero, J; Quildrian, S; Rojas Bilbao, E | 1 |
| Cao, KJ; Cao, Y; Chen, MY; Chen, QY; Fan, W; Guo, L; Guo, X; Hua, YJ; Huang, PY; Li, J; Lin, XP; Liu, H; Liu, LZ; Luo, DH; Lv, X; Mai, HQ; Mo, HY; Mo, YX; Qian, CN; Qiu, F; Sun, R; Tang, LQ; Wang, L; Xiang, YQ; Zeng, MS; Zhang, L; Zhang, X; Zhao, C; Zou, RH | 1 |
| Shim, KN; Yun, HW | 1 |
| Gao, G; Gong, B; Shen, W | 1 |
| Huang, D; Li, B; Wang, H; Xu, H; Yao, Y; Yu, W; Zhao, X | 1 |
| Fan, Q; Graves, E; Loo, B; Mazin, S; Nanduri, A; Yamamoto, T; Yang, J; Zhu, L | 1 |
| Amant, F; Berteloot, P; Dauwen, H; Deroose, CM; Leunen, K; Neven, P; Op de Beeck, K; Timmerman, D; Van Calster, B; Vergote, I | 1 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Embry, S; Hudson, K; Warren, LA | 1 |
| Bourgeois, AC; Bradley, YC; Chang, TT; Fish, LM | 1 |
| Brunetti, J | 1 |
| Fan, W; Li, J; Wang, GH; Zhang, WD; Zhang, WG | 1 |
| Bonichon, F; Cazeau, AL; de Baère, T; Descat, E; Devillers, A; Galy-Lacour, C; Godbert, Y; Lagoarde-Segot, L; Leboulleux, S; Meunier, C; Palussière, J; Pulido, M | 1 |
| Bruno, A; Cavalleri, L; Chinaglia, D; Collini, P; Conter, V; Foglia, C; Giraldi, E; Provenzi, M; Saettini, F; Spreafico, F; Vai, P | 1 |
| Tateishi, U | 1 |
| Kang, HG; Kim, HS; Kim, JH; Kim, SK; Kim, YI | 1 |
| Bhethanabhotla, S; Durgapal, P; Gajendra, S; Gogia, A; Gupta, R; Sahoo, MK; Tanwar, P | 1 |
| Crivellaro, C; Cuzzocrea, M; Dell'Anna, T; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Milani, R; Signorelli, M; Sina, F | 1 |
| August, CZ; Calata, JF; Maker, AV; Sukerkar, AN | 1 |
| Asa, S; Halaç, M; Kabasakal, L; Kanmaz, B; Maecke, H; Ocak, M; Önsel, Ç; Sager, G; Sager, S; Uslu, L | 1 |
| Arana Yi, C; Axelrod, R; Machtay, M; McCue, P; Morris, GJ; Rosen, M | 1 |
| Chen, L; Li, F; Liu, Y; Niu, N | 1 |
| Appelbaum, DE; Chen, JL; Cowey, CL; Kocherginsky, M; McDermott, DF; Rathmell, WK; Stadler, WM | 1 |
| Aldrich, J; Baker, A; Benson, H; Carpten, JD; Christoforides, A; Craig, DW; Demeure, MJ; Hostetter, G; Izatt, T; Kiefer, JA; Kurdoglu, A; Liang, WS; Marsh, V; Phillips, L; Reiman, R; Sinari, S; Von Hoff, DD; Weiss, GJ | 1 |
| Chung, SK; Chung, YA; Jeon, HM; Kim, SH; Kim, YS; Oh, JK; Park, YH | 1 |
| Bal, C; Gupta, SK; Karunanithi, S; Kumar, R; Lata, S; Malhotra, A; Naswa, N; Patnecha, M; Reddy, RM; Sharma, P | 1 |
| Erba, PA; Iung, B; Lazzeri, E; Petrosillo, N | 1 |
| Baulieu, F; Benbouzid, F; Cachin, F; Cammilleri, S; Chezal, JM; D'Incan, M; Degoul, F; Gachon, F; Gaudy, C; Gillet, B; Granel-Brocard, F; Grange, JD; Isnardi, V; Kelly, A; Labeille, B; Lacour, JP; Merlin, C; Mestas, D; Meyer, N; Miot-Noirault, E; Payoux, P; Razzouk-Cadet, M; Tychyj, C | 1 |
| Berthelsen, AK; Binderup, T; Brinch, K; Brünner, N; Engelmann, BE; Gerds, TA; Højgaard, L; Høyer-Hansen, G; Kjær, A; Kristensen, MH; Kurt, EY; Latocha, JE; Lindblom, G; Loft, A; Nielsen, HJ; Sloth, C | 1 |
| Chong, S; Coupe, NA; Karikios, D; Lin, M; Merrett, N; Ng, W; Yap, J | 1 |
| Chu, YK; Li, WY; Yang, RH | 1 |
| Beer, AJ; Eiber, M; Fürst, S; Gaertner, FC; Loeffelbein, DJ; Mayerhoefer, ME; Rummeny, EJ; Schwaiger, M; Souvatzoglou, M; Takei, T; Ziegler, SI | 1 |
| Chang, ZH; Guo, QY; Han, CB; Liu, ZY; Lu, ZM; Ma, JT; Zheng, JH | 1 |
| Honda, H; Kamada, T; Shinoto, M; Shioyama, Y; Tsujii, H; Yamada, S; Yasuda, S; Yoshikawa, K | 1 |
| Gao, S; Li, S; Tang, Q; Yang, X | 1 |
| Fukuda, M; Keino, D; Kinoshita, A; Kitagawa, H; Kondoh, K; Morimoto, M; Murata, S; Muto, S; Ohyama, R; Wakisaka, M | 1 |
| Domenech, A; Escalera, S; Sampedro, F | 1 |
| Balm, AJ; Hamming-Vrieze, O; Lange, CA; Lodder, WL; Pameijer, FA; Van Den Brekel, MW; Van Velthuysen, ML; Vogel, WV | 1 |
| De Carolis, V; Evangelista, L; Geuna, E; Ghiotto, C; Racca, M; Redana, S; Saladini, G; Varetto, T; Vinante, L; Zago, G | 1 |
| Benzon, EV; Brünner, N; Christensen, IJ; Engelmann, BE; Gerds, TA; Hansson, SH; Holländer, NH; Højgaard, L; Kjær, A; Kristensen, MH; Löfgren, J; Loft, A; Markova, E; Nielsen, HJ; Sloth, C | 1 |
| Koizumi, M; Koyama, M | 1 |
| Hwang, JY; Jolepalem, P; Wong, CY | 1 |
| Cho, KJ; Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Park, JP; Roh, JL | 1 |
| Schlemmer, HP; Stieltjes, B; Wilhelm, T | 1 |
| Chen, YR; Hsieh, TC; Kao, CH; Yen, KY | 1 |
| Avery, RJ; Davis, MA; Gimber, LH; Scalcione, LR; Taljanovic, MS; Thompson, RB | 1 |
| Bansal, P; Behera, D; Gupta, A; Gupta, N; Maturu, VN; Rai Mittal, B; Singh, N | 1 |
| Badawi, RD; Cherry, SR; Jones, T; Price, PM | 1 |
| Baas, IO; Bulten, BF; de Haas, MJ; de Klerk, JM; Rodenburg, CJ; van Ooijen, B | 1 |
| Gallivanone, F; Gastiglioni, I; Gilardi, MC; Messa, C; Stefano, A | 1 |
| Li, F; Li, L; Li, Y; Su, M; Tian, R | 1 |
| Baltazart, B; Castetbon, V; de Monès, E; Digue, L; Fernandez, P | 1 |
| Choi, JM; Choi, YH; Han, YM; Jang, DK; Kim, JW; Lee, M; Lee, SA; Moon, HR; Oh, S; Yeum, TS | 1 |
| Cervino, AR; Evangelista, L | 1 |
| Li, S; Li, W; Sun, L; Sun, X; Xing, L; Zhang, X; Zhao, F | 1 |
| Bagni, O; Ciorra, A; Filippi, L; Sardella, B; Scopinaro, F | 1 |
| Agrawal, K; Mohan, HK; Weaver, J | 1 |
| Adler, L; Biersack, HJ; Ezziddin, S; Fischer, HP; Grabellus, F; Höller, T; Nagarajah, J; Pöppel, TD; Sabet, A; Simon, B; Yüce, A | 1 |
| Hayashi, N; Ikeda, I; Inoue, T; Kakizoe, M; Kishida, T; Kobayashi, K; Kubota, Y; Makiyama, K; Minamimoto, R; Morita, S; Nakaigawa, N; Namura, K; Noguchi, S; Ohgo, Y; Sano, F; Taguri, M; Tateishi, U; Ueno, D; Yao, M | 1 |
| Jain, S; Karunanithi, S; Kumar, R; Sharma, P; Singla, S | 1 |
| Blomqvist, LK; Farnebo, J; Grybäck, P; Harmenberg, U; Laurell, A; Sandström, P; Ullén, A; Wersäll, P | 1 |
| Beiderwellen, K; Grueneisen, J; Heusch, P; Huebner, M; Kuehl, H; Lauenstein, TC; Nensa, F; Rosenbaum-Krumme, S; Ruhlmann, V; Umutlu, L | 1 |
| Feng, B; Fu, Z; Hu, M; Kong, L; Yu, JM; Zhang, GL; Zhang, XL; Zhang, Y; Zhao, F | 1 |
| Allendorf, JD; Chabot, JA; Einersen, P; Epelboym, I; Leung, D; Winner, MD | 1 |
| Bowyer, SE; Hicks, RJ; Long, GV; Lyle, M; McArthur, GA; Millward, M; Raleigh, JM; Rao, AD; Sandhu, S | 1 |
| Hendel, HW; Høgdall, EV; Jensen, BV; Johannesen, HH; Nielsen, D; Schou, JV; Skougaard, K | 1 |
| Beck, T; Grosu, AL; Jilg, CA; Meyer, PT; Rischke, HC; Schultze-Seemann, W; Vach, W; Wieser, G | 1 |
| Bousquet, G; Espié, M; Groheux, D; Hindié, E; Marty, M; Merlet, P; Misset, JL; Ohnona, J; Rubello, D; Toubert, ME; Vercellino, L | 1 |
| Amini, B; Jorgensen, JL; Kumar, R; Salem, U; Zhang, L | 1 |
| Clark, AS; Lynch, MC; Mankoff, D; McDonald, E | 1 |
| Chang, JS; Cho, A; Choi, SH; Kim, KH; Lee, JD; Lee, Y; Park, JY; Seong, J; Song, SY; Yun, M | 1 |
| Dostbil, Z; Inal, A; Simsek, FS; Tasdemir, B; Unal, K; Yildirim, S | 1 |
| Ichikawa, T; Nambu, A; Onishi, H; Satoh, Y | 1 |
| Hu, C; Shi, Q; Yang, Z; Zhang, Y | 1 |
| Liang, S; Ma, C; Wang, H; Zhang, L | 1 |
| Kowalska, A; Lesiak, J; Młynarczyk, J; Trybek, T | 1 |
| Jain, TK; Karunanithi, S; Kumar, R; Sharma, P; Vijay, MK | 1 |
| Guo, M; Hu, S; Huang, D; Jin, K; Liu, C; Liu, L; Liu, Z; Long, J; Luo, G; Ni, Q; Xiao, Z; Xu, J; Yu, X; Zhang, B | 1 |
| Aleman, BM; Boot, H; Sanders, J; Stiekema, J; van Sandick, JW; Vegt, E; Vermeulen, D; Voncken, FE | 1 |
| Choi, YY; Kim, JY; Lee, S; Paik, SS; Park, J | 1 |
| Gambhir, SS; Iagaru, A; Lutz, AM; Mittra, ES; Mosci, C; Sampath, SC; Willmann, JK | 1 |
| Machida, Y; Maeda, S; Matoba, M; Motomo, N; Sagawa, M; Sakuma, T; Tanaka, M; Tonami, H; Ueda, Y; Ueno, M; Usuda, K | 1 |
| Lam, MGEH; Lips, IM; Meijer, GJ; Reerink, O; Ruurda, JP; van Hillegersberg, R; van Lier, ALHMW; van Rossum, PSN; van Vulpen, M | 1 |
| Abhyankar, A; Basu, S | 1 |
| Goldman, DA; Gonen, M; Jochelson, M; Morrow, M; Riedl, CC; Slobod, E; Ulaner, GA; Weber, WA | 1 |
| Berry, MF; D'Amico, TA; Englum, BR; Erhunmwunsee, L; Onaitis, MW | 1 |
| Bahri, H; Boucher, E; Clement, B; Cuggia, M; Devillers, A; Edeline, J; Garin, E; Laurence, L; Leghzali, H; Mesbah, H; Raoul, JL | 1 |
| Adalet, I; Aykan, F; Has Simsek, D; Kuyumcu, S; Sanlı, Y; Turkmen, C; Unal, S | 1 |
| Beheshti, M; Dinkelborg, L; Haim, S; Kunit, T; Langsteger, W; Loidl, W; Schiller, C; Stephens, A; Zakavi, R | 1 |
| Deng, H; Jia, Z; Li, J; Shen, G; Wang, Q; Zhang, W | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Hassel, JC; Larribere, L; Pan, L; Sachpekidis, C | 1 |
| Bang, YJ; Cho, BC; Chung, JS; Han, JY; Kang, JH; Kim, DW; Kim, H; Kim, MJ; Kwon, JH; Oh, DY; Park, KU; Shin, SH | 1 |
| David, O; Lu, Y; Zivin, S | 1 |
| Adalet, I; Aral, F; Gecer, MF; Kuyumcu, S; Ozel, S; Ozkan, ZG; Uzum, AK | 1 |
| Calais, J; Castier, Y; De Kerviler, E; Lussato, D; Menard, J; Merlet, P; Mongiat-Artus, P | 1 |
| Miwa, K | 1 |
| de Roquancourt, A; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hamy, AS; Hindié, E; Merlet, P | 1 |
| Albers, P; Decoene, J; Winter, C | 1 |
| Flamen, P | 1 |
| Choi, M; Heilbrun, LK; Kollepara, SL; Philip, PA; Shields, AF; Smith, D | 1 |
| Bruder, O; Heusch, P; Jensen, CJ; Köhler, J; Nassenstein, K; Nensa, F; Poeppel, TD; Schelhorn, J; Schlosser, T; Tezgah, E | 1 |
| Daldrup-Link, HE; Donig, J; Link, M; Quon, A; Rosenberg, J; Uslu, L | 1 |
| Calais, J; Dubray, B; Gardin, I; Modzelewski, R; Thiberville, L; Thureau, S; Vera, P | 1 |
| Duan, F; Hanna, L; Hillner, BE; Quinn, B; Shields, AF; Siegel, BA | 1 |
| Koizumi, M; Koyama, M; Takahashi, S; Takeshima, N; Umayahara, K | 1 |
| Liu, FY; Wang, JY; Yang, TS; Yen, TC | 1 |
| Doss, M; Edwards, KW; Hayes, SB; Huang, M; Walia, R; Yu, JQ | 1 |
| Bai, X; Codreanu, I; Kaplan, SL; Servaes, S; Zhuang, H | 1 |
| Li, ZG; Qin, XJ | 1 |
| Almquist, H; Bläckberg, M; Cronberg, C; Garpered, S; Gudjonsson, S; Kleist, J; Kollberg, P; Liedberg, F; Lyttkens, K; Patschan, O | 1 |
| Asman, Y; Even-Sapir, E; Evenson, AR; Shibolet, O | 1 |
| Makis, W; McCann, K; McEwan, AJ | 1 |
| Brade, J; Buesing, KA; Kaiser, CG; Krammer, J; Schnitzer, A; Schoenberg, SO; Sperk, E; Suetterlin, M; Sutton, EJ; Wasgindt, S; Wasser, K | 1 |
| Adams, HJ; de Klerk, JM; Dubois, SV; Fijnheer, R; Kwee, TC; Nievelstein, RA | 1 |
| Herrmann, K; Lordick, F; Ott, K; Schmidt, T | 1 |
| Aogi, K; Kadoya, T; Kiyoto, S; Masumoto, N; Okada, M; Shigematsu, H; Sugawara, Y | 1 |
| Aldred, VL; Buccheri, V; Cerci, JJ; de Paula, HM; Gonçalves, Mde C; Linardi, Cda C; Siqueira, SA; Zerbini, MC | 1 |
| Kawai, K; Kobayashi, M; Kusanagi, K; Mizutani, A; Nakajima, S; Ogura, M; Okui, Y; Sagara, J; Shikano, N; Yamaguchi, N | 1 |
| Boellaard, R; de Bree, R; Hoekstra, OS; Leemans, CR; Meeuwis, J; Witte, BI | 1 |
| Cahen-Doidy, L; Delaloge, S; Espié, M; Giacchetti, S; Groheux, D; Nikpayam, M; Rivera, S; Uzan, C | 1 |
| Chacón, M; Eleta, M; Espindola, AR; Méndez, G; Pupareli, C; Roca, E; Rojo, S | 1 |
| Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T | 1 |
| Peller, PJ | 1 |
| Rohren, EM | 1 |
| Ciarallo, A; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Duman, G; Güner, A; Karyağar, S; Kece, C; Kesici, U; Küçütulu, U | 1 |
| Matsusaka, Y; Murakami, K | 1 |
| Amer, S; Dong, Y; Hou, H; Li, J; Tian, M; Wang, C; Yao, Q | 1 |
| Ahn, JS; Bom, HS; Byun, BH; Chae, YS; Do, YR; Jung, SH; Kim, HJ; Kim, YK; Kweon, SS; Lee, JJ; Lee, SW; Min, JJ; Moon, JH; Sohn, SK; Yang, DH | 1 |
| Buskens, E; de Bock, GH; de Vries, EF; de Vries, EG; Feenstra, T; Glaudemans, AW; Greuter, MJ; Hospers, GA; Koleva-Kolarova, RG; van Kruchten, M; Vermeulen, KM | 1 |
| Bruna-Muraille, C; Dabakuyo-Yonli, TS; Dalac, A; Dalban, C; Fieffe, S; Guendouzen, S; Masson-Deshayes, S; Papathanassiou, D; Pochart, JM; Schvartz, C | 1 |
| Ozturk, H | 2 |
| Han, EJ; Kim, SH; O, JH; Park, HL; Yoo, IeR | 1 |
| Ahn, SJ; Marashdeh, W; Marcus, C; Subramaniam, RM; Taghipour, M | 1 |
| Chen, S; Dong, Y; Ma, C; Wang, S; Zhang, X | 1 |
| Altini, C; Di Palo, A; Fanelli, M; Ferrari, C; Moschetta, M; Niccoli Asabella, A; Rubini, G | 1 |
| Freiwald-Chilla, B; Froehlich, JM; Hauser, N; Kubik-Huch, RA; Queiroz, MA; Veit-Haibach, P; von Schulthess, G | 1 |
| d'Amico, A; Grabinska, K; Pelak, M; Tukiendorf, A; Wydmanski, J | 1 |
| Fujii, Y; Fukui, I; Kihara, K; Kohno, A; Koizumi, M; Komai, Y; Masuda, H; Sakai, Y; Tanaka, H; Urakami, S; Yamamoto, S; Yonese, J; Yoshida, S; Yuasa, T | 1 |
| Biermann, M; Bjørge, L; Haldorsen, IS; Husby, JA; Magnussen, IJ; Reitan, BC; Salvesen, HB; Salvesen, ØO; Trovik, J | 1 |
| Basu, S; Kand, P; Ranade, R | 1 |
| Hess, S; Høilund-Carlsen, PF; Lund, L; Petersen, H; Poulsen, MH | 1 |
| Hodul, P; Kim, J; Kim, R; Kothari, N; Mahipal, A; Malafa, M; Morse, B; Prithviraj, G; Springett, G; Yue, B | 1 |
| Cui, XJ; Fang, N; Wang, YL; Wu, ZJ; Zeng, L | 1 |
| Biswal, S; Gambhir, SS; Ganjoo, K; Iagaru, A; Jackson, T; Mittra, E; Mosci, C; von Eyben, R | 1 |
| Bivalacqua, TJ; Blackford, A; Carter, HB; Cho, SY; Cornish, TC; Dannals, RF; Faraj, SF; Gage, KL; Gonzalez-Roibon, N; Guner, G; Han, M; Holt, D; Lodge, MA; Macura, KJ; Mease, RC; Munari, E; Netto, GJ; Partin, AW; Pavlovich, CP; Pomper, MG; Rowe, SP | 1 |
| Baumann, M; Bütof, R; Hofheinz, F; Jentsch, C; Kotzerke, J; Löck, S; Schmollack, J; Stadelmann, T; van den Hoff, J; Zöphel, K | 1 |
| Hickeson, M; Lisbona, R; Malibari, N | 1 |
| Alabed, YZ; Sakellis, C | 1 |
| Bacanovic, S; Burger, IA; Hafner, J; Huellner, MW; Stolzmann, P | 1 |
| Arteaga, CL; Barry, WT; Dees, EC; Falkson, CI; Guo, H; Hobday, TJ; Krop, IE; Lin, NU; Mayer, IA; Najita, JS; Nanda, R; Richardson, AL; Rimawi, MF; Ryabin, N; Van den Abbeele, AD; Winer, EP; Wolff, AC; Yap, JT | 1 |
| Chen, X; Mi, B; Niu, G; Pan, D; Wan, W; Yang, M; Yu, C | 1 |
| Ahn, BC; Chae, YS; Jeong, SY; Lee, J; Lee, SW; Son, SH; Song, BI | 1 |
| Brendle, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Rempp, H; Schmidt, H; Schraml, C; Schwenzer, NF | 1 |
| Bassa, P; García Garzon, JR; Llinares, E; Moragas, M; Riera, E; Soler, M | 1 |
| Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
| Hong, SH; Jang, HS; Kang, JH; Kim, SJ; Kim, YK; Kim, YS; Lee, DS; Lee, KY; Na, SJ; Park, KR; Yoo, IR | 1 |
| Ishihara, Y; Matsuki, T; Miura, K; Miura, N; Miyoshi, F; Ogawa, T; Ping, B; Shinohara, Y; Shiota, G; Tanabe, Y; Tanaka, N; Tsuno, S; Wang, X; Yamashita, T | 1 |
| Dashevsky, B; Goldman, DA; Gönen, M; Hogan, MP; Hudis, C; Jochelson, M; Morrow, M; Osborne, JR; Riedl, CC; Ulaner, GA | 1 |
| Carvalho, DP; Vaisman, F; Vaisman, M | 1 |
| Al Tamimi, AS; Ng, DC; Osmany, S; Zaheer, S | 1 |
| Basu, S; Goliwale, F | 1 |
| Jeraj, R; Liu, G; Perlman, S; Simoncic, U | 1 |
| Alongi, P; Caobelli, F; Castello, A; Cocciolillo, F; Crivellaro, C; De Biasi, V; Dolci, C; Evangelista, L; Geatti, O; Kirienko, M; Laghai, I; Picchio, M; Popescu, CE; Quartuccio, N; Rensi, M; Saladini, G; Seghezzi, S | 1 |
| Eigentler, TK; Garbe, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Schüle, SC | 1 |
| Allaf, ME; Gorin, MA; Hammers, HJ; Javadi, MS; Pomper, MG; Rowe, SP | 1 |
| Amaria, RN; Bagrosky, BM; Glueck, DH; Gonzalez, R; Koo, PJ; Kreidler, SM; Kwak, JJ; Lewis, K; Schmitt, RJ | 1 |
| Broski, SM; Glazebrook, KN; Moran, EK; Nathan, MA | 1 |
| Agarwal Sharma, R; Khong, PL; Lee, EY; Ngu, SF; Vardhanabhuti, V | 1 |
| Cengiz, M; Halaç, M; Kemik, A; Kocael, A; Kocael, P; Şimşek, O; Sönmezoğlu, K; Ulualp, K; Vatankulu, B | 1 |
| Dimitrakopoulou-Strauss, A; Hassel, JC; Sachpekidis, C | 1 |
| Álvarez-Pérez, RM; Borrego-Dorado, I; Caballero-Gullón, L; Martínez-Esteve, A; Sancho-Márquez, MP | 1 |
| Bluemel, C; Buck, AK; Einsele, H; Hänscheid, H; Herrmann, K; Keller, U; Knop, S; Knott, M; Kropf, S; Lapa, C; Lassmann, M; Lückerath, K; Osl, T; Poschenrieder, A; Samnick, S; Schirbel, A; Schottelius, M; Schreder, M; Wester, HJ | 1 |
| Guo, W; Ji, D; Li, J; Li, W; Liu, X; Tao, Z; Wang, C; Zhang, X; Zhang, Y; Zhou, M; Zhu, X | 1 |
| Luo, QY; Qiu, ZL; Shen, CT; Song, HJ; Wei, WJ | 1 |
| Barrington, S; Bird, T; Guerrero Urbano, T; Jeannon, JP; Lei, M; Lyons, A; Oakley, R; Simo, R; Thavaraj, S | 1 |
| Kang, F; Li, G; Li, X; Liu, C; Tian, F; Wang, J; Wang, S; Wang, Z; Yang, W; Zhang, M; Zhao, M | 1 |
| Chung, YA; Eo, JS; Hong, IK; Hyun, SH; Kim, DY; Kim, SU; Kim, TS; Lee, JD; Lee, JW; Moon, DH; Na, SJ; Oh, JK; Song, BI; Yun, M | 1 |
| Camera, L; Ciarmiello, A; Colao, A; De Luca, S; Del Vecchio, S; Faggiano, A; Fonti, R; Salvatore, B; Salvatore, M; Segreto, S | 1 |
| Castelijns, JA; de Bree, R; Hoekstra, OS; Leemans, CR; Senft, A | 1 |
| Chang, J; Chang, YR; Jang, JY; Jung, W; Kang, MJ; Kim, SW; Shin, YC | 1 |
| de Geus-Oei, LF; Oyen, WJG; van der Graaf, WTA; van Erp, NP; van Herpen, CML; Vlenterie, M; Willemsen, AECAB | 1 |
| Cheong, JH; Cho, A; Chung, HC; Hyung, WJ; Jung, M; Kang, B; Kim, H; Kim, HI; Kim, HS; Lim, SM; Noh, SH; Rha, SY; Yun, M | 1 |
| Bilski, M; Duchnowska, R; Hryciuk, B; Kamiński, G; Szczylik, C; Szymanowski, B; Łapińska, G | 1 |
| Hasumi, H; Ikeda, I; Inoue, T; Kaneta, T; Kishida, T; Kobayashi, K; Kondo, K; Kubota, Y; Makiyama, K; Minamimoto, R; Nakaigawa, N; Namura, K; Tateishi, U; Ueno, D; Yao, M | 1 |
| Bradley, KM; di Carlo, S; Findlay, JM; Franklin, JM; Gillies, RS; Gleeson, FV; Jones, GE; Maynard, ND; Middleton, MR; Teoh, EJ | 1 |
| Cheon, GJ; Goo, JM; Kim, YT; Lee, SM; Paeng, JC; Park, CM; Park, YS; Yoon, SH | 1 |
| Agrawal, K; Gupta, R; Kaman, L; Kochhar, R; Mittal, BR; Singh, R; Singh, V; Verma, GR; Vineeth Kumar, PM | 1 |
| Dickler, M; Gönen, M; Jochelson, M; McArthur, H; Ong, L; Pinker, K; Riedl, CC; Ulaner, GA; Weber, WA | 1 |
| Doyle-Lindrud, S | 1 |
| Aguilera, T; Diehn, M; Gudur, M; Li, R; Loo, BW; Rubin, DL; Shultz, D; Wu, J | 1 |
| Chen, Z; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X; Zong, Z | 1 |
| Freed, M; Kim, SG; Margolis, NE; McKellop, J; Melsaether, AN; Moy, L; Sigmund, EE | 1 |
| Boellaard, R; Hoekstra, OS; Menke-van der Houven van Oordt, CW; Mulder, ER; Roth, C; van Helden, EJ; Verheul, HM | 1 |
| Corey, A; El-Deiry, MW; Galt, JR; Hudgins, PA; Kendi, AT; Magliocca, KR; Saba, NF; Schuster, DM; Switchenko, J; Wadsworth, JT | 1 |
| Abdelatif, B; Amal, G; Ghita, B; Ghofrane, CS; Majdouline, H; Malika, AI; Nabil, C; Najoua, T; Sara, T; Souha, S; Zineb, B | 1 |
| Currin, ER; Krohn, KA; Kurland, BF; Lee, JH; Linden, HM; Link, JM; Mankoff, DA; Peterson, LM; Schubert, EK | 1 |
| Danilov, AV; Friedberg, JW; Li, H; Noy, A; Press, OW; Reid, E; Shapira, I; Smith, SM; Swinnen, LJ | 1 |
| Basu, S; Parghane, RV | 1 |
| Baek, KH; Cho, JK; Choi, JY; Choi, N; Hyun, SH; Jeong, HS; Kim, MJ; Lee, SH | 1 |
| Byrtek, M; Dawson, KL; Flowers, CR; Friedberg, JW; Reid, E; Wong-Sefidan, I; Zelenetz, AD; Zhou, X | 1 |
| Hashizume, A; Kawai, M; Kishida, T; Mizuno, N | 1 |
| Acosta, O; Castelli, J; De Crevoisier, R; Devillers, A; Garin, E; Lavoue, V; Lejeune, F; Leseur, J; Ospina-Arango, JD; Roman-Jimenez, G; Terve, P; Williaume, D | 1 |
| Han, J; Qin, L; Zhang, C; Zhao, H | 1 |
| Dejust, S; Fabre, G; Morland, D; Papathanassiou, D; Prevost, A | 1 |
| Cazes, A; Combaret, V; Delattre, O; Janoueix-Lerosey, I; Montravers, F; Prignon, A; Provost, C; Talbot, JN | 1 |
| Joy, A; Nanabala, R; Sasikumar, A; Tk, P; Unni, M | 1 |
| He, F; Liu, H; Liu, T; Meng, B; Shi, X; Wang, S; Yang, H; Zhou, F | 1 |
| Baudin, E; Berdelou, A; Bidault, F; Borget, I; Deandreis, D; Dercle, L; Deschamps, F; Hartl, D; Leboulleux, S; Lumbroso, J; Ricard, M; Schlumberger, M; Terroir, M; Tselikas, L | 1 |
| Balci, D; Bilgic, S; Elhan, AH; Gecim, E; Kucuk, NO; Soydal, C | 1 |
| Alfieri, S; Barbaro, B; Bonomo, L; Coco, C; Di Matteo, M; Gambacorta, MA; Giordano, A; Leccisotti, L; Persiani, R; Poscia, A; Salsano, M; Serra, T; Valentini, V; Vecchio, FM | 1 |
| Bikas, A; Burman, KD; Desale, S; Garcia, CA; Singh, I; Wartofsky, L | 1 |
| Bang, JI; Han, SW; Jeong, SY; Kang, GH; Kim, JH; Kim, TY; Lee, KH; Lim, Y; Paeng, JC; Park, KJ | 1 |
| Chen, Y; Huang, Z; Liu, L; Zhu, Y | 1 |
| Chan, M; Schembri, GP | 1 |
| Alnaji, R; Attwood, K; Du, W; Gabriel, E; Hochwald, S; Kukar, M | 1 |
| Bärwolf, R; Freesmeyer, M; Zirnsak, M | 1 |
| Ichinose, M; Okamoto, K | 1 |
| Derlin, T; Hueper, K; Sohns, JM | 1 |
| Berthelsen, AK; Birk Christensen, C; Højgaard, L; Loft-Jakobsen, A; Munck Af Rosenschöld, P; Roed, H | 1 |
| Brunner, TB; Hawkins, MA; Mukherjee, S; Partridge, M; Wilson, JM | 1 |
| Basu, S; Kalshetty, A | 1 |
| Basher, RK; Bhatia, A; Jain, TK; Mittal, BR; Prakash, G; Sood, A | 1 |
| Gatenby, RA; Gillies, RJ; Robey, I | 1 |
| Basu, S | 1 |
| Arora, A; Deshpande, M; Pathak, S; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR; Singh, N | 1 |
| Cornfeld, D; Modarresifar, H; Ojha, B; Saif, MW | 1 |
| Berrebi, O; Keller, A; Ratib, O; Rougemont, AL; Steiner, C | 1 |
| Durnick, DK; Peller, PJ; Subramaniam, RM | 1 |
| Borkar, S; Pandit-Taskar, N | 1 |
| Conrad, GR; Jackson, RT; Sinha, P | 1 |
| Mahmood, S; Martinez de Llano, SR | 1 |
| Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC | 1 |
| Abad, MJ; Arsenak, M; Caridad, V; Colmenter, LF; Guillén, N; Martín, R; Taylor, P | 1 |
| Roarke, MC | 1 |
| Antoch, G; Broelsch, CE; Gerken, G; Grabellus, F; Kaiser, GM; Kuehl, H; Li, J; Müller, SP; Nadalin, S; Paul, A; Radunz, S | 1 |
| Ameshima, S; Demura, Y; Fujibayashi, Y; Ishizaki, T; Miyamori, I; Okazawa, H; Sasaki, M; Uesaka, D | 1 |
| Bipat, S; Coenegrachts, K; De Geeter, F; Rigauts, H; Stoker, J; ter Beek, L; Walgraeve, N | 1 |
| Hofman, MS; Nunan, T; O'Doherty, MJ; Rankin, SC; Smeeton, NC | 1 |
| Kwee, RM; Kwee, TC | 1 |
| Endo, K; Nakajima, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tsushima, Y | 1 |
| Chua, ET; Chua, ML; Fong, KW; Gao, F; Khoo, JB; Low, JS; Ng, DC; Ong, SC; Tan, TW; Wee, JT | 1 |
| Gambhir, SS; Iagaru, AH; McDougall, IR; Mittra, ES; Quon, A | 1 |
| Baurain, JF; Crott, R; Krug, B; Lonneux, M; Pirson, AS; Vander Borght, T | 1 |
| Jain, MK; Spratt, SE; Wong, TZ | 1 |
| Aygun, N; Bartelt, D; Bonekamp, D; Jacene, H | 1 |
| Dua, SG; Pramesh, CS; Purandare, NC; Rajnish, A; Rangarajan, V; Shah, S | 1 |
| Conrad, EU; Eary, JF; Lisle, JW; O'Sullivan, J | 1 |
| Labarthe, P; Lebret, T; Méjean, A | 1 |
| Abgral, R; Bizais, Y; Kraeber-Bodéré, F; Le Duc-Pennec, A; Le Roux, PY; Marianovski, R; Potard, G; Pradier, O; Querellou, S; Salaun, PY | 1 |
| Dupuis, J; Gaulard, P; Haioun, C; Itti, E; Lin, C; Meignan, M; Paone, G | 1 |
| Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Jablonka, R; Kuehl, H; Rosenbaum, S; Veit-Haibach, P; Vogt, FM | 1 |
| Auperin, A; Bournaud, C; Busaidy, NL; Corone, C; Ewertz, ME; Jacene, HA; Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR; Sherman, SI; Wahl, RL | 1 |
| Dietrich, C; Hartung, E; Ignee, A | 1 |
| Baillet, G; Barré, E; Bousquet, G; Desgrandchamps, F; Hindié, E; Just, PA; Mathieu, O; Misset, JL; Moretti, JL; Vercellino, L | 1 |
| Brown, G; Houghton, SL; Husband, JE; Potter, KC; Thomas, K | 1 |
| Fujiwara, K; Kanazawa, S; Kawai, H; Matsuo, K; Okumura, Y; Rai, K; Sato, S; Sato, T; Shinya, T; Watanabe, K; Yonei, T | 1 |
| Fan, C; Fan, Q; Li, F; Su, M; Tian, Y; Yang, X; Zhuang, H | 1 |
| Mende, KA; Ramach, C; Schwarz, EI; Strobel, K | 1 |
| Patel, CN; Rankine, JJ; Scarsbrook, AF; Smith, JT | 1 |
| Gershman, BM; Guo, H; Miao, Y; Shenoy, N; Sklar, LA; Yang, J | 1 |
| Horiuchi, C; Inoue, T; Lee, J; Nagashima, T; Suzuki, A; Tsukuda, M; Yoshida, K | 1 |
| Domeki, Y; Kaji, Y; Kitajima, K; Murakami, K; Suganuma, N; Sugimura, K; Sunagawa, M; Tsubaki, M; Yamasaki, E | 1 |
| Aoki, K; Hirata, M; Hyodo, T; Miyagawa, M; Mochizuki, T; Murakami, M; Sugawara, Y; Tanji, N; Tsuda, T; Yanagihara, Y; Yokoyama, M | 1 |
| Podoloff, DA | 1 |
| Avram, AM; Cahill, JM; Frey, KA; Wong, KK; Zarzhevsky, N | 1 |
| Boucher, E; Bouriel, C; Cuggia, M; de Lajarte-Thirouard, AS; Devillers, A; Garin, E; Le Jeune, F; Raoul, JL | 1 |
| Alpe, T; Anaissie, E; Angtuaco, E; Barlogie, B; Bartel, TB; Brown, TL; Crowley, J; Epstein, J; Haessler, J; Shaughnessy, JD; van Rhee, F; Walker, R | 1 |
| Baillet, G; Espié, M; Giacchetti, S; Groheux, D; Hindié, E; Misset, JL; Moretti, JL; Rubello, D | 1 |
| Andreopoulou, E; Cristofanilli, M; Dawood, S; De Giorgi, U; Doyle, GV; Fritsche, HA; Handy, BC; Hortobagyi, GN; Jackson, S; Macapinlac, HA; Miller, MC; Reuben, JM; Rohren, E; Ueno, NT; Valero, V | 1 |
| Bansal, S; D'Souza, MM; Jaimini, A; Jain, J; Jain, N; Mondal, A; Sharma, R; Srivastava, M; Tripathi, M | 1 |
| Fukuda, H; Hiraide, T; Kaneta, T; Mitamura, A; Takahashi, S; Takanami, K; Yamada, S | 1 |
| Boijsen, M; Lundstam, S; Lyrdal, D; Stierner, U; Suurküla, M | 1 |
| Genden, EM; Kao, J; Kostakoglu, L; Mocherla, B; Packer, S; Park, EE; Som, PM; Vu, HL | 1 |
| Bouillet, P; El Badaoui, A; Lavau-Denes, S; Le Brun-Ly, V; Leobon, S; Mahmoudi, N; Martin, J; Maubon, A; Monteil, J; Pouquet, M; Roudaut, PY; Tubiana-Mathieu, N; Vandroux, JC; Venat-Bouvet, L; Verbeke, S | 1 |
| McCarville, MB | 1 |
| Bauer, J; Delaloye, AB; Guillou, L; Marx, K; Prior, J | 1 |
| Bai, CM; Meng, QL; Ning, XH; Wang, YZ | 1 |
| Diener, J; Grünwald, F; Kovács, AF; Wallowy, P | 1 |
| Alberini, JL; Cherel, P; Fourme, E; Gontier, E; Le Stanc, E; Lerebours, F; Madar, O; Pecking, AP; Wartski, M | 1 |
| Aukema, TS; Baas, P; Belderbos, JS; Burgers, SA; Klomp, HM; Teertstra, HJ; Valdés Olmos, RA; van den Heuvel, MM; Vogel, WV | 1 |
| Feng, X; Guan, Y; Hua, F; Huang, Z; Zhao, J | 1 |
| Celen, Z; Karakok, M; Sevinc, A; Yilmaz, M | 1 |
| Bihan, H; Cohen, R; des Guetz, G; Martin, A; Wind, P | 1 |
| Chao, TC; Hsueh, C; Lin, JD | 1 |
| Landa, J; Schwartz, LH | 1 |
| Chen, Y; Li, T; Liu, J; Qu, B; Tian, J; Wang, H; Wang, S; Zhang, J | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Kubota, K; Kurata, A; Murata, Y; Osanai, T; Shibuya, H | 1 |
| Huang, YT; Kumar, AS; Lee, JC | 1 |
| Balink, H; de Visscher, JG; Dijkstra, PU; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF | 1 |
| Cigarral, C; de la Torre, A; Montero, A; Rodríguez, G; Salas, C | 1 |
| Jaaback, K; Proietto, A; Raj, G | 1 |
| Horiuchi, C; Komatsu, M; Matsuda, H; Nishimura, G; Taguchi, T; Takahashi, M; Tsukuda, M; Watanabe, M | 1 |
| Ahn, BC; Lee, J; Lee, SW; Seo, JH | 1 |
| Boerman, OC; Dijkgraaf, I | 1 |
| Blackman, G; Bomanji, J; Boulos, PB; Ell, PJ; Engledow, AH; Groves, A; Skipworth, JR; Warren, SJ | 1 |
| Chan, SC; Chang, JT; Liao, CT; Lin, CY; Lo, CW; Ng, SH; Wang, HM; Yen, TC | 1 |
| Hama, Y; Nakagawa, K | 1 |
| Li, B; Xu, H; Zhai, G; Zhang, M | 1 |
| Aide, N; Denoyer, D; Dorow, DS; Greguric, I; Hicks, RJ; Katsifis, A; Neels, OC; Roselt, P; Taylor, SR | 1 |
| Allen-Auerbach, MS; Benz, MR; Chmielowski, B; Czernin, J; Gomez-Navarro, J; McCarthy, T; Radu, C; Ribas, A; Seja, E; Williams, JL | 1 |
| Freeman, M; Hendler, A; McSweeney, S; Metser, U; You, J | 1 |
| Antoch, G; Bockisch, A; Forsting, M; Hahn, S; Hamami, ME; Heusner, TA; Koeninger, A; Kuemmel, S; Lauenstein, T; Quinsten, A; Stahl, A | 1 |
| Adli, M; Celen, Z; Dirier, A; Yilmaz, M; Zincirkeser, S | 1 |
| Anand, A; Dzik-Jurasz, A; Hu, J; Rathkopf, D; Ross, RW; Scher, HI; Tanaka, E; Wong, BY; Woo, MM; Yang, W | 1 |
| Cho, YH; Chung, HW; Kim, JH; Kim, SY; Lee, EJ; Lee, KY; Lee, MH; Lee, SY; Park, HS; So, Y; Sung, IK; Yoo, MW; Yoon, SY | 1 |
| Inoue, T; Kawaguchi, M; Shizukuishi, K; Suzuki, A; Tateishi, U | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Schmitt, T; Strauss, LG; Vasamiliette, J | 1 |
| Bolton, DM; Davis, ID; Lawrentschuk, N; Scott, AM | 1 |
| Anderson, SB; Banks, KP; Webb, MD | 1 |
| Arnott, J; Hahn, NM; Hammers, H; Harrison, MR; Kim, K; Liu, G; Oh, WK; Perlman, S; Pili, R; Sidor, C; Sweeney, C; Wilding, G | 1 |
| Comans, EF; de Bree, R; Golding, RP; Hoekstra, OS; Kuik, JD; Leemans, CR; Senft, A; Van Waesberghe, JH | 1 |
| Chen, KY; Chiu, JS; Hsu, HK; Hung, GU; Kao, CH | 1 |
| Kley, K; Oehr, P | 1 |
| Dirksen, U; Franzius, C; Juergens, H; Schober, O; Stegger, L; Vrachimis, A; Weckesser, M; Wenning, C; Wessling, J | 1 |
| Gedik, GK; Kara, F; Kara, PO; Kara, T; Sari, O | 1 |
| Ansquer, C; Frampas, E; Meurette, G; Pery, C; Regenet, N | 1 |
| Ishii, S; Kawai, N; Kishi, K; Minamiguchi, H; Nakai, M; Noda, Y; Sanda, H; Sato, M; Sonomura, T; Takasaka, I; Takeuchi, T | 1 |
| Asakura, K; Endo, M; Kaira, K; Murakami, H; Naito, T; Nakamura, Y; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
| Ayers, DC; Barthel, TK; Bouxsein, ML; Cheng, D; Hussain, S; Jones, MD; Lian, JB; Liu, JC; Lovria, E; Mukherjee, S; Mulay, S; Schoonmaker, JA; Stein, GS | 1 |
| Bauman, JE; Capell, PT; Carr, LL; Eaton, KD; Goulart, BH; Kell, EM; Mankoff, DA; Martins, RG | 1 |
| Baek, JH; Choi, BS; Choi, JW; Jeong, KS; Kim, TY; Kim, WB; Lee, JH; Ryu, JS; Shong, YK | 1 |
| Aikawa, M; Imabayashi, E; Koyama, I; Matsuda, H; Miyazawa, M; Okada, K; Okamoto, K; Toshimitsu, Y | 1 |
| Haug, AR; Klingenstein, A; Nentwich, MM; Schaller, UC; Tiling, R | 1 |
| Choi, JY; Chung, JH; Jang, HW; Kim, HK; Kim, SW; Lee, JI; Shin, HW; Shin, JH | 1 |
| Hamakawa, H; Katakami, N; Kokubo, M; Neri, S; Takahashi, Y; Terashi, T; Tomii, K | 1 |
| Al Ghuzlan, A; Baudin, E; Bidart, JM; Caillou, B; Deandreis, D; Garsi, JP; Lacroix, L; Leboulleux, S; Lumbroso, J; Schlumberger, M; Talbot, M | 1 |
| Kim, J; Visioni, A | 1 |
| Gerbaudo, VH; Hatabu, H; Mamede, M; Sugarbaker, DJ; Trotman-Dickenson, B | 1 |
| Bartenstein, P; Berking, C; Coppenrath, E; La Fougere, C; Melzer, HI; Pfluger, T; Schneider, V; Weiss, M | 1 |
| Kaji, M; Kanazawa, S; Katayama, N; Katsui, K; Okumura, Y; Sato, S; Suzuki, E; Takemoto, M; Yoshio, K | 1 |
| Gomaa, O; Kalkanis, A; Kalkanis, D; Paes, FM; Sfakianakis, GN | 1 |
| Fulham, M; Prakoso, E; Selby, WS; Thompson, JF | 1 |
| Koyama, M; Murakami, K; Okazumi, S; Shimada, H | 1 |
| Chevreau, C; Courbon, F; Julian, A; Meyer, N; Payoux, P; Wagner, T; Zerdoud, S | 1 |
| Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
| Aractingi, S; Avril, MF; Boitier, F; Guégan, S; Kerob, D; Khosrotehrani, K; Mansard, S; Maubec, E; Merheb, C; Moguelet, P; Mortier, L; Nassar, D; Nguyen Huu, S; Oster, M; Prignon, A; Richard, MA | 1 |
| Brouwers, AH; de Vries, EG; Fiebrich, HB; Hospers, GA; Links, TP; Remkes, WS; Siemerink, EJ | 1 |
| Kao, YH; Magsombol, BM; Padhy, AK; Saad, U; Tan, AE | 1 |
| Endo, M; Kaira, K; Kondo, H; Murakami, H; Nakajima, T; Ohde, Y; Okumura, T; Oriuchi, N; Takahashi, T; Yamamoto, N | 1 |
| Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
| Bom, HS; Byun, BH; Chong, A; Hong, SP; Kang, SR; Kim, DY; Kim, J; Min, JJ; Oh, JR; Song, HC; Yoo, SW | 1 |
| Fujii, S; Hamanaka, Y; Hara, T; Hayashida, K; Higashi, T; Konishi, I; Nakamoto, Y; Saga, T; Suga, T; Tatsumi, M; Togashi, K | 1 |
| Kim, IJ; Kim, SJ; Kim, YD; Kim, YK; Lee, MK | 1 |
| Chan, SC; Chin, SC; Liao, CT; Lin, CY; Ng, SH; Wai, YY; Wang, HM; Wang, JJ; Yen, TC | 1 |
| Bernit, E; Chagnaud, C; Ebbo, M; Harlé, JR; Mosnier, E; Schleinitz, N; Siles, P; Tintignac, A; Veit, V | 1 |
| Costelloe, CM; Hayashi, N; Hortobagyi, GN; Liu, J; Madewell, JE; Niikura, N; Palla, SL; Theriault, RL; Tokuda, Y; Ueno, NT; Yu, TK | 1 |
| Brooks, FJ; Grigsby, PW | 1 |
| Fukuda, H | 1 |
| Arisaka, Y; Endo, K; Higuchi, T; Nakazawa, A; Oriuchi, N | 1 |
| Brechtel, K; Claussen, CD; Heller, S; Kalender, G; Lescan, M; Scharpf, M; Schmehl, J | 1 |
| Avril, N; Bomanji, J; Chowdhury, S; Dickson, J; Ell, P; Kayani, I; Lim, L; Nathan, P; Powles, T; Reynolds, A; Rockall, A; Sahdev, A; Shamash, J; Sharpe, K; Wilson, P | 1 |
| Kajander, S; Kemppainen, J; Minn, H; Seppänen, M | 1 |
| Blay, JY; Bompas, E; Cassier, PA; Dômont, J; Gelderblom, H; Italiano, A; Kroep, JR; Maki, RG; Seddon, B; Stacchiotti, S; Thomas, D; van der Graaf, WT; Wagner, AJ | 1 |
| Arita, H; Fujimoto, Y; Goto, T; Hashimoto, N; Hatazawa, J; Isohashi, K; Kagawa, N; Kinoshita, M; Kishima, H; Okita, Y; Saitoh, Y; Shimosegawa, E; Yoshimine, T | 1 |
| Hu, SL; Zhang, YJ; Zhou, ZR | 1 |
| Dunnwald, LK; Krohn, KA; Kurland, BF; Lee, JH; Linden, HM; Link, JM; Mankoff, DA; Peterson, LM; Schubert, EK | 1 |
| Abulafi, M; Artho, G; Brown, G; Garant, A; Hunter, CJ; Lisbona, R; Tekkis, P; Vuong, T | 1 |
| George, DJ; Harrison, MR | 1 |
| Aukema, TS; Hoefnagel, CA; Koolen, BB; Loo, CE; Oldenburg, HS; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Valdés Olmos, RA; van der Hage, JA; Vogel, WV; Vrancken Peeters, MJ | 1 |
| Appelbaum, DE; Chen, CT; Chen, S; Kampalath, R; Liao, S; Penney, BC; Pu, Y; Salgia, R; Shih, MC; Shimada, N; Simon, CA; Suzuki, K; Wroblewski, K; Zhang, H | 1 |
| Chung, SK; Kim, SH; Lin, C; Lin, Q; Na, SJ; O, JH; Yoo, IeR | 1 |
| Arora, B; Asopa, RV; Banavali, S; Basu, S; Gupta, K; Nair, N; Pawaskar, A; Rajan, MG | 1 |
| Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S | 1 |
| Li, BY; Li, HS; Wang, QS; Wang, QY; Wu, HB; Zhou, WL | 1 |
| Bellan, E; Cambioli, S; Campana, D; Castellucci, P; Fanti, S; Fuccio, C; Grassetto, G; Massaro, A; Montini, GC; Musto, A; Nanni, C; Pantaleo, MA; Rubello, D; Tomassetti, P | 1 |
| Nguyen, BD; Nguyen, CC; Nguyen, VX | 1 |
| Kotek, A; Parlak, C; Pehlivan, B; Topkan, E; Yapar, AF | 1 |
| Ameye, L; Awada, A; Covas, A; Deleporte, A; Emonts, P; Flamen, P; Garcia, C; Golfinopoulos, V; Hendlisz, A; Machiels, G; Paesmans, M; Piccart, M; Toussaint, E; Vanderlinden, B | 1 |
| Akdemir, UO; Baykara, M; Benekli, M; Buyukberber, S; Cakir, T; Coskun, U; Demirci, U; Kapucu, O; Ozkan, S | 1 |
| Ell, PJ; Engledow, AH; Groves, AM; Imber, C; Pakzad, F; Skipworth, JR | 1 |
| Shah, MA; Smyth, EC | 1 |
| Padhy, AK; Tan, ML | 1 |
| Alberini, JL; Bellet, D; Champion, L; Edeline, V; Giraudet, AL; Le Stanc, E; Lerebours, F; Madar, O; Mortazavi-Jehanno, N; Pecking, AP | 1 |
| Salem, SS; Shahin, MA | 1 |
| Bom, HS; Chong, A; Kim, YC; Min, JJ; Oh, JR; Seo, JH; Song, HC | 1 |
| Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Senthil, R; Singh, G | 1 |
| Antoch, G; Bockisch, A; Hahn, S; Hecktor, J; Herrmann, J; Heusner, TA; Kuemmel, S; Lauenstein, T; Nagarajah, J; Otterbach, F; Riegger, C | 1 |
| Kwee, SA; Lan, BY; Wong, LL | 1 |
| Fair, JR; Golden, MJ | 1 |
| Eaton, A; Evangelista, L; Fazio, M; Howard, J; Hudis, CA; Jhaveri, K; Jochelson, MS; Larson, S; McArthur, HL; Morris, PG; Park, JY; Patil, S; Serna-Tamayo, C; Ulaner, GA | 1 |
| Colavolpe, C; Dessi, P; Fakhry, N; Giovanni, A; Michel, J; Varoquaux, A | 1 |
| Cheoi, K; Chung, H; Lee, H; Lee, JH; Lee, SK; Lee, YC; Park, JC; Shin, SK; Yun, MJ | 1 |
| Endozo, R; Engledow, A; Goh, V; Groves, AM; Halligan, S; Meagher, M; Peck, J; Rodriguez-Justo, M; Shastry, M; Taylor, SA | 1 |
| Bale, RJ; Eisterer, W; Gabriel, M; Gastl, G; Kendler, D; Kroiss, A; Madleitner, R; Putzer, D; Uprimny, C; Virgolini, IJ | 1 |
| Aggarwal, MM; Bhattacharya, A; Kashyap, R; Mandal, AK; Manohar, K; Mittal, BR | 1 |
| Gatsonis, C; Shiu, SY | 1 |
| Al-Nahhas, A; Ariff, B; Barwick, T; Habib, N; Hatice, G; Tait, P; Towey, D; Wasan, H; Zerizer, I | 1 |
| Chuang, HH; Deniz, F; Habra, MA; Jimenez, C; Rubin De Celis, C; Sircar, K; Wood, CG | 1 |
| Herold, CJ; Karanikas, G; Mayerhoefer, ME; Prosch, H; Weber, M | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yi, JS | 1 |
| Conti, PS; Desai, B; Dorff, TB; Groshen, SG; Gross, ME; Jadvar, H; Ji, L; Pinski, JK; Quinn, DI | 1 |
| Bakir, B; Bilge, O; Gulluoglu, M; Kuyumcu, S; Mudun, A; Ozkan, ZG; Sanli, Y; Turkmen, C | 1 |
| Buvat, I; Emonts, P; Flamen, P; Garcia, C; Hendlisz, A; Necib, H; Vanderlinden, B; Wagner, A | 1 |
| Binse, I; Bockisch, A; Görges, R; Rosenbaum-Krumme, SJ | 1 |
| Carrasquillo, JA; Coit, DG; Fields, RC; Fleming, SE; Lu, Y | 1 |
| Antunovic, L; Balestreri, L; Baresic, T; Borsatti, E; Canzonieri, V; Cecchin, D; Cimitan, M; Giorda, G; Pepe, G; Rubello, D; Sorio, R; Steffan, A; Tatta, R | 1 |
| Adalet, I; Kuyumcu, S; Ozkan, ZG; Sanli, Y; Turkmen, C; Yilmazbayhan, D | 1 |
| Kong, L; Li, M; Qu, W; Sun, X; Xing, L; Yu, J; Yue, J; Zhu, WQ | 1 |
| Carrió-Gasset, I; Fuertes-Cabero, S; García-Garzón, JR; Lomeña-Caballero, F; Moragas-Solanes, M; Ponce-López, A; Riera-Gil, E; Soler-Peter, M; Valls-Ferrusola, E | 1 |
| Goto, Y; Hirata, T; Ikeda, Y; Nokihara, H; Tamura, T; Tanioka, M; Yamada, K; Yamada, Y; Yamamoto, N | 1 |
| Bresee, C; Friedman, M; Waxman, A; Yu, R; Zalom, M | 1 |
| Eaton, A; Fury, M; Lee, NY; Lim, R; Ohri, N; Rao, S; Schöder, H; Setton, J; Wong, R | 1 |
| Henderson, R; Ho, L; Luong, T; Malkhassian, S; Wassef, H | 1 |
| Chen, L; Li, F; Xiao, Y; Zhang, J; Zhuang, H | 1 |
| Clark, OH; Duh, QY; Gosnell, J; Guerrero, MA; Munoz-Perez, N; Rinkes, IH; Schreinemakers, JM; Shen, WT; Suh, I; Vriens, MR | 1 |
| Dickson, J; Ghosh-Ray, S; Sanghera, B; Sonoda, LI; Wong, WL | 1 |
| Kampalath, R; Liao, S; Penney, BC; Pu, Y; Wroblewski, K; Zhang, H; Zhang, Y | 1 |
| Abakay, A; Erdem, V; Kaya, H; Kömek, H; Selimoğlu Şen, H; Senyiğit, A; Sezgi, C; Tanrikulu, AC | 1 |
| Brogsitter, C; Kämmerer, E; Kotzerke, J; Stein, A; Wunderlich, G; Zöphel, K | 1 |
| Basaran, G; Dane, F; Demir, G; Korkmaz, T; Madenci, OC; Okutur, K; Ones, T; Polat, O; Seber, S; Turhal, NS; Yumuk, F | 1 |
| Dimitrakopoulou-Strauss, A; Epelbaum, R; Frenkel, A; Haddad, R; Israel, O; Sikorski, N; Strauss, LG | 1 |
| Harders, SW | 1 |
| Chen, W; Chen, Z; Liang, H; Rao, L; Shi, X; Wang, X; Yi, C; Zhang, X | 1 |
| Abramson, S; Arora, VC; Fleming, S; LaQuaglia, MP; Magnan, H; Price, AP; Sohn, MJ | 1 |
| Hawkins, DS; Jones, RL; Newman, EN | 1 |
| Kurabayashi, T; Nakamura, S; Okochi, K; Shibuya, H; Toriihara, A; Watanabe, H | 1 |
| Baik, SH; Hur, H; Kang, J; Kim, H; Kim, NK; Lee, KY; Min, BS; Sohn, SK | 1 |
| de Lima, JM; Dick, DW; Gambhir, SS; Iagaru, A; Isidoro, J; Iyer, V; Lapa, P; Mittra, E; Mosci, C; Prakash, V; Sathekge, M | 1 |
| Appelbaum, D; Chmura, SJ; Farrey, K; Salama, JK; Solanki, AA; Weichselbaum, RR; Yenice, KM | 1 |
| Choi, H; Chung, JK; Kang, KW; Kim, DW; Lee, DS; Lee, JK; Paeng, JC; Park, CM | 1 |
| Candiani, M; Gentile, C; Gianolli, L; Giorgione, V; Mangili, G; Mapelli, P; Messa, C; Picchio, M; Rabaiotti, E; Spinapolice, EG | 1 |
| Asopa, RV; Malhotra, G; Sridhar, E | 1 |
| Delbeke, D; Vitola, J | 1 |
| Abella-Columna, E; Valk, PE | 1 |
| Larson, SM; Robbins, R | 1 |
| Aigner, RM; Richtig, E; Schwarz, T | 1 |
| Kalaigian, H; Kolbert, K; Larson, SM; Robbins, RJ; Sonenberg, M; Tuttle, RM; Wang, W | 1 |
| Dupont, P; Garmyn, M; Gysen, M; Hoe, LV; Mortelmans, L; Stas, M; Stroobants, S; Wever, ID | 1 |
| Arrighi, JA; Fogarasi, MC; Kummar, S; Messana, SA; Seibyl, JP; Zelkowitz, RS | 1 |
| Chin, BB; Cohade, C; Patel, PV | 1 |
| Czernin, J | 1 |
| Bingham, JB | 1 |
| Antoch, G; Bockisch, A; Brandt-Mainz, K; Görges, R; Müller, S; Stattaus, J | 1 |
| Akhurst, T; Bains, MS; Downey, RJ; Ginsberg, R; Gollub, M; Gonen, M; Ilson, D; Koong, H; Larson, SM; Minsky, BD; Rusch, V; Turnbull, A; Zakowski, M | 1 |
| Dehdashti, F; Grigsby, PW; Lewis, JS; Mintun, MA; Siegel, BA; Welch, MJ | 1 |
| Bredow, J; Franke, WG; Grüning, T; Kropp, J; Tiepolt, C; Zöphel, K | 1 |
| Ball, DL; Fisher, R; Hicks, R; MacManus, MR; Michael, M; Rischin, D; Wirth, A | 1 |
| Fukuda, H; Ido, T; Kanamaru, R; Kubota, K; Saginoya, T; Takahashi, H; Yamaguchi, K; Yamaura, G; Yamazaki, T; Yoshioka, T | 1 |
| Gallowitsch, HJ; Gasser, J; Igerc, I; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P | 1 |
| Eyrich, GK; Goerres, GW; Grätz, KW; Schmid, DT; von Schulthess, GK | 1 |
| Bui, CD; Carlos, RC; Ching, AS; Mukherji, SK; Shreve, PD | 1 |
| Jeong, SY; Kang, HS; Kang, KW; Kim, SK; Kim, SW; Lee, ES; Lee, IG; Sim, JS | 1 |
| Hicks, RJ; Mac Manus, MP | 1 |
| Chang, TC; Chen, JT; Chou, HH; Hong, JH; Hsueh, S; Huang, KG; Lai, CH; Lin, WJ; Lui, KW; Ma, SY; Ng, KK; See, LC; Tsai, CS; Yen, TC | 1 |
| Borson-Chazot, F; Bournaud, C; Desuzinges, C; Giammarile, F; Hafdi, Z; Houzard, C; Itti, R; Janier, M; Sassolas, G | 1 |
| Uno, K | 1 |
| Blaufox, MD; Dadachova, E; Lin, EY; Lu, P; Mani, J; Moadel, RM; Nguyen, AV; Pollard, JW | 1 |
| Albani, JM; Bukowski, RM; Elson, P; Kanvinde, MH; Majhail, NS; Mekhail, TM; Novick, AC; Olencki, TE; Rice, TW; Urbain, JL | 1 |
| Gordon, LL; Pope, TL; Ravenel, JG; Reed, CE | 1 |
| Chen, J; Li, QG; Liu, QW; Yao, SZ; Zhang, CQ | 1 |
| Jamar, F; Lonneux, M | 1 |
| Barrington, SF; Leslie, MD; Plunkett, TA; Tutt, AN | 1 |
| Agress, H; Cooper, BZ | 1 |
| Aide, N; Balogova, S; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N | 1 |
| Chin, BB; Cohade, C; Ewertz, M; Ladenson, P; Patel, P; Wahl, R | 1 |
| Al-Nahhas, AM | 1 |
| Annema, JT; Hoekstra, OS; Rabe, KF; Smit, EF; Versteegh, MI; Veseliç, M | 1 |
| Baillet, G; Moretti, JL; Tamgac, F; Tofighi, M; Weinmann, P | 1 |
| Boom, RP; Buter, J; Comans, EF; Hoekstra, OS; Krak, NC; Lammertsma, AA; Meijer, S; Pinedo, HM; Teule, GJ; van der Hoeven, JJ; van der Wall, E; van Geldere, D | 1 |
| Conrad, EU; Farwell, DG; Krohn, KA; Mankoff, DA; Muzi, M; O'Sullivan, F; Peterson, LM; Rajendran, JG; Schwartz, DL; Spence, AM | 1 |
| Greven, KM | 1 |
| Berner, U; Döbert, N; Grünwald, F; Menzel, Ch; Wördehoff, N | 1 |
| Brink, I; Hentschel, M; Hopt, UT; Imdahl, A; Kleimaier, M | 1 |
| Carrasquillo, JA; Choyke, P; Finkelstein, SE; Galen, B; Hoffman, JM; Rosenberg, SA; Sherry, RM; White, DE | 1 |
| Austin-Seymour, M; Bhattacharya, M; Ellis, G; Eubank, WB; Gralow, J; Linden, H; Lindsley, S; Livingston, R; Mankoff, D | 1 |
| Helmberger, T; Linke, R; Schroeder, M; Voltz, R | 1 |
| Fukuchi, M; Kato, H; Kuwano, H; Manda, R; Miyazaki, T; Nakajima, M | 1 |
| Döbert, N; Grünwald, F; Hamscho, N; Matic, V; Menzel, C; Vasvatekis, S; Wördehoff, N; Zaplatnikov, K | 1 |
| Bradley, JD; Dehdashti, F; Govindan, R; Mintun, MA; Siegel, BA; Trinkaus, K | 1 |
| Halkar, RK; Schuster, DM | 1 |
| Aquino, SL; Fischman, AJ | 1 |
| Coppens, E; El Nakadi, I; Gay, F; Gelin, M; Goldman, S; Liberale, G; Nagy, N; Van Laethem, JL | 1 |
| Hellwig, D; Ukena, D | 1 |
| Endo, K; Faried, A; Fukai, Y; Fukuchi, M; Kato, H; Kimura, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Ojima, H; Oriuchi, N; Sohda, M; Takita, J; Tsukada, K | 1 |
| Barranger, E; Cortez, A; Daraï, E; David-Montefiore, E; Kerrou, K; Petegnief, Y | 1 |
| Hain, SF | 1 |
| DeYoung, BR; Funk, GF; Goldstein, DP; Graham, MM; Yao, M | 1 |
| Alavi, A; Gupta, NC; Lakhani, P; Mavi, A; Zhuang, H | 1 |
| Kraus, DH; Kutler, DI; Wong, RJ | 1 |
| Kang, KW; Kim, SK; Lee, ES; Park, SY; Roh, JW; Sim, JS | 1 |
| Amesur, N; Avril, N; Bienert, M; Carr, BI; Geller, DA; McCook, B; Sheetz, M; Tutor, C | 1 |
| Börner, AR; Knapp, WH; Mirzayan, MJ; Petrich, T; Samii, A; Samii, M | 1 |
| Havrilesky, LJ; Kulasingam, SL; Matchar, DB; Myers, ER | 1 |
| Bading, JR; Bart, R; Bremner, R; Chen, X; Conti, PS; Hou, Y; Park, R; Sievers, E; Tohme, M | 1 |
| Blaufox, MD; Isasi, CR; Moadel, RM | 1 |
| Mistry, RC; Pramesh, CS | 1 |
| Bilfinger, TV; Franceschi, D; Komaroff, E; Sachs, S | 1 |
| Akhurst, T; Chu, E; Ditullio, M; Heller, G; Kelly, WK; Larson, SM; Morris, MJ; Scher, HI; Schwartz, L; Siedlecki, K; Slovin, S; Verbel, D | 1 |
| Aamdal, S; Hersey, P; Joshua, A; Kefford, R; Lynch, K; Millward, MJ; Thomson, D; Toner, G | 1 |
| Helmberger, T; Jacobs, TF; Münzing, W; Pöpperl, G; Schmid, R; Tatsch, K | 1 |
| Gong, G; Hong, SJ; Kim, TY; Kim, WB; Ryu, JS; Shong, YK | 1 |
| Brink, I; Ghanem, N; Kelly, T; Langer, M; Moser, E; Schäfer, O; Uhl, M | 1 |
| Aoyagi, S; Sato-Matsumura, KC; Shimizu, H | 1 |
| Higashi, T; Ishimori, T; Ishizu, K; Kitaichi, M; Li, M; Mamede, M; Manabe, T; Nakamoto, Y; Saga, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Gladish, GW; Macapinlac, HA; Marom, EM; Munden, RF; Podoloff, DA; Sabloff, BS; Truong, MT; Yi, JG | 1 |
| Changchien, CR; Chen, JS; Ho, KC; Liu, FY; Liu, SH; Yeh, CY; Yen, TC | 1 |
| Ezuddin, S; Fragkaki, C | 1 |
| Baker, JG; Bednarczyk, EM; Nabi, HA; Zubeldia, JM | 1 |
| Bucerius, J; Flacke, S; Hortling, N; Jaeger, U; Joe, A; Palmedo, H; Reinhardt, M; Strunk, H | 1 |
| Lardinois, D; Moch, H; Roudas, M; Stahel, RA; Steinert, HC; Tutic, M; von Schulthess, GK; Weder, W | 1 |
| Biersack, HJ; Jaeger, U; Joe, AY; Matthies, A; Reinhardt, MJ; Strunk, H; Wiethoelter, N | 1 |
| Chang, TC; Chang, YC; Jung, SM; Lai, CH; Li, YT; Ng, KK; Wu, TI; Wu, YC; Yen, TC | 1 |
| Bae, JM; Chang, HJ; Choi, JY; Kang, KW; Kim, HK; Kim, SK; Kim, YW; Lee, JH; Lee, JS; Ryu, KW | 1 |
| Alavi, A; Hustinx, R; Zhuang, H | 1 |
| Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS | 1 |
| Carpentier, P; Kirova, J; Kolesnikov-Gauthier, H; Levy, E; Meignan, M; Merlet, P; Piedbois, P; Syrota, A | 1 |
| Comte, F; Eberlé, MC; Lamy, PJ | 1 |
| Dehdashti, F; Gao, F; Gibb, RK; Grigsby, PW; Herzog, TJ; Huettner, PC; Mutch, DG; Powell, MA; Rader, JS; Siegel, BA; Wright, JD | 1 |
| Drucker, W; Gonen, M; Grewal, RK; Larson, SM; Reibke, R; Robbins, RJ; Strauss, HW; Tuttle, RM; Wan, Q | 1 |
| Arveux, P; Bedenne, L; Bey, P; Bismuth, MJ; Conroy, T; Faivre, J; Guillemin, F; Lejeune, C; Zanni, C | 1 |
| Beer, AJ; Fischer, M; Lordick, F; Ott, K; Rummeny, EJ; Schwaiger, M; Siewer, JR; Weber, WA; Wieder, HA; Ziegler, S | 1 |
| Ciernik, IF; Eyrich, GK; Goerres, GW; Schuknecht, B; Stoeckli, SJ; Wild, D | 1 |
| Hamada, K; Hatazawa, J; Tomita, Y; Ueda, T; Yoshikawa, H | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Caillou, B; Dromain, C; Leboulleux, S; Lumbroso, J; Schlumberger, M; Sigal, R | 1 |
| Knoepp, UW; Ravenel, JG | 1 |
| Grigsby, PW | 2 |
| Cornide, M; de las Heras, PM; Domínguez, ML; García-Bernardo, L; García-Rico, E; Maldonado, A; Ortega, F; Serna, JA; Suárez, JP | 1 |
| Hayanga, AJ | 1 |
| Boethius, J; Ericson, K; Wang, SX | 1 |
| Newman, LA | 1 |
| Borgen, P; Caravelli, J; Gonen, M; Larson, S; Liberman, L; Port, ER; Yeung, H | 1 |
| Haug, AR; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Clark, PB; Kraas, J; Levine, EA; Shen, P; Soo, V | 1 |
| Kraus, DH; Kutler, DI; Schoder, H; Wong, RJ | 1 |
| Alavi, A; Chandra, P; Chauhan, A; Kumar, R; Schnall, M; Zhuang, H | 1 |
| Connolly, LP; Gauger, PG; Hurwitz, CA; Kunter, G; Mackie, GC; Mody, RJ; Ribeiro, RC; Rodriguez-Galindo, C; Schteingart, DE; Shulkin, BL; Wallis, JW; Worden, FP | 1 |
| Carlson, DL; Erdi, YE; Gönen, M; Huvos, AG; Kraus, DH; Larson, SM; Schöder, H; Shah, JP; Stambuk, HE; Wong, RJ; Yeung, HW | 1 |
| Beer, AJ; Goebel, M; Grosu, AL; Haubner, R; Luderschmidt, S; Martinez, MJ; Niemeyer, M; Schwaiger, M; Weber, WA; Wester, HJ; Wolf, I | 1 |
| de Bruin, PC; Koelemij, R; Oreel, MA; Tiel-van Buul, MM; Verzijlbergen, JF | 1 |
| Grahek, D; Talbot, JN | 1 |
| Cachin, F; Hicks, RJ; Hogg, A; Prince, HM; Ware, RE | 1 |
| Francken, AB; Fulham, MJ; Millward, MJ; Thompson, JF | 1 |
| Bosquet, L; Bourguet, P; Hitzel, A; Houvenaeghel, G; Vinatier, D | 1 |
| Buell, U; Coenen, HH; DiMartino, E; Eble, M; Gagel, B; Hamacher, K; Reinartz, P; Westhofen, M; Zimny, M | 1 |
| Chang, HM; Kim, HC; Kim, JC; Kim, JH; Park, IJ; Ryu, JS; Ryu, MH; Yeo, JS; Yu, CS | 1 |
| Daghighian, F; Essner, R; Gulec, SA | 1 |
| Bläser, D; Kuwert, T; Maschauer, S; Prante, O | 1 |
| Ambrosini, V; Banti, E; Carpi, A; Fanti, S; Farsad, M; Franchi, R; Muzzio, P; Nanni, C; Rampin, L; Rubello, D | 1 |
| Franzius, C; Gabbert, HE; Hermann, S; Hotfilder, M; Jürgens, H; Poremba, C; Schäfers, K; Schäfers, M; Schober, O; Vormoor, J | 1 |
| Brown, RK; Morag, Y; Walsh, MA | 1 |
| Alexander, M; Brasić, JR | 1 |
| de Geus-Oei, LF; Krabbe, PF; Oyen, WJ; Punt, CJ; Ruers, TJ; Wiering, B | 1 |
| Ishida, Y; Isozaki, H; Morimoto, T; Mukai, K; Nishiyama, S; Okajima, K | 1 |
| Chawla, S; Conti, PS; Iagaru, A; Menendez, L | 1 |
| Al-Salihi, O; Bomanji, J; Du, Y; Ell, P; Gacinovic, S; Gomes, M; Pepe, G | 1 |
| Blasberg, R; Humm, J; Ling, C; Serganova, I | 1 |
| Alavi, A; Cohen, AB; Dalmau, J; Galetta, SL; Mathew, RM | 1 |
| Bosly, A; Graux, C; Krug, B; Nollevaux, MC; Sonet, A; Vander Borght, T | 1 |
| Arii, S; Ishiwata, K; Kawamura, K; Liu, HY; Oda, K; Teramoto, K | 1 |
| Miranda, EP | 1 |
| Tafra, L | 1 |
| Bhat, S; Bhatt, B; Camazine, B; Erickson, RA; Gupta, R; Jadhav, Y; Khan, A; Khode, R; Mukhopadhyay, P; Reddy, R; Shah, RS; Sharma, A; Sikka, P; Singh, P; Smith, DD; Yaqub, Y; Zheng, Q | 1 |
| Couturier, O; Hustinx, R; Jerusalem, G; N'Guyen, JM | 1 |
| Fulham, MJ; Mohamed, A; O' Neill, GF; Thambugala, GM | 1 |
| Hicks, RJ; Lau, EW; Ware, RE | 1 |
| Rankin, SC | 1 |
| Cho, BY; Choi, MY; Chung, JK; Jeong, JM; Lee, DS; Lee, HY; Lee, MC; Park, DJ; So, Y | 1 |
| Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H | 1 |
| Iagaru, A; McDougall, IR | 1 |
| Bellon-Guardia, M; Cabello-García, D; Ferrón-Orihuela, A; Gomez-Rio, M; Gutiérrez-Sáinz, J; Llamas-Elvira, JM; Ramos-Font, C; Rebollo-Aguirre, AC; Rodríguez-Fernández, A | 1 |
| Chen, YK; Cheng, RH; Chi, KH; Hsu, CH; Su, CT; Wang, SC | 1 |
| Chung, SK; Kim, SH; O, JH; Sohn, HS; Yoo, IeR | 1 |
| Dimitrakopoulou-Strauss, A; Haberkorn, U; Klippel, S; Pan, L; Schönleben, K; Strauss, LG | 1 |
| Avril, N; Bencherif, B; Bencherif, BB; Branstetter, B; Carty, SE; Degirmenci, B; Joyce, JM; Kuffner, HA; McCook, BM; Mountz, JM; Shammas, A | 1 |
| Chatziioannou, AF; Chow, PL; De, A; Deroose, CM; Gambhir, SS; Loening, AM; Ray, P | 1 |
| Dunnwald, LK; Ellis, GK; Gralow, JR; Kurland, BF; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK; Specht, JM; Tam, SL | 1 |
| Blumstein, NM; Buck, AK; Glatting, G; Mottaghy, FM; Neumaier, B; Ozdemir, C; Reske, SN; Scharffetter-Kochanek, K; Schubert, R; Sunderkötter, C; Wohlfart, P | 1 |
| Blackstone, EH; Bybel, B; Falk, GW; Little, SG; Mason, DP; Murthy, SC; Rice, TW; Rybicki, LA | 1 |
| Anniko, M; Blomquist, E; Ekberg, T; Engström, M; Sörensen, J; Sundin, A | 1 |
| Baumann, K; Dummer, R; Joller-Jemelka, H; Kalff, V; Seifert, B; Skalsky, J; Steinert, HC; Strobel, K | 1 |
| Doddamane, I; Gönen, M; Larson, SM; Ong, SC; Patel, SG; Schöder, H; Shah, JP; Shaha, AR; Tabangay-Lim, IM; Tuttle, RM | 1 |
| Akaki, S; Iguchi, T; Kanazawa, S; Matsuoka, J; Mifune, H; Okumura, Y; Omori, M; Sato, S | 1 |
| AL-Nahhas, A; Canelo, R; Gishen, P; Stamp, G; Tait, P; Tehranipour, N; Woo, K | 1 |
| Juengling, FD; Krause, T; Muggli, B; Weidner, S; Weimann, R; Wissmeyer, M | 1 |
| Alavi, A; Basu, S | 1 |
| Bell, B; Solis, V; Vinson, AE; Williams, HT | 1 |
| Chen, YK; Kao, CH; Shen, YY; Sun, SS | 1 |
| Nguyen, BD; Ram, PC; Roarke, MC | 1 |
| Benjamin, RS; Burgess, MA; Charnsangavej, C; Chen, LL; Choi, H; Faria, SC; Macapinlac, HA; Patel, SR; Podoloff, DA | 1 |
| Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S | 1 |
| Gamie, SH; Niederkohr, RD | 1 |
| Berlangieri, SU; Byrne, AJ; Clarke, CP; Knight, SR; Lee, ST; Mitchell, P; O'Keefe, GJ; Pathmaraj, K; Poon, AM; Scott, AM; Tabone, K | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lenders, JW; Ling, A; Pacak, K; Solis, D; Timmers, HJ | 1 |
| Bloomston, M; Hall, NC; Knopp, MV; Martin, EW; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
| Becker, K; Essler, M; Hartung, R; Krause, BJ; Maurer, T; Schwaiger, M; Souvatzoglu, M; Stollfuss, J; Treiber, U | 1 |
| Hamazawa, Y; Ikemoto, S; Inoue, Y; Koyama, K; Okamura, T; Ozawa, N; Senzaki, H; Tanabe, S | 1 |
| Al-Kutoubi, A; Arabi, M; Kinge, AR; Otrock, ZK; Shamseddine, A | 1 |
| Blocklet, D; Garcia, C; Goldman, S; Moreno-Reyes, R; Stallenberg, B; Tang, BN | 1 |
| Cullum, I; Du, Y; Ell, PJ; Illidge, TM | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Al-Saif, OH; Bloomston, M; Cao, Z; Hall, NC; Knopp, MV; Kocak, E; Marsh, S; Martin, EW; Murrey, DA; Povoski, SP; Sarikaya, I; Zhang, J | 1 |
| Dummer, R; Hany, TF; Husarik, DB; Pérez Lago, M; Steinert, HC; Strobel, K | 1 |
| Aydin, C; Cakir, B; Dirikoc, A; Ersoy, R; Topaloglu, O | 1 |
| Bazzi, L; Bellomi, M; Paganelli, G; Radice, D; Rizzo, S; Travaini, LL; Trifirò, G; Zampino, MG | 1 |
| Niederkohr, RD; Quon, A; Rosenberg, J; Shabo, G | 1 |
| Fujii, T; Kaida, Y; Shirouzu, K; Tayama, K; Toh, U | 1 |
| Chen, W | 1 |
| Tian, L; Wang, F; Wang, Z; Xie, H; Xu, J; Yao, W | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Freudenberg, LS; Rosenbaum, SJ | 1 |
| Eubank, WB | 1 |
| Schirrmeister, H | 1 |
| Choi, SH; Kim, JS; Kim, SY; Lee, JH; Nam, SY; Roh, JL; Yeo, NK | 1 |
| Higashino, T; Kotani, Y; Koyama, H; Nishimura, Y; Nogami, M; Ohno, Y; Sugimura, K; Takenaka, D; Yoshikawa, T; Yoshimura, M | 1 |
| Chen, LB; Song, HZ; Tong, JL; Wang, YC; Zhu, H | 1 |
| Al-Nahhas, A; Banti, E; Fanti, S; Ferdeghini, M; Gross, MD; Nanni, C; Rampin, L; Rubello, D | 1 |
| Erasmus, JJ; Macapinlac, HA; Swisher, SG | 1 |
| Bossuyt, PM; Comans, EF; Fockens, P; Groen, H; Jager, PL; Plukker, JT; Sloof, GW; Stoker, J; van der Jagt, EJ; van Dullemen, HM; van Lanschot, JJ; van Westreenen, HL; Westerterp, M | 1 |
| Collins, CD | 1 |
| Balachandran, A; Devine, CE; Iyer, RB | 1 |
| Caetano, R; Coeli, CM; Kuba, VM; Vaisman, M | 1 |
| Chuthapisith, S; El-Sheemy, M; Eremin, JM; Eremin, O; Griffiths, PA; Jibril, JA; Marshall, C; Mustafa, S; Wheatley, DC | 1 |
| Balan, KK; Gibbs, P; Huguet, EL; Jamieson, NV; Old, S; Praseedom, RK | 1 |
| Chaar, BT; Nguyen, NC; Osman, MM | 1 |
| Beer, AJ; Herrmann, K; Lordick, F; Lorenzen, S; Metz, S; Peschel, C; Schwaiger, M; Watzlowik, P; Wester, HJ | 1 |
| Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO | 1 |
| Borson-Chazot, F; Chayvialle, JA; Janier, M; Kryza, D; Le Bars, D; Nejjari, M; Perek, N; Poncet, G; Roche, C; Scoazec, JY | 1 |
| Heijenbrok-Kal, MH; Hunink, MG; Kuipers, EJ; Siersema, PD; van Vliet, EP | 1 |
| Bonardel, G; Bonnichon, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Mantzarides, M; Margery, J; Marotel, C; Rivière, F; Staub, E; Vaylet, F | 1 |
| Peterson, JJ | 1 |
| Baarslag, HJ; Creyghton, W; de Haas, M; de Klerk, J; Kemps, B; Rinkes, IB; van Ufford, HQ | 1 |
| Ahuja, AT; Chan, AT; Kam, MK; King, AD; Leung, SF; Ma, BB; Wong, JK; Yau, YY; Zee, B | 1 |
| Avril, N; Brenner, W; Dose-Schwarz, J; Habermann, CR; Jenicke, L; Mahner, S; Schirrmacher, S | 1 |
| de Bree, R; Golding, RP; Hoekstra, OS; Kuik, DJ; Leemans, CR; Oyen, WJ; Pruim, J; Roodenburg, JL; Senft, A; van den Hoogen, FJ | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Asai, T; Kinouchi Shimizu, N; Oku, N; Shimizu, K; Tsukada, H | 1 |
| Ghossein, RA; Gomez, D; Larson, SM; Rivera, M; Schoder, H; Tuttle, RM | 1 |
| Brenner, W; Dose-Schwarz, J; Habermann, CR; Jenicke, L; Mahner, S; Müller, V; Schirrmacher, S | 1 |
| Wong, RJ | 1 |
| Imura, J; Okumura, T; Sato, M; Shioyama, Y | 1 |
| Darcourt, J; Lagrange, JL; Maublant, J | 1 |
| Feine, U; Hanke, JP; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
| Hortobagyi, GN; Kim, EE; Nieweg, OE; Singletary, SE; Wong, WH | 1 |
| Kabelitz, D; Kremer, B; Lode, H; Meinertz, T; Sauerbruch, T; Sterry, W; Strauss, LG | 1 |
| Holle, LH; Lung-Kurt, S; Oberhausen, E; Püschel, W; Schmidt, S; Trampert, L; Villena-Heinsen, CE | 1 |
| Becker, M; Benchaou, M; Donath, A; Lehmann, W; Lemoine, R; Rufenacht, D; Slosman, DO | 1 |
| Feine, U; Hanke, JP; Held, J; Lietzenmayer, R; Müller-Schauenburg, W; Wöhrle, H | 1 |
| Fazio, F; Fridrich, L; Kendler, D; Landoni, C; Lucignani, G; Messa, C; Moncayo, R; Riccabona, G | 1 |
| Böni, R; Capaul, R; Huch-Böni, RA; Steinert, H; von Schulthess, GK; Westera, G | 1 |
| Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C | 1 |
| Bender, H; Biersack, HJ; Kozak, B; Oehr, P; Robertz-Vaupel, GM; Ruhlmann, J; Schomburg, A; Vaupel, H; Wolter, H | 1 |
| Birnbaum, EH; Dehdashti, F; Flanagan, FL; Fleshman, JW; Kodner, IJ; Ogunbiyi, OA; Philpott, GW; Read, TE; Siegel, BA; Trask, DD | 1 |
| Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; Vesselle, H | 1 |
| Dietlein, M; Scheidhauer, K; Schicha, H; Theissen, P; Voth, E | 1 |
| Hustinx, R; Paquet, P; Piérard, GE; Rigo, P | 1 |
| Dehdashti, F; Flanagan, FL; Kodner, IJ; Ogunbiyi, OA; Siegel, BA | 1 |
| Wahl, RL | 1 |
| Agresti, R; Giovanazzi, R; Greco, M | 1 |
| Chang, CC; Chieng, PU; Huang, TS; Yen, RF | 1 |
| Donald, PJ; Manolidis, S; Pounds, TR; Volk, P | 1 |
| Bruchhaus, H; Hillinger, S; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Bausart, R; Declerck, P; Delval, D; Jamar, F; Lonneux, M; Moens, R; Pauwels, S; Van Mael, P; Willockx, R; Zreik, H | 1 |
| Bruchhaus, H; Hillinger, S; Largiadèr, F; Schmid, RA; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Hoh, CK; Schiepers, C | 1 |
| Dussek, JE; Maisey, MN; O'Doherty, MJ; Saunders, CA | 1 |
| Cronin, BF; Lodge, MA; Lucas, JD; Marsden, PK; McKee, PH; O'Doherty, MJ; Smith, MA | 1 |
| Jadvar, H; McDougall, IR; Segall, GM | 1 |
| Abella-Columna, E; Greiss, HB; Haseman, MK; Hofer, GA; Myers, RW; Pounds, TR; Tesar, RD; Valk, PE | 1 |
| Godwin, HA; Zuger, JH | 1 |
| Maxon, HR | 1 |
| Dworkin, HJ; Wong, CO | 1 |
| Cho, BY; Choi, CW; Chung, JK; Hong, SW; Lee, DS; Lee, JS; Lee, MC; Lim, SM; So, Y; Youn, YK | 1 |
| Wagner, HN | 1 |
| Akashi, Y; Ichiya, Y; Kuwabara, Y; Masuda, K; Murayama, S; Nakagawa, M; Sasaki, M; Yoshida, T | 1 |
| Akhurst, T; Larson, SM | 1 |
| Friedman, DM; Keenan, RJ; Luketich, JD; Meehan, MA; Meltzer, CC; Townsend, DW; Weigel, TL | 1 |
| Biersack, HJ; Briele, B; Grünwald, F | 1 |
| Czernin, J; Farquhar, TH; Gambhir, SS; Hoffman, EJ; Hoh, CK; Hsu, C; Llacer, J; Qi, J; Seltzer, MA; Silverman, DH | 1 |
| Bødrogi, I; Dóczi, T; Esik, O; Fekete, S; Galuska, L; Kálvin, B; Kásler, M; Kubinyi, K; Lengyel, Z; Losonczy, H; Nyáry, I; Rácz, K; Rosta, A; Szakáll, S; Szentirmay, Z; Sziklai, I; Trón, L; Vitéz, A | 1 |
| Chisin, R; Freedman, N; Gimon, Z; Klein, M; Lotem, M; Marciano, R; Moshe, S | 1 |
| Dullaart, RP; Jager, PL; Links, TP; van Tol, KM | 1 |
| Beyer, T; Brun, T; Byars, L; Charron, M; Jerin, J; Kinahan, PE; Nutt, R; Roddy, R; Townsend, DW; Young, J | 1 |
| Bormans, G; Coosemans, W; De Leyn, P; De Wever, W; Dupont, P; Ectors, N; Flamen, P; Haustermans, K; Hiele, M; Lerut, A; Mortelmans, L; Peeters, M; Stroobants, S; Van Cutsem, E; Van Raemdonck, D | 1 |
| Nishimura, T; Yutani, K | 1 |
| Flamen, P; Mortelmans, L; Van Cutsem, E | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Buck, AC; Glatting, G; Guhlmann, A; Hörster, T; Koretz, K; Kreienberg, R; Kühn, T; Nüssle, K; Reske, SN; Rieber, A; Santjohanser, C; Schirrmeister, H | 1 |
| Pauwels, EK; Stokkel, MP; van der Hiel, B | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Al Suhaibani, H; Bakheet, S; Kerr, IG; Manji, MF; Powe, J; Subhi, J | 1 |
| Ball, DL; Hicks, RJ; Hogg, A; MacManus, MP; Matthews, JP; McKenzie, AF; Ware, RE; Wirth, A | 1 |
| Fawwaz, RA; van Heertum, RL | 1 |
| Chou, C; Cui, R; Yen, TC; Zhu, Z | 1 |
| Mandelkern, M; Tatlidil, R | 1 |
| Bamberg, M; Hellwig, D; Kirsch, CM; Paulsen, F; Ukena, D | 1 |
| Alavi, A; Fraker, DL; Mercier, GA | 1 |
| Choe, KJ; Chung, JK; Kim, TS; Lee, DS; Lee, MC; Moon, WK; Noh, DY; Oh, SK; Youn, YK | 1 |
| Amthauer, H; Felix, R; Schlag, PM; Stroszczynski, C | 1 |
| Coates, G; Nahmias, C; Rawlinson, J; Skehan, SJ; Somers, S; Zealley, IA | 1 |
| Bohuslavizki, KH; Broering, DC; Buchert, R; Clausen, M; Fritscher-Ravens, A; Jenicke, L; Rogiers, X; Schäfer, H | 1 |
| Haberkorn, U | 1 |
| Baumert, B; Dizendorf, E; Luetolf, UM; Steinert, HC; von Schulthess, GK | 1 |
| Hasegawa, S; Iino, K; Ikematsu, Y; Ishizu, K; Kida, H; Nishiwaki, Y; Okawada, T; Ozawa, T; Taniguchi, K; Taniguchi, M; Torizuka, T; Uchimura, M; Waki, S | 1 |
| Arslan, N; Rydzewski, B | 1 |
| Kitagawa, Y; Maruta, Y; Nakamura, M; Nishizawa, S; Ogasawara, T; Sadato, N; Sano, K; Yonekura, Y | 1 |
| Daldrup-Link, HE; Franzius, C; Heindel, WL; Jürgens, H; Schober, O; Sciuk, J; Wagner-Bohn, A | 1 |
| Cabrera Villegas, A; Gámez Cenzano, C; Martín Urreta, JC | 1 |
| Guller, U; Harder, F; Langer, I; Marti, WR; Moch, H; Nitzsche, EU; Oertli, D; Schirp, U; Torhorst, J; Viehl, CT; Zuber, M | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
| Brink, I; Klenzner, T; Krause, T; Mix, M; Moser, E; Nitzsche, EU; Ross, UH | 1 |
| Even-Sapir, E; Figer, A; Gutman, M; Inbar, M; Lerman, H; Livshitz, G; Rabau, M | 1 |
| Scott, AM | 1 |
| Avril, N; Dose, J; Rosé, C | 1 |
| de Vries, EG; Dullaart, RP; Jager, PL; Links, TP; Piers, DA; Pruim, J; van Tol, KM | 1 |
| Ido, T; Ishiwata, K; Itoh, J; Iwata, R; Kameyama, M; Tada, M; Takahashi, T; Tomura, M | 1 |
| Cody, R; Hutchins, G; Mudgett, E; Wahl, RL | 1 |
| Ahonen, A; Joensuu, H | 1 |
| Ahonen, A; Haaparanta, M; Johansson, R; Paul, R; Roeda, D; Sipilä, H; Solin, O | 1 |
123 review(s) available for fluorodeoxyglucose f18 and Neoplasm Metastasis
| Article | Year |
|---|---|
18F-FDG PET/CT in pancreatic adenocarcinoma: A role at initial imaging staging?
Topics: Carcinoma, Pancreatic Ductal; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Patient Care Planning; Patient Selection; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Fluorodeoxyglucose PET for Monitoring Response to Embolotherapy (Transarterial Chemoembolization) in Primary and Metastatic Liver Tumors.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Tumor Microenvironment | 2019 |
Multimodality Imaging of Prostate Cancer.
Topics: Aged; Antigens, Surface; Carboxylic Acids; Choline; Cyclobutanes; Disease Progression; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiparametric Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radionuclide Imaging; Theranostic Nanomedicine; Tomography, X-Ray Computed; Whole Body Imaging | 2019 |
Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis | 2020 |
A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Whole Body Imaging; Young Adult | 2020 |
PET/CT Variants and Pitfalls in Breast Cancers.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2021 |
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2017 |
Sarcomatoid renal cell carcinoma: a case report and literature review.
Topics: Carcinoma, Renal Cell; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Hematuria; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2018 |
Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis.
Topics: Adult; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome | 2018 |
Prostate cancer PET tracers: essentials for the urologist.
Topics: Antigens, Surface; Carbon Radioisotopes; Carboxylic Acids; Cyclobutanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Radiopharmaceuticals; Sodium Fluoride | 2018 |
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (
Topics: Adenocarcinoma; Aged; Cell Transformation, Neoplastic; Clinical Decision-Making; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioactive Tracers; Treatment Outcome | 2019 |
18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Performance of pre-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; MEDLINE; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Whole-Body MR Imaging: The Novel, "Intrinsically Hybrid," Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Forecasting; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2018 |
Differentiated thyroid cancer theranostics: radioiodine and beyond.
Topics: Ablation Techniques; Biomarkers; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Peptide; Recombinant Proteins; Risk Assessment; Symporters; Theranostic Nanomedicine; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2018 |
PET/MRI in Breast Cancer.
Topics: Adult; Algorithms; Axilla; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypoxia; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2 | 2019 |
Diagnostic performance of [
Topics: Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
18FDG PET-CT for diagnosis of distant metastases in breast cancer patients. A meta-analysis.
Topics: Bone and Bones; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
[Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies].
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Stomach Neoplasms | 2013 |
Meta-analysis of the additional value of integrated 18FDG PET-CT for tumor distant metastasis staging: comparison with 18FDG PET alone and CT alone.
Topics: Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Role of positron emission tomography/computed tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Precision Medicine; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2013 |
Positron emission tomography/computed tomography in melanoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2013 |
PET/CT in gynecologic malignancies.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Time Factors; Wilms Tumor | 2013 |
PET/CT in malignant lymphoma: basic information, clinical application, and proposal.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Common diagnostic flowcharts in infective endocarditis.
Topics: Decision Support Systems, Clinical; Echocardiography, Transesophageal; Endocarditis, Bacterial; Endocardium; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Male; Neoplasm Metastasis; Polymerase Chain Reaction; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
Topics: Ablation Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neoplasm, Residual; Positron-Emission Tomography; Radiofrequency Therapy; Tomography, X-Ray Computed | 2014 |
18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Choroid Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Intravitreal Injections; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2014 |
[FDG-PET/CT in staging of breast carcinoma: use in tumour stage III and locoregional recurrent breast carcinoma].
Topics: Aged; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Using nuclear medicine imaging in clinical practice: update on PET to guide treatment of patients with metastatic breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Estrogen | 2014 |
Imaging of oesophageal cancer with FDG-PET/CT and MRI.
Topics: Antineoplastic Protocols; Diffusion Magnetic Resonance Imaging; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
Topics: Carcinoma; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed | 2014 |
Optimizing the use of PET with selective internal radiation therapy.
Topics: Brachytherapy; Fluorodeoxyglucose F18; Humans; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2014 |
Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies.
Topics: Adolescent; Brain Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Wilms Tumor | 2015 |
[18F]fludeoxyglucose positron emission tomography and computed tomography as a prognostic tool before liver transplantation, resection, and loco-ablative therapies for hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Liver Transplantation; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Value of functional imaging by PET in esophageal cancer.
Topics: Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Multiple myeloma.
Topics: Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Paraproteinemias; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
PET/Computed Tomography and Patient Outcomes in Melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2015 |
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
FDG in Urologic Malignancies.
Topics: Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Urologic Neoplasms | 2014 |
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Humans; Lymph Nodes; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
A new appraisal of iodine refractory thyroid cancer.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Biological Transport, Active; Carcinoma; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Forecasting; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Molecular Targeted Therapy; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Prognosis; Proto-Oncogene Proteins B-raf; Signal Transduction; Survival Rate; Symporters; Thyroid Neoplasms; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases | 2015 |
18F-FDG PET/CT Prediction of an Aggressive Clinical Course for Dermatofibrosarcoma Protuberans.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2017 |
Causes and consequences of increased glucose metabolism of cancers.
Topics: Cell Hypoxia; Cell Transformation, Neoplastic; Evolution, Molecular; Female; Fluorodeoxyglucose F18; Game Theory; Glucose; Glycolysis; History, 19th Century; History, 20th Century; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Oncogenes; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Medical Oncology; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiology; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms | 2008 |
PET/CT and occult primary tumors.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Symporters; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Young Adult | 2009 |
Should FDG PET/CT be used for the initial staging of breast cancer?
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2009 |
PET-CT imaging in pediatric oncology.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET detection of a medullary thyroid carcinoma in a patient with metastatic colonic cancer; literature review.
Topics: Aged; Biopsy, Fine-Needle; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Thyroid Neoplasms; Thyroidectomy; Ultrasonography | 2009 |
Radionuclide imaging of tumor angiogenesis.
Topics: Alternative Splicing; Angiogenesis Inhibitors; Animals; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Magnetic Resonance Imaging; Matrix Metalloproteinases; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Receptors, Immunologic; Receptors, Peptide; Receptors, Vascular Endothelial Growth Factor | 2009 |
Functional imaging of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Decision Making; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Nodes; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Tomography, X-Ray Computed | 2010 |
Role and limitations of 18F-FDG positron emission tomography (PET) in the management of patients with pancreatic lesions.
Topics: Adenocarcinoma; Cystadenocarcinoma; Cystadenoma; Fluorodeoxyglucose F18; Humans; Insulinoma; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pancreatitis; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2010 |
Positron emission tomography for benign and malignant disease.
Topics: Breast Neoplasms; Colorectal Neoplasms; Dermatitis, Contact; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2011 |
Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Gastric Mucosa; Glucose Transporter Type 1; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Stomach Neoplasms; Treatment Outcome | 2011 |
[Hybrid PET/CT in cancer imaging].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
¹⁸F-FDG PET/CT imaging of the pancreas: spectrum of diseases.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Humans; Monitoring, Physiologic; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pancreas; Pancreatic Diseases; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Topics: Drug Therapy; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Peritoneal Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Stomach Neoplasms | 2011 |
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2012 |
LUCIS: lung cancer imaging studies.
Topics: Area Under Curve; Cohort Studies; Early Detection of Cancer; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Neoplasm Metastasis; Perfusion Imaging; Positron-Emission Tomography; Radiography, Thoracic; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2012 |
Positron emission tomography for evaluation of colorectal carcinoma.
Topics: Carcinoma; Colorectal Neoplasms; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography imaging in melanoma and lymphoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography in thyroid cancer management.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
Clinical applications of FDG-PET in oncology.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
PET scanning in lung cancer: current status and future directions.
Topics: Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Diagnosis of colorectal cancer with FDG-PET].
Topics: Colorectal Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
The role of nuclear medicine in the staging and management of liver metastases.
Topics: Carcinoma, Neuroendocrine; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2003 |
The role of positron emission tomography in the management of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
FDG PET and alternative imaging in the management of thyroid carcinoma.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Care Management; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
[The interest of 18FDG-PET in the management of testicular cancer].
Topics: Adolescent; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Positron-emission tomography for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Molecular imaging in breast cancer.
Topics: Breast; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiation Dosage; Radioimmunodetection; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Value of FDG PET in the management of NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Solitary Pulmonary Nodule; Time Factors | 2005 |
Functional imaging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prognosis | 2005 |
A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
[Combined role of tumor markers and 18fluoro-deoxyglucose-positron emission tomography (18FDG-PET) in follow-up of cancer patients].
Topics: Biomarkers, Tumor; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
CT and PET imaging in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
[Contribution of positron emission tomography to the detection and staging of breast cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer.
Topics: Carcinoma, Medullary; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed | 2006 |
Tumor hypoxia imaging.
Topics: Biomarkers; Cell Hypoxia; Fluorodeoxyglucose F18; Humans; Misonidazole; Models, Biological; Neoplasm Metastasis; Neoplasms; Oxygen; Positron-Emission Tomography | 2006 |
Positron Emission Tomography (PET) and Mammography (PEM) for breast cancer: importance to surgeons.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Dysplasia | 2007 |
[Usefulness of 18F-FDG-PET in breast cancer imaging].
Topics: Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2007 |
Clinical applications of PET in brain tumors.
Topics: Adult; Amino Acids; Biopsy; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Contrast Media; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Detection of bone metastases in breast cancer by positron emission tomography.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2007 |
PET/CT in oncology: for which tumours is it the reference standard?
Topics: Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
PET/CT and cross sectional imaging of gynecologic malignancy.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
[Utility of positron emission tomography with fluorodeoxyglucose (FDG-PET) in the evaluation of thyroid cancer: a systematic review].
Topics: Adenocarcinoma, Follicular; Biomarkers, Tumor; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms | 2007 |
Staging investigations for oesophageal cancer: a meta-analysis.
Topics: Endosonography; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
[Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2007 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
Current status of FDG-PET for head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2008 |
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
Overview of the current status of PET in breast cancer imaging.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carbon Radioisotopes; Copper; Copper Radioisotopes; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Methionine; Neoplasm Metastasis; Neoplasm Staging; Organometallic Compounds; Oxygen Radioisotopes; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Thiosemicarbazones; Tomography, Emission-Computed | 1998 |
Impact of the diagnostic methods on the therapeutic strategies.
Topics: Age Factors; Breast Neoplasms; Chemotherapy, Adjuvant; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Mammography; Mass Screening; Mastectomy, Segmental; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Radiographic Image Enhancement; Radiopharmaceuticals; Survival Rate; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
18-FDG imaging in breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Positron emission tomography (PET) in the evaluation of patients with cancer.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Detection of residual and recurrent thyroid cancer by radionuclide imaging.
Topics: Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm, Residual; Radiopharmaceuticals; Recombinant Proteins; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1999 |
Positron emission tomography imaging of colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Non-131I-scintigraphy in the treatment and follow-up of thyroid cancer. Single-photon-emitters or FDG-PET?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Radiopharmaceuticals; Recurrence; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
[Positron emission tomography for diagnosis of breast cancers].
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
A new imaging technique for colorectal cancer: positron emission tomography.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Central Nervous System Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Rats; Tomography, Emission-Computed | 2001 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
The role of nuclear medicine in the evaluation of pancreatic disease.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pancreatic Diseases; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed | 2001 |
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; MEDLINE; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Influence of positron emission tomography on surgical therapy planning in recurrent colorectal cancer].
Topics: Adult; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG pet.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Patient Selection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Positron emission tomography (PET) of non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
[Positron emission tomography (PET) in clinical oncology. Part II].
Topics: Adult; Aged; Colorectal Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphoma; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Current status of positron emission tomography in oncology.
Topics: Australia; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomography for the diagnosis of breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
73 trial(s) available for fluorodeoxyglucose f18 and Neoplasm Metastasis
| Article | Year |
|---|---|
Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclin-Dependent Kinases; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Letrozole; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Piperazines; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyridines; Receptors, Estrogen; Young Adult | 2020 |
Correlation between Skip N2 Metastases and SUV
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2020 |
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Topics: Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Immune Checkpoint Inhibitors; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated
Topics: Adult; Aged; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Indazoles; Indoles; London; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome | 2017 |
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Fluorodeoxyglucose F18; Glycolysis; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen | 2018 |
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.
Topics: Aged; Carcinoma, Pancreatic Ductal; Disease-Free Survival; Female; Fluorodeoxyglucose F18; GPI-Linked Proteins; Humans; Immunotherapy, Adoptive; Male; Mesothelin; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Antigen, T-Cell; RNA, Messenger; Survival Rate; T-Lymphocytes; Transplantation, Autologous | 2018 |
Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.
Topics: Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Retrospective Studies; Time Factors; Whole Body Imaging | 2018 |
Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2- Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study.
Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Receptor, ErbB-2; Receptors, Estrogen; Retrospective Studies; Survival Rate | 2018 |
Prospective comparison of (4S)-4-(3-
Topics: Adenocarcinoma; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glutamates; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prospective Studies; Safety | 2019 |
Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2019 |
Clinical significance of signs of autoimmune colitis in
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Colitis; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Salivary Gland Neoplasms; Young Adult | 2019 |
A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Nephrectomy; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Sulfonamides; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Withholding Treatment | 2013 |
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Italy; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Vincristine | 2013 |
Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Survival Analysis; Tomography, X-Ray Computed; Treatment Failure | 2013 |
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.
Topics: Ablation Techniques; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radio Waves; Radiofrequency Therapy; Reference Standards; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Renal Cell; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Tumor Burden | 2013 |
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
Topics: Aged; Benzamides; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Melanins; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Receptors, Urokinase Plasminogen Activator; Survival Analysis; Tissue Inhibitor of Metalloproteinase-1; Tomography, X-Ray Computed | 2014 |
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2014 |
BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study).
Topics: Aged; Aged, 80 and over; Bone Marrow; Choline; Fluorodeoxyglucose F18; Glutarates; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Organophosphonates; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radiometry; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Tumor Burden | 2014 |
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Prostatic Neoplasms; Registries; Sodium Fluoride; Treatment Outcome | 2015 |
Value of 18F-FDG PET negativity and Tg suppressibility as markers of prognosis in patients with elevated Tg and 131I-negative differentiated thyroid carcinoma (TENIS syndrome).
Topics: Adult; Biomarkers; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2015 |
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography I
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lapatinib; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Quinazolines; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2015 |
Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases.
Topics: Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peptides, Cyclic; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Stomach Neoplasms; Treatment Outcome; Young Adult | 2016 |
Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis.
Topics: Adult; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Tuberculosis | 2016 |
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Treatment Outcome; Vinblastine | 2017 |
Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prospective Studies; Pyridines; Treatment Outcome | 2017 |
Correlation of
Topics: Adult; Aged; Area Under Curve; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?
Topics: Carcinoma, Squamous Cell; False Negative Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Pyrroles; Radiopharmaceuticals; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.
Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; Bone Neoplasms; C-Reactive Protein; Cell Proliferation; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Male; Multiple Myeloma; Neoplasm Metastasis; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate | 2009 |
Evaluation of sorafenib treatment in metastatic renal cell carcinoma with 2-fluoro-2-deoxyglucose positron emission tomography and computed tomography.
Topics: Aged; Benzenesulfonates; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Positron-Emission Tomography; Pyridines; Sorafenib; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2009 |
18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study.
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Recurrence; Time Factors | 2009 |
The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2011 |
Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Cell Proliferation; CTLA-4 Antigen; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.
Topics: Adult; Aged; Breast Neoplasms; Diffusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Reference Standards; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.
Topics: Acetylation; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Indoles; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Panobinostat; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2010 |
Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
Topics: Discriminant Analysis; Doxorubicin; Drug Therapy, Combination; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Patient Selection; Positron-Emission Tomography; Risk; Sarcoma; Survival Analysis; Treatment Outcome | 2010 |
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
Topics: 2-Methoxyestradiol; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Estradiol; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nanoparticles; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Treatment Outcome | 2011 |
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Carcinoma, Medullary; Cell Differentiation; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Indoles; Iodine; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Pyrroles; Sunitinib; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Failure | 2010 |
Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2011 |
¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.
Topics: Biological Transport; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed | 2011 |
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Hormones; Humans; Middle Aged; Mucin-1; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
First experience with proteasome inhibitor treatment of radioiodine nonavid thyroid cancer using bortezomib.
Topics: Aged; Aged, 80 and over; Boronic Acids; Bortezomib; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Quality of Life; Thyroid Neoplasms; Treatment Failure | 2012 |
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer.
Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Sodium Fluoride; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Piperidines; Positron-Emission Tomography; Pyrroles; Triazines | 2012 |
Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2013 |
Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; International Cooperation; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasms; Nuclear Medicine; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyrotropin; Tomography, Emission-Computed | 2004 |
Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
Topics: Adult; Aged; Biopsy, Needle; Carcinoma, Non-Small-Cell Lung; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Combined Modality Therapy; Decision Making; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.
Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Amidines; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Indans; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Topics: Adult; Aged; Aged, 80 and over; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stem Cell Transplantation; Survival Analysis | 2006 |
Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Health Care Costs; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Tomography, Emission-Computed | 1999 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2000 |
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed | 2001 |
High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasms, Second Primary; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.
Topics: Adolescent; Adult; Biopsy; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Bone Tissue; Recurrence; Tomography, Emission-Computed | 2002 |
Better yield of (18)fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Stimulation, Chemical; Thyroid Neoplasms; Thyrotropin; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
718 other study(ies) available for fluorodeoxyglucose f18 and Neoplasm Metastasis
| Article | Year |
|---|---|
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Distant Metastasis Patterns of Lung Cancer on Positron Emission Tomography/Computed Tomography Association with Age and Histological Subtype.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Small Cell Lung Carcinoma | 2021 |
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Sternum; Thrombosis | 2023 |
Restaging [
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
What is this image? 2019: Image 3 result : Multimodal imaging of pericardial synovial sarcoma and two years postoperative follow-up by
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Male; Necrosis; Neoplasm Metastasis; Pericardium; Positron Emission Tomography Computed Tomography; Postoperative Period; Sarcoma, Synovial | 2019 |
18F-FDG PET/CT Findings of Ovarian Mesothelioma: A Case Study.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mesothelioma; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Gliosarcoma; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Recurrence; Whole Body Imaging | 2019 |
18F-FDG PET/CT of Multiorgan Sarcoid-Like Reaction During Anti-PD-1 Treatment for Melanoma.
Topics: Antibodies; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Sarcoidosis | 2019 |
The Great Mimicker-Tuberculosis Involving Prostate and Vertebrae Posing as Metastatic Prostate Carcinoma on FDG PET/CT.
Topics: Aged; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Spine; Tuberculosis | 2020 |
Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2019 |
Predominance and homogeneity patterns of physiological FDG accumulation in thoracic and lumbar vertebrae: suspected mechanism of "bone pseudometastasis" on FDG-PET in Japanese patients with esophageal cancer.
Topics: Aged; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lumbar Vertebrae; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Vertebrae | 2020 |
68Ga-ZHER2 PET/CT Reveals HER2-Positive Metastatic Gastric Cancer With Better Image Quality Than 18F-FDG.
Topics: Adult; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recombinant Fusion Proteins; Stomach Neoplasms | 2020 |
18F-FDG PET/CT Findings in Metastatic Pilomatrix Carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Hair Follicle; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT.
Topics: Adolescent; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Neoplasm Metastasis; Neoplasm Staging; Neurons; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2020 |
Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sweden | 2020 |
Comparison of 18F-FDG PET/CT Criteria for the Prediction of Therapy Response and Clinical Outcome in Patients With Metastatic Melanoma Treated With Ipilimumab and PD-1 Inhibitors.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors | 2020 |
Treatment patterns and survival after 18F-fluorodeoxyglucose positron emission tomography/computed tomography-guided local consolidation therapy for oligometastatic non-small cell lung cancer: a two-center propensity score-matched analysis.
Topics: Carcinoma, Non-Small-Cell Lung; Consolidation Chemotherapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Propensity Score; Radiopharmaceuticals; Retrospective Studies | 2020 |
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
The Predictive Value of Early Changes in
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Fulvestrant; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Receptors, Estrogen | 2020 |
Is It Time to Introduce PET/CT in Colon Cancer Guidelines?
Topics: Adenocarcinoma; Aged; Biopsy; Colonic Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic | 2020 |
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2020 |
Complete Metabolic Response Assessed by FDG PET/CT to FOLFOXIRI-Bevacizumab in First-Line Treatment of BRAFV600E Mutated Metastatic Colorectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cetuximab; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Leucovorin; Middle Aged; Mutation; Neoplasm Metastasis; Organoplatinum Compounds; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Treatment Outcome | 2020 |
Accuracy of peritoneal carcinomatosis extent diagnosis by initial FDG PET CT in epithelial ovarian cancer: A multicentre study of the FRANCOGYN research group.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; France; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Rate | 2020 |
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; CA-125 Antigen; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Time Factors; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2 | 2020 |
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2020 |
Assessment of Bone Lesions with
Topics: Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Technetium | 2021 |
Isolated Metastasis to Spleen-Stomach Space From Follicular Thyroid Cancer Combined With a Benign Subcutaneous Nodule on 18F-FDG PET/CT and 131I Scintigraphy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Spleen; Stomach; Thyroid Neoplasms; Whole Body Imaging | 2021 |
Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Topics: Aged; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lysine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Urea | 2020 |
Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors.
Topics: Fluorodeoxyglucose F18; France; Humans; Neoplasm Metastasis; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Surveys and Questionnaires | 2020 |
Utility of Bone Scintigraphy and PET-CT in the Surgical Staging of Skeletal Chondrosarcoma.
Topics: Bone and Bones; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Tomography, X-Ray Computed | 2020 |
Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma?
Topics: Aged; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Osteosarcoma; Positron Emission Tomography Computed Tomography; Sternum | 2021 |
Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
Topics: Clinical Decision-Making; Disease Progression; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2020 |
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Male; Merkel cell polyomavirus; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Topics: Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms | 2021 |
Metabolic Response by 18F-FDG PET/CT in Metastatic Malignant Struma Ovarii Treated With Targeted Therapies.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Molecular Targeted Therapy; Neoplasm Metastasis; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Struma Ovarii; Treatment Outcome | 2021 |
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Young Adult | 2021 |
The role of histogram analysis of grayscale sonograms to differentiate thyroid nodules identified by 18F-FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Biopsy, Large-Core Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Gland; Thyroid Nodule; Ultrasonography | 2020 |
Epithelioid Hemangioma of Vertebra Mimicking Metastasis on FDG PET/CT in a Patient With Renal Cell Cancer.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Endothelial Cells; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Spinal Neoplasms | 2021 |
Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
Topics: Cerebellar Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Medulloblastoma; Neoplasm Metastasis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
18F-FDG PET/CT for Monitoring of Disease Progression in Metastatic Perivascular Epithelioid Cell Tumor.
Topics: Adult; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Perivascular Epithelioid Cell Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2020 |
RADIOISOTOPE DIAGNOSTIC ALGORITHM FOR THE RELAPSE AND METASTASES DETECTION IN THE IODINE-NEGATIVE DIFFERENTIATED THYROID CANCER.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Survival Analysis; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Gland; Thyroid Neoplasms; Ukraine; Whole-Body Counting | 2020 |
Metastatic Adamantinoma of the Femur on FDG PET/CT: Atypical Presentation of a Rare Disease.
Topics: Adamantinoma; Aged; Female; Femur; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Rare Diseases | 2021 |
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Hedgehog Proteins; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Signal Transduction; Skin Neoplasms; Treatment Outcome | 2021 |
Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Topics: Adolescent; Adult; Age Factors; Aged; Algorithms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; ROC Curve; Sex Factors | 2021 |
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging; Young Adult | 2021 |
Value of regular endosonography and [18F]fluorodeoxyglucose PET-CT after surgery for gastro-oesophageal junction, stomach or pancreatic cancer.
Topics: Adenocarcinoma; Aged; Biopsy, Fine-Needle; Endosonography; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2021 |
Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Spatiotemporal Evolution of Radiation Myositis on 18F-FDG PET/CT Following Hypofractionated Radiotherapy of Intramuscular Melanoma Metastases.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Myositis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiation Dose Hypofractionation; Radiation Injuries | 2021 |
Primary splenic epithelioid hemangioendothelioma with diffuse metastases revealed by FDG PET/CT imaging: A case report.
Topics: Adult; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Splenic Neoplasms | 2021 |
Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Topics: Antibodies, Monoclonal, Humanized; Calcium; Cinacalcet; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immune System; Immunotherapy; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Molecular Biology; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2021 |
PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre.
Topics: Adenocarcinoma; Aged; Australia; Biopsy; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2021 |
Role of
Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Rhabdomyosarcoma; Sarcoma | 2021 |
Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma.
Topics: Aged; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2022 |
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Renal Cell; Disease-Free Survival; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2017 |
Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multidetector Computed Tomography; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Mice; Molecular Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Oxygen; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2017 |
Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.
Topics: Adult; Aged; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2017 |
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome | 2017 |
18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carrier Proteins; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2017 |
"Pseudo-progression" in advanced thyroid cancer in response to kinase inhibitor therapy.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin | 2017 |
Bilateral Tibial Osteofibrous Dysplasia on 18F-FDG PET/CT.
Topics: Adolescent; Bone Diseases, Developmental; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Tibia | 2017 |
18F-FDG PET/CT of Malignant Angiomyolipoma With Tumor Thrombus.
Topics: Angiomyolipoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Nephrectomy; Positron Emission Tomography Computed Tomography; Thrombosis | 2017 |
[
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease Progression; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Induction Chemotherapy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Urinary Bladder Neoplasms; Vinblastine | 2017 |
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms | 2018 |
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Models, Statistical; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron-Emission Tomography; ROC Curve; Treatment Outcome; Tumor Burden | 2017 |
Primary Cutaneous Angiosarcoma Mimicking Metastasis on 18F-FDG PET/CT in Woman With Cervix Cancer.
Topics: Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Cervical Neoplasms | 2017 |
Prognostic value of primary gross tumor volume and standardized uptake value of
Topics: Adult; Aged; Carcinoma; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
Topics: Adult; Aged; Aged, 80 and over; Animals; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Marek Disease; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Young Adult | 2018 |
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome | 2017 |
The value of 18F-FDG PET/CT imaging in breast cancer staging.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, Emission-Computed; Young Adult | 2018 |
Imaging-Guided Use of Combined
Topics: Adult; Capecitabine; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Radiotherapy, Image-Guided | 2017 |
Intra-articular Melanoma Metastasis in the Ankle Joint.
Topics: Aged; Ankle Joint; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2017 |
Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Positron-Emission Tomography; Prognosis; Sarcoma, Ewing; Treatment Outcome | 2017 |
68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma: Comparison With 18F-FDG.
Topics: Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Hemangioendothelioma, Epithelioid; Humans; Middle Aged; Molecular Imaging; Neoplasm Metastasis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Receptors, Somatostatin | 2017 |
Bone Marrow Metastasis Is an Early Stage of Bone Metastasis in Breast Cancer Detected Clinically by F18-FDG-PET/CT Imaging.
Topics: Adult; Aged; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radionuclide Imaging | 2017 |
Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2017 |
Case report of
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multiple Endocrine Neoplasia; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Small Cell Lung Carcinoma | 2018 |
Topics: Adenocarcinoma; Aged; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden | 2018 |
Multiple Hypermetabolic Subcutaneous Lesions From Hidradenitis Suppurativa Mimicking Metastases on 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin | 2018 |
Prognostic value of combining a quantitative image feature from positron emission tomography with clinical factors in oligometastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals | 2018 |
Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
Topics: Adult; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Ovary; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult | 2018 |
Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
Topics: Adaptation, Physiological; Adenocarcinoma; Adenocarcinoma of Lung; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Nivolumab; Positron Emission Tomography Computed Tomography | 2018 |
[A Case of Local Recurrence with Negative FDG/PET Findings after a Total Proctocolectomy for Ulcerative Colitis Associated with Colon Cancer with Retroperitoneal Penetration].
Topics: Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Wounds, Penetrating | 2017 |
18F-FDG avid Sclerosing Angiomatoid Nodular Transformation (SANT) of spleen on PET-CT - a rare mimicker of metastasis.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Spleen | 2018 |
A hierarchical prognostic model for risk stratification in patients with early breast cancer according to
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Models, Statistical; Multimodal Imaging; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models | 2018 |
Pulmonary actinomycosis mimicking a lung metastasis from esophageal cancer; a case report.
Topics: Actinomycosis; Aged; Biopsy, Needle; Diagnosis, Differential; Endoscopy, Digestive System; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pleural Effusion; Pneumonia, Bacterial; Positron Emission Tomography Computed Tomography | 2018 |
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Tomography, X-Ray Computed | 2018 |
Iodine/FDG "Flip-Flop" Phenomenon Inside a Large Metastatic Thyroid Cancer Lesion Better Characterized on SPECT/CT and PET/CT Studies.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2018 |
Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Sarcoma, Ewing | 2018 |
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2018 |
Prostate-Specific Membrane Antigen-Negative Metastases-A Potential Pitfall in Prostate-Specific Membrane Antigen PET.
Topics: Adult; Diagnosis, Differential; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Histiocytoma; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer.
Topics: Adenocarcinoma; Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2018 |
Peliosis Hepatis Simulating Metastatic Liver Disease on FDG PET/CT.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Neoplasm Metastasis; Peliosis Hepatis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2018 |
[Role of PET/CT in primitive non-small cell bronchopulmonary cancer].
Topics: Aged; Aged, 80 and over; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Morocco; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2017 |
Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis.
Topics: Aged; Bone and Bones; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Retrospective Studies | 2018 |
The role of initial
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Plasmacytoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Colonic metastasis from breast carcinoma detection by CESM and PET/CT: A case report.
Topics: Aged; Asymptomatic Diseases; Breast; Breast Neoplasms; Carcinoma, Lobular; Colectomy; Colon; Colonic Neoplasms; Colonoscopy; Female; Fluorodeoxyglucose F18; Humans; Mammography; Mucin-1; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Receptors, Cell Surface; Treatment Outcome | 2018 |
Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR.
Topics: Biomarkers, Tumor; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Mazabraud's Syndrome Mimicking Metastases on FDG PET/CT in a Patient With Colon Cancer.
Topics: Aged; Colonic Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Myxoma; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2018 |
Hematopoietically Active Adrenal Myelolipoma Mimicking Breast Cancer Metastasis.
Topics: Adrenal Gland Neoplasms; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Myelolipoma; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2018 |
Metastasizing pleomorphic adenoma in the multiple organs: A case report on FDG-PET/CT imaging.
Topics: Adenoma, Pleomorphic; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Liver Neoplasms; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteolysis; Parotid Gland; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Salivary Glands; Tomography, X-Ray Computed | 2018 |
Progression of Focal to Diffuse Thyroid Uptake Detected by 18F-FDG PET/CT: Malignant Metastatic Disease or Benign Thyroiditis?
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroiditis | 2018 |
FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies | 2018 |
Prognostic Value of FDG-PET/CT Metabolic Parameters in Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2018 |
Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tumor Burden | 2018 |
Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Treatment Outcome | 2018 |
Radiomics analysis of pre-treatment [
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Positron Emission Tomography Computed Tomography; Retrospective Studies; Tumor Burden; Young Adult | 2018 |
FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Topics: Breast; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiation Oncology; Radiopharmaceuticals; Radiotherapy | 2019 |
FDG-PET/CT of invasive thymoma extending into the superior vena cava and right atrium.
Topics: Aged; Cisplatin; Fluorodeoxyglucose F18; Heart Atria; Humans; Ifosfamide; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Thymoma; Thymus Neoplasms; Vena Cava, Superior | 2019 |
A smart and operator independent system to delineate tumours in Positron Emission Tomography scans.
Topics: Algorithms; Brain Neoplasms; Diagnosis, Computer-Assisted; False Positive Reactions; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Observer Variation; Pattern Recognition, Automated; Phantoms, Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Software; Tomography, X-Ray Computed | 2018 |
Bone Sequestration as a Consequence of Esophageal Carcinoma Metastasis Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteolysis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Significance of
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Treatment Outcome; Tumor Burden | 2019 |
Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
Topics: Adult; Age Factors; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2018 |
18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Topics: Aged; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2019 |
Hemosiderotic Fibrolipomatous Tumor on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2019 |
Prognostic significance of maximum standardized uptake value on 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2018 |
Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
Topics: Adenoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2019 |
Focal mass-like cardiac uptake on oncologic FDG PET/CT: Real lesion or atypical pattern of physiologic uptake?
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Can benign lymphoid tissue changes in
Topics: Antineoplastic Agents, Immunological; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Ipilimumab; Lymphoid Tissue; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2019 |
Diagnostic Accuracy of 18F-FDG PET/CT in Patients With Biochemical Evidence of Recurrent, Residual, or Metastatic Medullary Thyroid Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Young Adult | 2019 |
Preoperative Metabolic Tumor Volume
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Phenotype; Positron-Emission Tomography; Preoperative Period; Prognosis; Transcriptome; Tumor Burden | 2019 |
Dual-Tracer PET/CT Differentiates 2 Types of Primary Cancers and Metastases in a Patient With Crossed Fused Renal Ectopia.
Topics: Acetates; Carbon Radioisotopes; Carcinoma, Renal Cell; Colonic Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radioactive Tracers | 2019 |
Diffuse Skeletal Hemangiomatosis Mimicking Metastastic Disease on 18F-FDG PET/CT.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Hemangioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2019 |
Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography useful to discriminate metachronous lung cancer from metastasis in patients with oncological history?
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2020 |
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Prognosis; Vincristine | 2019 |
Rectal adenocarcinoma presenting with thigh muscle metastasis as the only metastatic site.
Topics: Adenocarcinoma; Chemoradiotherapy, Adjuvant; Colorectal Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Metastasectomy; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Thigh; Treatment Outcome | 2019 |
Diagnosis of Primary Clear Cell Carcinoma of the Vagina by 18F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Vaginal Neoplasms | 2019 |
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Topics: Adult; Aged; Aorta; Biomarkers, Tumor; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Detection of distant metastatic disease by positron emission tomography with
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2019 |
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
Topics: Aged; Alleles; Autoantigens; beta Catenin; Cyclin-Dependent Kinase Inhibitor p16; Extracellular Signal-Regulated MAP Kinases; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 1; Melanoma; Neoplasm Metastasis; Oncogene Proteins, Fusion; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Skin Neoplasms | 2019 |
Workup of Suspected Chest Metastases on
Topics: Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Thorax; Time-to-Treatment; United States | 2019 |
An exceptional group of non-small cell lung cancer difficult to diagnose: Evaluation of lipid-poor adrenal lesions.
Topics: Adrenal Gland Neoplasms; Aged; Biopsy; Blood Glucose; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Humans; Lipids; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Unknown Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2019 |
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.
Topics: Adenocarcinoma of Lung; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2019 |
Correlation Between Uptake of
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis; Treatment Outcome | 2019 |
Complete Metabolic Response Assessed by FDG PET/CT to FOLFIRI-Aflibercept in Second-Line Treatment of Metastatic Colorectal Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Metastatic Extramammary Paget Disease of the Perianal Region.
Topics: Aged; Fluorodeoxyglucose F18; Groin; Humans; Male; Neoplasm Metastasis; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2019 |
FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cell Differentiation; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Thyroid Neoplasms; Young Adult | 2019 |
Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Glycolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tumor Burden | 2019 |
Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Magnetic Resonance Imaging; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Retrospective Studies; Transcriptome; Treatment Outcome; Young Adult | 2019 |
Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Kidney Transplantation; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography | 2019 |
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lysine; Male; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea | 2019 |
18F-FDG PET/CT in Metastatic Extramammary Paget's Disease.
Topics: Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography | 2019 |
FDG PET/CT in the detection of metastases in a patient with Tg and 131I WBS negative follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Organometallic Compounds; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Thyroglobulin levels and thyroglobulin doubling time independently predict a positive 18F-FDG PET/CT scan in patients with biochemical recurrence of differentiated thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Predictive Value of Tests; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Time Factors | 2013 |
Limited efficacy of (18)F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming pancreatitis.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Pancreatitis; Radiography; Radionuclide Imaging | 2013 |
A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
Topics: ACTH Syndrome, Ectopic; Adult; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2013 |
Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Observer Variation; Paraneoplastic Syndromes, Nervous System; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2013 |
Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiation Dosage; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
(18)F-FDG PET/CT imaging of metastatic atypical fibroxanthoma.
Topics: Adult; Ankle; Biopsy; Bone Neoplasms; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Radiography; Radionuclide Imaging; Xanthomatosis | 2013 |
Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Anti-CTLA4 antibody therapy related complications on FDG PET/CT.
Topics: Antibodies, Monoclonal; CTLA-4 Antigen; Fluorodeoxyglucose F18; Humans; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2013 |
Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Topics: Adenocarcinoma, Papillary; Adult; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Topics: Carcinoma; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2013 |
Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Rabbits; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Toward a planning scheme for emission guided radiation therapy (EGRT): FDG based tumor tracking in a metastatic breast cancer patient.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Neoplasm Metastasis; Organs at Risk; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided | 2013 |
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography; Young Adult | 2013 |
[The compared study in detecting the recurrence and metastases of breast cancer patients post treatment between (18)F-FDG PET/CT and conventional workup].
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Clinical outcome prediction of percutaneous cementoplasty for metastatic bone tumor using (18)F-FDG PET-CT.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Cementoplasty; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pain; Positron-Emission Tomography; Postoperative Complications; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Biopsy; Bone Marrow; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography | 2014 |
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Benign adrenal hemangiomas may mimic metastases on PET.
Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Hemangioma; Humans; Incidental Findings; Male; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.
Topics: Adolescent; Adult; Aged; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Octreotide; Positron-Emission Tomography; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Young Adult | 2013 |
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Bone Neoplasms; Diagnosis, Differential; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Multiple organ metastases from ameloblastoma detected by FDG PET/CT imaging.
Topics: Aged; Ameloblastoma; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges.
Topics: Adult; Aged; DNA Copy Number Variations; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Pilot Projects; Positron-Emission Tomography; Tomography, X-Ray Computed; Transcriptome; Young Adult | 2013 |
Value of F-18 FDG PET/CT in detection and prognostication of isolated extra-axillary lymph node recurrences in postoperative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Postoperative Period; Prognosis; Radiopharmaceuticals; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Metabolic information on staging FDG-PET-CT as a prognostic tool in the evaluation of 97 patients with gastric cancer.
Topics: Aged; Analysis of Variance; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Nodes; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Unusual site of metastasis detected with FDG PET/CT in a case of recurrent rectosigmoid cancer.
Topics: Aged; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography as predictor of distant metastasis in preoperative carbon-ion radiotherapy for pancreatic cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Care; Survival Analysis | 2013 |
High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for recurrent primary mediastinal malignant germ cell tumor: a case report.
Topics: Adolescent; Antineoplastic Agents; Biopsy; Brachiocephalic Veins; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prognosis; Recurrence; Subclavian Vein; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Superior | 2014 |
Obtaining quantitative global tumoral state indicators based on whole-body PET/CT scans: a breast cancer case study.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2014 |
Detection of extranodal spread in head and neck cancer with [18F]FDG PET and MRI: improved accuracy?
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Hormones; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
FDG-PET images of acrometastases.
Topics: Fluorodeoxyglucose F18; Foot; Hand; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Whole Body Imaging | 2014 |
Radiation therapy-induced phrenic neuropathy mimicking metastasis to the diaphragmatic crus on ¹⁸F-FDG PET/CT.
Topics: Diagnosis, Differential; Diaphragm; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Peripheral Nervous System Diseases; Phrenic Nerve; Positron-Emission Tomography; Radiation Injuries; Tomography, X-Ray Computed | 2014 |
18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Male; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Whole-body-MR-diffusion weighted imaging in oncology.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Reference Values; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Distant metastases in a young woman with Stewart-Treves syndrome demonstrated by an FDG-PET/CT scan.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lymphangiosarcoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Paget sarcoma of the pelvic bone with widespread metastatic disease on radiography, CT, MRI, and 18F-FDG PET/CT with pathologic correlation.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Metastasis; Osteitis Deformans; Pelvic Bones; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2014 |
Ultra staging to unmask the prescribing of adjuvant therapy in cancer patients: the future opportunity to image micrometastases using total-body 18F-FDG PET scanning.
Topics: Chemoradiotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Micrometastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2014 |
Metabolic impact of partial volume correction of [18F]FDG PET-CT oncological studies on the assessment of tumor response to treatment.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Phantoms, Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Reproducibility of Results; Tomography, X-Ray Computed | 2014 |
Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; China; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Diagnosis of squamous cell carcinoma metastasis with 18F-FDG PET/CT in stoma after percutaneous endoscopic gastrostomy: a rare and poorly known iatrogenic cause of spread of head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Gastrostomy; Head and Neck Neoplasms; Humans; Iatrogenic Disease; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Surgical Stomas; Tomography, X-Ray Computed | 2014 |
Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.
Topics: Aged; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2014 |
Nuclear imaging and early breast cancer detection.
Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Molecular Imaging; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Inferior glucose metabolism and chemosensitivity of post-radiotherapy local recurrence in comparison with distant metastases as assessed by sequential (18)F-FDG PET/CT imaging.
Topics: Adult; Aged; Biological Transport; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Tumor thrombus in the renal vein from an adrenal metastasis of lung cancer: 18FDG PET/CT findings.
Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Renal Veins; Tomography, X-Ray Computed; Venous Thromboembolism | 2014 |
Metastasis to the thyroid from non-small cell carcinoma of the lung: findings in (18)F-FDG PET/CT study.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading system.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis | 2014 |
The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Metastases to hernial sac detected on (18)F-FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hernia; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Cone-Beam Computed Tomography; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Indazoles; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome | 2014 |
Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma.
Topics: Aged; Antineoplastic Agents; Biopsy; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Male; MAP Kinase Signaling System; Melanoma; Middle Aged; Mutation; Neoplasm Metastasis; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Retrospective Studies; Signal Transduction; Skin Neoplasms; Treatment Outcome | 2014 |
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo.
Topics: Aged; Biological Transport; Choline; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Neoplasm Metastasis; Organ Specificity; Prostatic Neoplasms; Quality Control; Radionuclide Imaging; Retrospective Studies; Urinary Tract; Urography | 2014 |
¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Topics: Adult; Aged; Breast Neoplasms, Male; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2014 |
Adhesive capsulitis mimicking metastasis on 18F-FDG-PET/CT.
Topics: Aged; Bursitis; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Shoulder Joint; Tomography, X-Ray Computed | 2015 |
Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent chemoradiation therapy.
Topics: Aged; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET/CT tumor imaging.
Topics: Adult; Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Scalp; Skull; Tomography, X-Ray Computed | 2014 |
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Adding maximum standard uptake value of primary lesion and lymph nodes in 18F-fluorodeoxyglucose PET helps predict distant metastasis in patients with nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2014 |
A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice.
Topics: Animals; Body Weight; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Reproducibility of Results; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tomography, X-Ray Computed; X-Ray Microtomography | 2015 |
The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2014 |
Multiple hepatic lesions in a case of isolated hepatic tuberculosis simulating metastases on 18F-FDG PET/CT imaging.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Tuberculosis, Hepatic | 2014 |
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
Topics: Adult; Diagnosis, Differential; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Recurrence and metastasis of lung cancer demonstrate decreased diffusion on diffusion-weighted magnetic resonance imaging.
Topics: Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATE.
Topics: Adult; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Receptors, Peptide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammography; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Impact of pretreatment imaging on survival of esophagectomy after induction therapy for esophageal cancer: who should be given the benefit of the doubt?: esophagectomy outcomes of patients with suspicious metastatic lesions.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2015 |
High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
Topics: Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Probability; Prognosis; Proportional Hazards Models; Radionuclide Imaging; ROC Curve; Stomach Neoplasms; Treatment Outcome | 2014 |
Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intestinal Neoplasms; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed | 2014 |
Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm, Residual; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Resection of a solitary pulmonary metastasis from prostatic Adenocarcinoma misdiagnosed as a Bronchocele: usefulness of 18F-choline and 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2014 |
[Management of respiratory motion in FDG-PET/CT: respiratory-gated and deep-inspiration breath-hold techniques].
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer.
Topics: Breast Neoplasms; Carcinoma; Drug Therapy; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms | 2015 |
PET scans as a predictive marker of survival in advanced colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Fourier Analysis; Heart; Heart Neoplasms; Heparin; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Prospective Studies; ROC Curve; Young Adult | 2015 |
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Risk Factors; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging.
Topics: Bone Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Early prediction by 18F-FDG PET/CT for progression-free survival and overall survival in patients with metastatic colorectal cancer receiving third-line cetuximab-based therapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Solitary subcutaneous gouty nodule mimicking metastatic melanoma on FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Medical Errors; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Subcutaneous Tissue; Tomography, X-Ray Computed | 2015 |
Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Extensive invasive extramammary Paget disease evaluated by F-18 FDG PET/CT: a case report.
Topics: Adenocarcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Groin; Hip; Humans; Male; Middle Aged; Neoplasm Metastasis; Paget Disease, Extramammary; Penis; Positron-Emission Tomography; Radiotherapy; Scrotum; Skin Neoplasms; Thigh; Tomography, X-Ray Computed | 2015 |
[(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cohort Studies; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle, Smooth; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Incidental Acinic Cell Carcinoma of the Parotid Gland Discordant on 123I-MIBG, 111In-Octreotide, and 18F-FDG PET/CT in a Patient With Neuroendocrine Tumor of the Cecum.
Topics: 3-Iodobenzylguanidine; Carcinoma, Acinar Cell; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
(18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
Topics: Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Patient Care Planning; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2015 |
CT-based versus FDG-PET/CT-based NCCN international prognostic index risk stratification in DLBCL.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the (18)F-fluorodeoxyglucose-positron emission tomography era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
A strategy for improving FDG accumulation for early detection of metastasis from primary pancreatic cancer: stimulation of the Warburg effect in AsPC-1 cells.
Topics: Ascites; Biological Transport; Cell Line, Tumor; Early Detection of Cancer; Fluorodeoxyglucose F18; Glycolysis; Hexoses; Humans; Neoplasm Metastasis; Pancreatic Neoplasms; Phosphofructokinase-1; Positron-Emission Tomography | 2015 |
18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Retrospective Studies | 2015 |
Impact of radical surgery on outcome in locally advanced breast cancer patients without metastasis at the time of diagnosis.
Topics: Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Image Interpretation, Computer-Assisted; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
Topics: Aged; Choline; Combined Modality Therapy; Diagnosis, Differential; Early Diagnosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Care; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tomography, X-Ray Computed | 2015 |
Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
[Imaging diagnosis of biliary tract cancer on PET].
Topics: Biliary Tract Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence | 2015 |
The diagnostic value of 18F-FDG PET/CT in association with serum tumor marker assays in breast cancer recurrence and metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mucin-1; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography | 2015 |
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2015 |
The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients.
Topics: Biopsy; Breast Neoplasms; Computer Simulation; Diagnostic Imaging; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prognostic value of (18)F-FDG PET/CT metabolic parameters in metastatic differentiated thyroid cancers.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Diagnostic role of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in restaging renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gastrointestinal Tract; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Topics: Aged; Biopsy; Colorectal Neoplasms; Electronic Health Records; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.
Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Radiopharmaceuticals; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Sensitivity and Specificity | 2017 |
18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed | 2015 |
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.
Topics: Adult; Aged; Area Under Curve; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Factors; ROC Curve; Stomach Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Surveys and Questionnaires; Urinary Bladder Neoplasms; Urothelium | 2016 |
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed | 2016 |
Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Topics: Aged; Antigens, Surface; Biomarkers, Tumor; Biopsy; Cysteine; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Hypertrophy; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Prognostic Value of Pretherapeutic Tumor-to-Blood Standardized Uptake Ratio in Patients with Esophageal Carcinoma.
Topics: Aged; Aorta; Carcinoma; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Umbilical Plugoma Mimics Melanoma Metastasis on FDG PET/CT.
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Hernia, Abdominal; Humans; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Umbilicus | 2015 |
Ipilimumab-Induced Adrenalitis: A Possible Pitfall in 18F-FDG-PET/CT.
Topics: Adrenocortical Hyperfunction; Aged; Antibodies, Monoclonal; Antineoplastic Agents; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Comparing RECIST with EORTC criteria in metastatic bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2016 |
Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.
Topics: Adolescent; Adult; Child; Colorectal Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
Metastatic Renal Cell Cancer Treated With Antiangiogenic Therapy Monitoring by 18F-FDG PET/CT.
Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sex Factors; Smoking; Tomography, X-Ray Computed | 2015 |
Comparative study of ¹⁸F-FDG-PET/CT imaging and serum hTERT mRNA quantification in cancer diagnosis.
Topics: Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prospective Studies; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Telomerase; Tomography, X-Ray Computed | 2015 |
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone and Bones; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies | 2015 |
The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Singapore; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms, Castration-Resistant; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Regression Analysis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2016 |
Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.
Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Lysine; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urea | 2016 |
Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; MAP Kinase Kinase Kinases; Melanoma; Middle Aged; Multimodal Imaging; Mutation; Neoplasm Metastasis; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
BRAF Inhibitor-Induced Panniculitis: Appearance on 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Imidazoles; Indoles; Male; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Oximes; Panniculitis; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Sulfonamides; Tomography, X-Ray Computed; Vemurafenib | 2016 |
Unusual Case of Postmenopausal Diffuse Endometriosis Mimicking Metastastic Ovarian Malignancy.
Topics: Aged; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Receptors, Vascular Endothelial Growth Factor; Retrospective Studies; ROC Curve; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor D; Vascular Endothelial Growth Factor Receptor-3 | 2016 |
18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With Pembrolizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed | 2016 |
Breast metastasis from melanoma mimicking inflammatory breast cancer.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease.
Topics: Aged; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Peptides; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptors, CXCR4; Treatment Outcome | 2016 |
Metastatic Malignant Fibrous Histiocytoma Infiltrating Sigmoid Colon: A Case Diagnosed With the Help of 18F-FDG PET/CT.
Topics: Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2016 |
(18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Retrospective Studies; Risk Assessment; Treatment Outcome | 2016 |
Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aging; Carcinoma, Hepatocellular; Chemoradiotherapy; Cohort Studies; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Analysis | 2016 |
Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thyroid Neoplasms; Young Adult | 2016 |
Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later.
Topics: Attitude of Health Personnel; Carcinoma, Squamous Cell; Early Detection of Cancer; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Health Care Surveys; Humans; Neoplasm Metastasis; Netherlands; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Surgeons; Tomography, X-Ray Computed | 2016 |
The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in follow-up of curatively resected pancreatic cancer patients.
Topics: Adult; Aged; Aged, 80 and over; CA-19-9 Antigen; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatectomy; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2016 |
Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2016 |
FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Decision Theory; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
Preoperative staging of non-small cell lung cancer: prospective comparison of PET/MR and PET/CT.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pneumonectomy; Positron Emission Tomography Computed Tomography; Preoperative Period; Prospective Studies; Radiopharmaceuticals; ROC Curve | 2016 |
FLT PET/CT Is Better Than FDG PET/CT in Differentiating Benign From Malignant Pancreatobiliary Lesions.
Topics: Adult; Aged; Biliary Tract Neoplasms; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2016 |
The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.
Topics: Adult; Aged; Aged, 80 and over; Body Composition; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Treatment Outcome | 2016 |
Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies | 2016 |
18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Reproducibility of Results; Sodium Fluoride; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2016 |
Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Agents; Biomarkers; Cetuximab; Colorectal Neoplasms; ErbB Receptors; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pilot Projects; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins p21(ras); Treatment Outcome | 2016 |
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
Topics: Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden | 2016 |
[Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Topics: Adult; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2016 |
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Breast Neoplasms, Male; Disease-Free Survival; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2 | 2017 |
Grouping of Metastatic Thyroid Carcinoma by Molecular Imaging Features to Allow for Individualized Treatment, with Emphasis on the TENIS Syndrome.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Precision Medicine; Thyroglobulin; Thyroid Neoplasms; Treatment Outcome; Young Adult | 2016 |
Prognostic significance of clinical and
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Young Adult | 2016 |
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
[A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome | 2016 |
Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Tumor Burden; Uterine Cervical Neoplasms | 2016 |
Primary Left Tibial Epithelioid Hemangioendotheliomas With Multiple Metastases Revealed by FDG PET/CT Imaging.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tibia | 2016 |
18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Pyrimidines; Radiopharmaceuticals; Receptor Protein-Tyrosine Kinases; Sulfones | 2016 |
68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunohistochemistry; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Receptors, Somatostatin; Tissue Distribution | 2016 |
Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Topics: Aged, 80 and over; Carcinoma, Renal Cell; Edetic Acid; Female; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Kidney Neoplasms; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2016 |
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2017 |
Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver Metastasis.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Survival Analysis | 2016 |
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cohort Studies; Diffusion Magnetic Resonance Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Rectal Neoplasms; Risk Assessment; Statistics, Nonparametric; Survival Analysis | 2017 |
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2017 |
Unsuspected Metastatic Ovarian Cancer Revealed by 18F-NaF PET/CT Performed to Evaluate Lower-Back Pain.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Low Back Pain; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate | 2017 |
Breath-hold and free-breathing F-18-FDG-PET/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters.
Topics: Adult; Aged; Aged, 80 and over; Breath Holding; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Respiration; Tomography, X-Ray Computed; Young Adult | 2017 |
Idiopathic fibrosing mediastinitis mimicking nodal metastasis from breast cancer.
Topics: Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunohistochemistry; Mediastinitis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Radiopharmaceuticals; Sclerosis; Treatment Outcome | 2017 |
68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma: Comparison With 18F-FDG.
Topics: Chordoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clinical Decision-Making; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Tumor Burden; Young Adult | 2018 |
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Molecular Targeted Therapy; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Thyroid Neoplasms | 2017 |
Topics: Adult; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pineal Gland; Positron Emission Tomography Computed Tomography | 2017 |
Functional mapping of pattern and probability of locoregional and distant metastases: can FDG-PET/CT imaging data be the basis for multidimensional scaling in patients with cancer?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Probability; Tomography, X-Ray Computed | 2008 |
Percutaneous endoscopic gastrostomy site metastases in head and neck cancer: use of FDG PET-CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Gastroscopy; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
Topics: Adult; Aged; Biopsy, Fine-Needle; Diagnosis, Differential; Endosonography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones.
Topics: Bone and Bones; Cell Proliferation; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2008 |
F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
Topics: Adenoma, Oxyphilic; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Lip Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Submandibular Gland Neoplasms; Tomography, X-Ray Computed | 2008 |
F-18 FDG uptake in cutaneous metastases from breast cancer.
Topics: Aged; Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Demonstration of thyroidal metastasis from lung cancer by F-18 FDG PET scan.
Topics: Adenocarcinoma; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms | 2008 |
Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Humerus; Lung Neoplasms; Male; Mesothelioma; Neoplasm Metastasis; Neoplasms, Second Primary; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging | 2008 |
Effective radiotherapy of primary tumors and metastasis with 18F-2-deoxy-2-fluoro-D-glucose in C57BL/6 mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gentian Violet; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiation Oncology; Radiopharmaceuticals | 2008 |
Benign F-18 FDG uptake along a mediastinoscopy tract: demonstration by F-18 FDG PET/CT imaging.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mediastinoscopy; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2008 |
Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Topics: Aged; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome | 2008 |
Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Female; Ferric Compounds; Ferrosoferric Oxide; Fluorodeoxyglucose F18; Humans; Iron; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Metastasis; Oxides; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Referral and Consultation; Tomography, X-Ray Computed | 2009 |
Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Topics: Aged; Blotting, Western; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 2; Hexokinase; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Risk Assessment; Treatment Outcome | 2008 |
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.
Topics: Carcinoma, Papillary; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Conversion of FDG PET activity of fibrous dysplasia of the skull late in life mimicking metastatic disease.
Topics: Aged; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Molecular Mimicry; Neoplasm Metastasis; Positron-Emission Tomography; Skull; Temporal Lobe | 2008 |
Isolated asymptomatic skeletal muscle metastasis in a potentially resectable non-small cell lung cancer: detection with FDG PET-CT scanning.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Risk assessment based on FDG-PET imaging in patients with synovial sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sarcoma, Synovial; Survival Analysis | 2009 |
[PET-FDG in metastases from urological malignancies].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Urologic Neoplasms | 2008 |
Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ileal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography | 2009 |
Assessment of the incremental value of recombinant thyrotropin stimulation before 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging to localize residual differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Fluorodeoxyglucose F18; Genetic Variation; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm, Residual; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Tomography, X-Ray Computed | 2009 |
The use of contrast-enhanced ultrasound in patients with GIST metastases that are negative in CT and PET.
Topics: Adult; Antineoplastic Agents; Benzamides; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Topics: Carcinoembryonic Antigen; Colorectal Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2009 |
Lung sequestration and Pott disease masquerading as primary lung cancer with bone metastases on FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Spondylitis; Tomography, X-Ray Computed; Tuberculosis, Spinal | 2009 |
Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging.
Topics: Adult; Diagnosis, Differential; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Neoplasm Metastasis; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET/CT can help differentiate SAPHO syndrome from suspected metastatic bone disease.
Topics: Acquired Hyperostosis Syndrome; Adult; Back Pain; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.
Topics: alpha-MSH; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line, Tumor; Feasibility Studies; Fluorodeoxyglucose F18; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Lactams; Melanoma; Mice; Neoplasm Metastasis; Neoplasm Staging; Peptides, Cyclic; Reproducibility of Results; Staining and Labeling; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Staging primary head and neck cancers with (18)F-FDG PET/CT: is intravenous contrast administration really necessary?
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
Topics: Carcinoma, Renal Cell; Disease Progression; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
Topics: Adult; Aged; Disease Progression; Endocrine Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin | 2009 |
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
Topics: Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplastic Cells, Circulating; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Metastatic choriocarcinoma with tumor thrombus in the right atrium and pulmonary vessels: diagnosis and therapy monitoring with F-18 flurodeoxyglucose PET/CT.
Topics: Adult; Blood Vessels; Choriocarcinoma; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Veins; Thrombosis; Tomography, X-Ray Computed | 2009 |
FDG accumulation in obturator herniation of the bladder mimicking metastatic disease.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hernia, Obturator; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder; Whole Body Imaging | 2009 |
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Chemotherapy response evaluation in metastatic colorectal cancer with FDG PET/CT and CT scans.
Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Bellini duct carcinoma: visualization on F-18 FDG PET/CT.
Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Application of 18F-fluorodeoxyglucose positron emission tomography in diagnosis of malignant diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2009 |
18F-FDG PET for detecting metastases and synchronous primary malignancies in patients with oral and oropharyngeal cancer.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Oropharyngeal Neoplasms; Palatal Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tongue Neoplasms | 2009 |
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment.
Topics: Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Small Cell Lung Carcinoma; Tomography, X-Ray Computed | 2009 |
Non-Hodgkin's lymphoma of supraclavicular lymph nodes can mimic metastasis of breast cancer during chemotherapy on FDG PET/CT.
Topics: Adult; Breast Neoplasms; Clavicle; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
Topics: Aged; Carcinoma, Small Cell; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2009 |
Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biopsy, Fine-Needle; Carcinoma, Papillary; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Analysis; Taiwan; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2009 |
Contemporary imaging in sarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Topics: Animals; Biological Transport; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Linear Models; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed | 2009 |
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome | 2009 |
Multiple (18)F-FDG, PET-CT for postoperative monitoring of breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
Variable F-18 fluorodeoxyglucose avidity of metastatic recurrent adult granulosa cell tumor.
Topics: Abdominal Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2009 |
Chylothorax due to metastatic prostate carcinoma: an unusual complication.
Topics: Adenocarcinoma; Biopsy; Chylothorax; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Radiotherapy; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Positron emission tomography and granulosa cell tumor recurrence: a report of 2 cases.
Topics: Aged; Female; Fluorodeoxyglucose F18; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Recurrence | 2009 |
[The role and limitations of FDG-PET in head and neck cancer].
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT.
Topics: Amyloidosis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Dosage; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone | 2013 |
The clinical significance of 18F-FDG-PET/CT in early detection of second primary malignancy in cancer patients.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Topics: Animals; Autoradiography; Cell Line, Tumor; Cell Transformation, Neoplastic; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney; Melanins; Melanoma; Mice; Neoplasm Metastasis; Niacinamide; Positron-Emission Tomography; Pyridines; Substrate Specificity; Tomography, X-Ray Computed; Transplantation, Homologous; Whole Body Imaging | 2010 |
Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiographic Image Interpretation, Computer-Assisted; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2010 |
FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2010 |
High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Positron-Emission Tomography; Proportional Hazards Models; Reproducibility of Results; Sensitivity and Specificity; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT.
Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Systems Integration; Tomography, X-Ray Computed | 2010 |
Adrenal collision tumor diagnosed by F-18 fluorodeoxyglucose PET/CT.
Topics: Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Middle Aged; Neoplasm Metastasis; Observer Variation; Positron-Emission Tomography; Radiography, Thoracic; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Asymptomatic port-site metastasis following video-assisted thoracoscopic surgery detected by FDG-PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2010 |
Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis.
Topics: Biomarkers, Tumor; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2010 |
PET surveillance of patients with Ewing sarcomas of the trunk: Must the lower legs be included?
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Leg; Male; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoma, Ewing | 2010 |
Evaluation of FDG uptake in pulmonary hila with FDG PET/CT and contrast-enhanced CT in patients with thoracic and non-thoracic tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Child; Contrast Media; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Thoracic Neoplasms; Tomography, X-Ray Computed; Young Adult | 2010 |
Pleomorphic carcinoma of the lung with intrapulmonary aerogenic metastases on FDG PET.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Whole Body Imaging | 2010 |
Ratio of standardized uptake value on PET helps predict response and outcome after chemotherapy in advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genes.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, SCID; Neoplasm Metastasis; Osteolysis; Positron-Emission Tomography; Protease Inhibitors; Pyrazines; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2010 |
Diagnostic accuracy of ultrasound and 18-F-FDG PET or PET/CT for patients with suspected recurrent papillary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Young Adult | 2010 |
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Preoperative Period | 2011 |
Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Uveal Neoplasms | 2010 |
Localization of medullary thyroid carcinoma after surgery using (11)C-methionine PET/CT: comparison with (18)F-FDG PET/CT.
Topics: Adult; Aged; Calcitonin; Carbon Radioisotopes; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy | 2010 |
Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; Retrospective Studies; Salvage Therapy | 2010 |
Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2011 |
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Algorithms; Biological Transport; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pleural Neoplasms; Positron-Emission Tomography; Radiography, Abdominal; Radiography, Thoracic; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Treatment Failure | 2011 |
PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Cell Differentiation; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Thyroid Neoplasms; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Metastatic female adnexal tumor of possible wolffian origin (FATWO) of the appendix demonstrated by FDG PET/CT: the first reported case.
Topics: Adenoma; Adnexal Diseases; Appendix; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2011 |
F-18 FDG PET positive hilar and mediastinal lymphadenopathy mimicking metastatic disease in a melanoma patient treated with interferon-alpha-2b.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Interferon-alpha; Lymphatic Diseases; Male; Mediastinal Diseases; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Capsule Endoscopy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Intestinal Neoplasms; Intestine, Small; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; New South Wales; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Survival Rate; Young Adult | 2011 |
Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis.
Topics: Animals; Cell Proliferation; Female; Fluorodeoxyglucose F18; Inflammation; Lymphangiogenesis; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Animal; Skin | 2011 |
Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Blood Glucose; Everolimus; Female; Fluorodeoxyglucose F18; Humans; Hypoglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases | 2011 |
Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Uterine Neoplasms | 2011 |
Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Solitary Pulmonary Nodule; Survival Analysis; Tumor Burden; Young Adult | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Clinical value of FDG-PET for preoperative evaluation of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Preoperative Period; Retrospective Studies | 2011 |
Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; ROC Curve; Time Factors; Tomography, X-Ray Computed | 2011 |
Clinical images: Bone sarcoidosis mimicking multiple metastases.
Topics: Adult; Bone Diseases; Female; Fluorodeoxyglucose F18; Humans; Low Back Pain; Magnetic Resonance Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed | 2011 |
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome.
Topics: Cervix Uteri; Contrast Media; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Models, Theoretical; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
[Usefulness of positron emission tomography in oncology].
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prognosis | 2011 |
Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Biomarkers, Tumor; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Epithelioid angiosarcoma with metastatic disease after endovascular therapy of abdominal aortic aneurysm.
Topics: Aged, 80 and over; Angiography; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Embolization, Therapeutic; Fatal Outcome; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Immunohistochemistry; Multimodal Imaging; Neoplasm Grading; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Retrospective Studies; Synovitis, Pigmented Villonodular | 2012 |
Imaging ¹⁸F-fluorodeoxy glucose/¹¹C-methionine uptake decoupling for identification of tumor cell infiltration in peritumoral brain edema.
Topics: Adult; Aged; Brain Edema; Brain Neoplasms; Carbon Radioisotopes; Female; Fluorodeoxyglucose F18; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Meningioma; Methionine; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2012 |
Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases.
Topics: Adult; Aged; Calcinosis; Carcinoma, Papillary; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.
Topics: Adult; Aged; Analysis of Variance; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Retrospective Studies | 2011 |
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Topics: Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Rectal Neoplasms; Risk Assessment; Tomography, X-Ray Computed | 2012 |
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Topics: Adult; Aged; Breast Neoplasms; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Topics: Aged; Biological Transport; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Potential role of FDG PET imaging in predicting metastatic potential and assessment of therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma family of tumors.
Topics: Adolescent; Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoma, Ewing; Treatment Outcome; Young Adult | 2011 |
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Choline; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
Topics: Aged; Fluorodeoxyglucose F18; Humans; Liver; Male; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Deoxycytidine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging; Young Adult | 2012 |
The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
The role of 18FDG PET/CT in the management of colorectal liver metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Umbilical metastatic deposit from recurrent cholangiocarcinoma: F18-FDG PET-CT findings.
Topics: Aged; Cholangiocarcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Recurrence; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2011 |
¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2012 |
Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Q Fever masquerading as prostate cancer metastases.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Q Fever; Radionuclide Imaging; Technetium Tc 99m Medronate; Whole Body Imaging | 2012 |
Standardized uptake value by positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Endoscopy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Function Tests; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factor.
Topics: Adenocarcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Assessment of the metabolic flow phenotype of primary colorectal cancer: correlations with microvessel density are influenced by the histological scoring method.
Topics: Aged; Aged, 80 and over; Algorithms; Antigens, CD; Colorectal Neoplasms; Endoglin; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microcirculation; Middle Aged; Neoplasm Metastasis; Perfusion; Phenotype; Positron-Emission Tomography; Receptors, Cell Surface | 2012 |
A rare case of malignant urinary bladder paraganglioma with distant metastases demonstrated by 18F-FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2012 |
On ROC analysis with nonbinary reference standard.
Topics: Breast Neoplasms; Diagnostic Tests, Routine; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Models, Statistical; Neoplasm Metastasis; Positron-Emission Tomography; Reference Standards; ROC Curve | 2012 |
The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Topics: Adult; Aged; Biomarkers, Tumor; Colorectal Neoplasms; Contrast Media; Disease-Free Survival; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2012 |
[¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography | 2012 |
Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2012 |
Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.
Topics: Adenoma; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Dosage; Retrospective Studies; Risk; Thyroglobulin; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Failure; Whole Body Imaging; Young Adult | 2012 |
Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Somatostatin; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities.
Topics: CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Positron-Emission Tomography; Prognosis; Receptors, Somatostatin; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2012 |
Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Young Adult | 2012 |
Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Topics: Aged; Antineoplastic Agents; Benzamides; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease.
Topics: Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2012 |
18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Topics: Biological Transport; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2012 |
18F-FDG PET/CT appearance of metastatic brachial plexopathy involving epidural space from breast carcinoma.
Topics: Aged; Brachial Plexus Neuropathies; Breast Neoplasms; Epidural Space; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Recurrent and metastatic osteoclast-like giant cell tumor of the liver revealed by FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Giant Cell Tumors; Humans; Liver Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Osteoclasts; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
FDG injection site extravasation: potential pitfall of misinterpretation and missing metastases.
Topics: Carcinoma, Non-Small-Cell Lung; Extravasation of Diagnostic and Therapeutic Materials; Fluorodeoxyglucose F18; Humans; Injections; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Pneumonectomy; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2013 |
[Prognostic factors in non-small cell lung cancer patients and prognostic importance of PET/CT SUV max value].
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Comparison between F-18 fluorodeoxyglucose and Ga-68 DOTATOC in metastasized melanoma.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed | 2013 |
[Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
Topics: Adult; Aged; Aged, 80 and over; alpha-Fetoproteins; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Characteristic imaging features of desmoplastic small round cell tumour.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Desmoplastic Small Round Cell Tumor; Digestive System Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2013 |
An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.
Topics: Adolescent; Adult; Biopsy, Needle; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Young Adult | 2013 |
Optimal timing of post-treatment [18F]fluorodeoxyglucose-PET/CT for patients with head and neck malignancy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2013 |
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence?
Topics: Aged; Biomarkers; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Rectal Neoplasms; Recurrence; Surgical Procedures, Operative; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Anaplastic Lymphoma Kinase; DNA Mutational Analysis; ErbB Receptors; Female; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Multimodal Imaging; Mutation; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Receptor Protein-Tyrosine Kinases; Tomography, X-Ray Computed; Young Adult | 2013 |
Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.
Topics: Adolescent; Adult; Endosonography; Female; Fluorodeoxyglucose F18; Gestational Trophoblastic Disease; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Pregnancy; Prognosis; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Young Adult | 2013 |
Unusual case of isolated parasellar metastasis from carcinoma of thyroid.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Pituitary Gland; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
[Malignant melanoma: diagnostic value of F-18 FDG positron emission tomography].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Positron emission tomography for the evaluation of patients with colorectal cancer.
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Carcinoembryonic Antigen; Cecal Neoplasms; Colectomy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hepatectomy; Humans; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radioimmunodetection; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma.
Topics: Aged; Fallopian Tube Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Where can FDG-PET contribute most to anatomical imaging problems?
Topics: Brain Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Diagnosis in medullary thyroid cancer with [18F]FDG-PET and improvement using a combined PET/CT scanner.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Irradiation | 2003 |
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cell Hypoxia; Combined Modality Therapy; Coordination Complexes; Copper Radioisotopes; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Life Tables; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Prospective Studies; Radiation Tolerance; Radiopharmaceuticals; Survival Rate; Thiosemicarbazones; Tomography, Emission-Computed; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Isotretinoin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2003 |
FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burden.
Topics: Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed | 2003 |
Evaluation of 18F-FDG PET in patients with advanced, metastatic, or recurrent gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Stomach Neoplasms; Tomography, Emission-Computed | 2003 |
F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Topics: Biomarkers, Tumor; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Carcinoma, Papillary; Child; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Salivary Gland Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Thyroid Gland; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2003 |
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2003 |
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Transgenic; Necrosis; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Treatment Outcome | 2003 |
F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
FDG-PET uptake in occult acute pelvic fracture.
Topics: Bone Neoplasms; Diagnosis, Differential; Esophageal Neoplasms; Fluorodeoxyglucose F18; Fractures, Bone; Humans; Ilium; Male; Middle Aged; Neoplasm Metastasis; Radiography; Tomography, Emission-Computed | 2004 |
[Clinical evaluation of 18F-FDE PET-CT in detecting malignant liver tumors].
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.
Topics: Aged; Aged, 80 and over; Biopsy; Blood Glucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Multiple Primary; Precancerous Conditions; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
[[18F]-FDG imaging in apparently isolated pleural lesions].
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pleural Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Topics: Cell Line, Tumor; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Hypoxia; Image Processing, Computer-Assisted; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |
18F-FDG-PET in metastatic gastrointestinal stromal tumour.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Stromal Cells; Tomography, Emission-Computed; Treatment Outcome | 2004 |
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2004 |
Impact of FDG-PET for staging of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy.
Topics: Adult; Diagnostic Imaging; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antibody Specificity; Autoantibodies; Autoimmune Diseases of the Nervous System; Carcinoma; Carcinoma, Small Cell; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Unknown Primary; Neuroblastoma; Neurons; Ovarian Neoplasms; Paraneoplastic Polyneuropathy; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Spiral Computed | 2004 |
Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
Topics: Adult; Aged; Esophageal Neoplasms; Esophagectomy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer.
Topics: Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Reference Values; Retrospective Studies | 2004 |
Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Solitary Pulmonary Nodule; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 2004 |
The role of PET scan in the preoperative management of oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
Topics: Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Laparoscopy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2005 |
Positron emission tomography in cancer of the head and neck.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymph Nodes; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Benign lesions in cancer patients: Case 1. Sarcoidosis after chemoradiation for head and neck cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Sarcoidosis | 2005 |
Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.
Topics: Adult; Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Uterine Cervical Neoplasms | 2005 |
90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Detection of multiple extracranial metastases from glioblastoma multiforme by means of whole-body [18F]FDG-PET.
Topics: Adult; Brain Neoplasms; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Whole Body Imaging | 2005 |
FDG-PET for management of cervical and ovarian cancer.
Topics: CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2005 |
Integrin alpha v beta 3-targeted imaging of lung cancer.
Topics: Animals; Cell Adhesion; Chromatography, High Pressure Liquid; Copper; Dimerization; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Kinetics; Lung; Lung Neoplasms; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Models, Chemical; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Peptides; Polyethylene Glycols; Positron-Emission Tomography; Protein Binding; Protein Structure, Tertiary; Radiopharmaceuticals; Time Factors | 2005 |
Role of PET scan in management of oesophageal cancer.
Topics: Esophageal Neoplasms; Esophagogastric Junction; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2005 |
Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Microtubules; Neoplasm Metastasis; Orchiectomy; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome | 2005 |
Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
Topics: Adult; Aged; Angiography; Biomarkers, Tumor; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Positron-Emission Tomography; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Papillary; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Thyroid Gland; Thyroid Neoplasms; Thyroid Nodule; Thyroiditis; Ultrasonography | 2005 |
Staging and assessment of lymph node involvement by 18F-fluorodeoxyglucose-positron emission tomography in invasive extramammary Paget's disease.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.
Topics: Adenocarcinoma; Adult; Aged; Cell Differentiation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Hexokinase; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Linear Models; Lung; Lung Neoplasms; Male; Middle Aged; Monosaccharide Transport Proteins; Necrosis; Neoplasm Metastasis; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Radiopharmaceuticals; Time Factors; Tuberculosis | 2005 |
Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Tomography, Emission-Computed | 2005 |
Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reference Values; Retrospective Studies | 2005 |
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2005 |
[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Topics: Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2005 |
PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.
Topics: Adult; Antineoplastic Agents; Chorionic Gonadotropin, beta Subunit, Human; Female; Fluorodeoxyglucose F18; Gestational Trophoblastic Disease; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Pregnancy; Tomography, X-Ray Computed | 2006 |
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Reproducibility of Results; Stomach Neoplasms; Tomography, X-Ray Computed | 2006 |
Effect of diazepam on the efficacy of dual-phase FDG PET imaging.
Topics: Administration, Oral; Carcinoma; Diazepam; Drug Interactions; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2006 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
FDG PET in patients with cancer of an unknown primary.
Topics: Adenocarcinoma; Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Prospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2005 |
Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Topics: Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymph Nodes; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2005 |
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Topics: Adult; Age Factors; Carcinoma, Papillary, Follicular; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sex Factors; Survival Analysis; Thyroglobulin; Thyroid Neoplasms; Thyrotropin | 2006 |
Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.
Topics: Colorectal Neoplasms; Cost-Benefit Analysis; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed | 2005 |
In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Second Primary; Nose Neoplasms; Orbital Neoplasms; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Whole Body Imaging | 2006 |
Myoepithelioma of soft tissue originating from the hand: 18F-FDG PET features.
Topics: Aged; Female; Fluorodeoxyglucose F18; Hand; Humans; Myoepithelioma; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2006 |
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2006 |
4th International Cervical Cancer Conference: update on PET and cervical cancer.
Topics: Brachytherapy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms; Whole Body Imaging | 2005 |
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer (Br J Surg 2005; 92: 1363-1367).
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
FDG-PET on irradiated brain tumor: ten years' summary.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma; Child; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis | 2006 |
The search for occult metastatic disease in breast cancer patients: how far should we go?
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Patient Satisfaction; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Patient Satisfaction; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Whole-body MRI and PET-CT in the management of cancer patients.
Topics: Early Diagnosis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Mass Screening; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, Spiral Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2006 |
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Regression Analysis | 2006 |
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Child; Child, Preschool; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2006 |
PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Oligopeptides; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals | 2006 |
Hürthle cell carcinoma with a giant cystic liver metastasis imaged with 18F-labeled fluorodeoxyglucose-positron emission tomography.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2006 |
Detection of metastatic disease in patients with uveal melanoma using positron emission tomography.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Uveal Neoplasms | 2006 |
[2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Humans; Meta-Analysis as Topic; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Quality of Health Care; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms | 2006 |
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypoxia; Misonidazole; Neoplasm Metastasis; Oxygen; Polarography; Positron-Emission Tomography; Reference Standards | 2006 |
Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2006 |
PET-Probe: Evaluation of Technical Performance and Clinical Utility of a Handheld High-Energy Gamma Probe in Oncologic Surgery.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Intraoperative Period; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiometry; Radiopharmaceuticals; Young Adult | 2016 |
In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-Iodide.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fluorodeoxyglucose F18; Glucose; In Vitro Techniques; Iodine Radioisotopes; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Positron-Emission Tomography; Rats; Signal Transduction; Thyroid Neoplasms; Thyrotropin | 2006 |
Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Fluorides; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mice; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoma, Ewing; Staining and Labeling; Transplantation, Heterologous | 2006 |
Incidental detection of an anterior cruciate ligament injury with FDG PET.
Topics: Anterior Cruciate Ligament; Bone and Bones; Bone Neoplasms; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
The diagnosis of esophageal cancer by 2-deoxy-2-F-18 fluoro-D-glucose positron emission tomography (F-18 FDG PET).
Topics: Aged; Bone and Bones; Esophageal Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2006 |
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Colorectal Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models | 2006 |
Usefulness of preoperative FDG-PET for detection of gastric cancer.
Topics: Adenocarcinoma; Aged; Female; Fluorodeoxyglucose F18; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neck; Neoplasm Metastasis; Positron-Emission Tomography; Preoperative Care; Stomach Neoplasms; Whole Body Imaging | 2006 |
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed | 2006 |
High-grade mucoepidermoid carcinoma of the accessory parotid gland with distant metastases identified by 18F-FDG PET-CT.
Topics: Adolescent; Carcinoma, Mucoepidermoid; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cerebellum; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Forecasting; Humans; Immunohistochemistry; Lymph Nodes; Middle Aged; Neoplasm Metastasis; Nerve Tissue Proteins; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Time Factors | 2006 |
Unsuspected FDG-PET findings in the follow-up of patients with lymphoma.
Topics: Aged; Biopsy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Infections; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Recurrence; Retrospective Studies | 2007 |
Tumor viability evaluation by positron emission tomography with [18F]FDG in the liver metastasis rat model.
Topics: Animals; Cell Survival; Colonic Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Liver; Liver Neoplasms; Male; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred F344; Time Factors | 2006 |
Futility of positron emission tomography and other modalities in the initial radiographic screening of patients with melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Medical Futility; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study.
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2007 |
Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Survival Analysis; Treatment Outcome | 2006 |
Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2006 |
PET/CT: will it change the way that we use CT in cancer imaging?
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoembryonic Antigen; Case Management; Colorectal Neoplasms; Diagnostic Errors; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Probability; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
PET in face and neck tumours.
Topics: Facial Neoplasms; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Second Primary; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
The clinical impact of 18F-FDG PET in papillary thyroid carcinoma with a negative 131I whole body scan: a single-center study of 108 patients.
Topics: Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroglobulin; Thyroid Neoplasms; Whole Body Imaging | 2006 |
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
Topics: Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2007 |
Utility of 18F-FDG PET/CT uptake patterns in Waldeyer's ring for differentiating benign from malignant lesions in lateral pharyngeal recess of nasopharynx.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Subtraction Technique | 2007 |
Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
Topics: Algorithms; Cell Differentiation; Colorectal Neoplasms; Decision Support Techniques; Fluorodeoxyglucose F18; Humans; Kinetics; Liver; Models, Statistical; Models, Theoretical; Neoplasm Metastasis; Positron-Emission Tomography; Probability; Radiopharmaceuticals; Software | 2007 |
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Thyroglobulin; Thyroid Gland; Thyroid Neoplasms; Whole Body Imaging | 2007 |
Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging.
Topics: Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Guanine; Herpesvirus 1, Human; Image Processing, Computer-Assisted; Luciferases; Luminescence; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine Kinase; Tomography, X-Ray Computed; Transplantation, Heterologous | 2007 |
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2007 |
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Positron-Emission Tomography; Reproducibility of Results; Risk; ROC Curve; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Is FDG-PET indicated for superficial esophageal cancer?
Topics: Adenocarcinoma; Diagnosis, Differential; Esophageal Neoplasms; Esophagoscopy; Esophagus; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Clinical impact of positron emission tomography (PET) with (18F)fluorodeoxyglucose (FDG) in head and neck tumours.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |
F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
Topics: Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
Topics: Drug Delivery Systems; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
FDG uptake in metastatic spreading mucoepidermoid carcinoma of the thyroid.
Topics: Aged; Carcinoma, Mucoepidermoid; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18-FDG-PET/CT leads to diagnosis of cryptococcal pneumonia where recurrent metastatic rhabdomyosarcoma was suspected.
Topics: Child; Cryptococcosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pneumonia; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyosarcoma; Tomography, X-Ray Computed | 2007 |
Misdiagnosis of multiple bone metastases due to increased FDG uptake in polyostotic fibrous dysplasia.
Topics: Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Female; Fibrous Dysplasia, Polyostotic; Fluorodeoxyglucose F18; Humans; Inflammation; Middle Aged; Neoplasm Metastasis; Radionuclide Imaging; Technetium; Tomography, X-Ray Computed | 2007 |
PET monitoring of clear cell sarcoma of tendons and aponeuroses.
Topics: Aged, 80 and over; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Tendons; Tomography, X-Ray Computed | 2007 |
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Topics: Antineoplastic Agents; Benzamides; Disease Progression; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Multivariate Analysis; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Protein-Tyrosine Kinases; Pyrimidines; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2007 |
F-18 FDG PET as an imaging tool for detecting and staging metastatic basal-cell carcinoma.
Topics: Carcinoma, Basal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Whole Body Imaging | 2007 |
Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Radiopharmaceuticals; Retrospective Studies; Solitary Pulmonary Nodule | 2007 |
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Iron-Sulfur Proteins; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Succinate Dehydrogenase | 2007 |
FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
Topics: Adult; Aged; Aged, 80 and over; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
Metastasized urachal carcinoma scanned with 11C-chlorine and 18F-fluorodeoxyglucose PET/CT.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antineoplastic Agents; Cystectomy; Fluorodeoxyglucose F18; Hematuria; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Paralysis; Positron-Emission Tomography; Spine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Renal Dialysis; Tomography, X-Ray Computed | 2007 |
Elastofibroma dorsi mimicking metastatic disease on fluorodeoxyglucose F-18 positron emission tomography in a breast cancer patient.
Topics: Aged; Breast; Breast Neoplasms; Diagnosis, Differential; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Soft Tissue Neoplasms | 2007 |
Dural metastases responsible for benign vertebral collapses.
Topics: Adolescent; Carcinoma; Fluorodeoxyglucose F18; Fractures, Spontaneous; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography; Spinal Fractures; Spinal Neoplasms; Spine; Tomography, Emission-Computed, Single-Photon | 2007 |
Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Period; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals | 2007 |
High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Pituitary metastasis of breast cancer confirmed by fluorine-18 fluorodeoxyglucose positron emission tomography: a case report.
Topics: Breast Neoplasms; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pituitary Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Rectal Neoplasms; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Head; Humans; Leg; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
The contribution of new imaging techniques in staging cervical cancer.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2007 |
Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Reproducibility of Results; ROC Curve; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
(18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer.
Topics: Adult; Aged; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
Topics: Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Thyroid Neoplasms; Tomography, X-Ray Computed | 2008 |
Positron emission tomography imaging in nonsmall-cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2007 |
Limited additional value of positron emission tomography in staging oesophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals | 2007 |
18F-FDG dual-headed gamma camera PET in detection of axillary nodal disease in patients with large or locally advanced breast cancer: possible alternative staging of axilla.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Fine-Needle; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
F18-FDG-PET evaluation of patients for resection of colorectal liver metastases.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2007 |
Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Topics: Aged; Aged, 80 and over; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Galactose; Humans; Integrin alphaVbeta3; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peptides, Cyclic; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Iohexol; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
In vitro and in vivo studies with [(18)F]fluorocholine on digestive tumoral cell lines and in an animal model of metastasized endocrine tumor.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Choline; Digestive System Neoplasms; Endocrine Gland Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mice; Neoplasm Metastasis; Radionuclide Imaging | 2008 |
Brown tumors simulating metastases on FDG PET in a patient with parathyroid carcinoma.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Parathyroid Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2008 |
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2008 |
[Lung neoplasms--ultrasonic endoscopy as a first diagnostic tool].
Topics: Aged; Aged, 80 and over; Biopsy, Fine-Needle; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2008 |
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiography, Thoracic; Radiopharmaceuticals; Risk Factors; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
Enhanced experimental tumor metastasis with age in senescence-accelerated mouse.
Topics: Aging; Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Idoxuridine; Immunologic Surveillance; Lung Neoplasms; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Nucleic Acid Synthesis Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Topics: Adult; Aged; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Survival Analysis; Thyroid Neoplasms | 2008 |
[Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Ultrasonography | 2008 |
Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis.
Topics: Aged; Autoimmune Diseases; Cholangiopancreatography, Magnetic Resonance; Diagnosis, Differential; Fibrosis; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunohistochemistry; Lymphoma; Male; Neoplasm Metastasis; Pancreatitis; Positron-Emission Tomography; Radiopharmaceuticals; Salivary Gland Neoplasms; Submandibular Gland; Tomography, X-Ray Computed | 2008 |
[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Topics: Adenocarcinoma, Follicular; Biological Transport; Carcinoma, Papillary; Cell Differentiation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Prognosis; Thyroid Neoplasms; Tomography, Emission-Computed | 1995 |
Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Tomography, Emission-Computed; Xeromammography | 1993 |
[Use of positron-emission tomography in oncology].
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Tomography, Emission-Computed | 1996 |
Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.
Topics: Breast Neoplasms; Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer.
Topics: Carcinoma, Squamous Cell; Cervical Vertebrae; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Oropharyngeal Neoplasms; Oropharynx; Retrospective Studies; Spinal Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1996 |
Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma; Carcinoma, Papillary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Radiography; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Tomography, Emission-Computed | 1997 |
[123I-alpha-methyltyrosine scintigraphy in malignant melanoma].
Topics: Adult; Aged; alpha-Methyltyrosine; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Melanoma; Methyltyrosines; Middle Aged; Neoplasm Metastasis; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium; Thyroid Neoplasms | 1997 |
Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sensitivity and Specificity; Tomography, Emission-Computed | 1997 |
Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer.
Topics: Abdomen; Administration, Intravesical; Artifacts; Catheterization; Colon; Colonic Neoplasms; Diuretics; Fluid Therapy; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Kidney; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Radiopharmaceuticals; Rectal Neoplasms; Sodium Chloride; Therapeutic Irrigation; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract | 1998 |
Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Topics: Adult; Aged; Algorithms; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Therapy, Computer-Assisted; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
Malignant melanoma staging using whole-body positron emission tomography.
Topics: Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Carcinoembryonic Antigen; Colorectal Neoplasms; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Predictive Value of Tests; Retrospective Studies; Tomography, Emission-Computed | 1998 |
Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports.
Topics: Adenocarcinoma, Follicular; Aged; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Radiopharmaceuticals; Technetium; Thallium Radioisotopes; Thyroid Neoplasms; Tomography, Emission-Computed | 1998 |
The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Topics: Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer.
Topics: Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pancreatic Neoplasms; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
[Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 1998 |
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer.
Topics: Adult; Aged; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 1999 |
Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adult; Carcinoma, Papillary; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Recurrence; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 1998 |
Role of FDG PET in metastatic thyroid cancer.
Topics: Autoantibodies; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Topics: Adult; Aged; Autoantibodies; Bone Neoplasms; Carcinoma, Papillary; Data Interpretation, Statistical; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
A new look at breast cancer.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |
Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; ROC Curve; Thymoma; Thymus Neoplasms; Tomography, Emission-Computed | 1999 |
Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Metastasis; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1999 |
ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm.
Topics: Algorithms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Neoplasm Metastasis; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed | 1999 |
[Positron emission tomography ia an effective tool in modern oncology].
Topics: Fluorodeoxyglucose F18; Humans; Methionine; Neoplasm Metastasis; Neoplasms; Tomography, Emission-Computed | 1999 |
Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Thyroglobulin; Thyroid Neoplasms; Tomography, Emission-Computed | 2000 |
A combined PET/CT scanner for clinical oncology.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Data Interpretation, Statistical; Duodenal Neoplasms; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2000 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2001 |
Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases.
Topics: Adult; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Laryngeal Muscles; Laryngeal Neoplasms; Male; Neoplasm Metastasis; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed | 2001 |
FDG-PET in the detection of gastrointestinal metastases in melanoma.
Topics: Adult; Aged; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
FDG positron emission tomography in isolated limb perfusion therapy in patients with locally advanced melanoma: preliminary results.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Drug Therapy, Combination; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha; Whole-Body Counting | 2001 |
FDG PET in the diagnosis of hilar cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 2001 |
[The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy].
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radiopharmaceuticals; Radiotherapy; Retrospective Studies; Tomography, Emission-Computed | 2001 |
Metastases of predominantly dopamine-secreting phaeochromocytoma that did not accumulate meta-iodobenzylguanidine: imaging with whole body positron emission tomography using 18F-labelled deoxyglucose.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Detection of a recurrent parathyroid carcinoma with FDG positron emission tomography.
Topics: Adult; Calcium; Carcinoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |
Lymph node staging in extracranial head and neck cancer with FDG PET--appropriate uptake period and size-dependence of the results.
Topics: Adult; Aged; Biological Transport; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lymph Nodes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Ultrasonography | 2002 |
Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Retrospective Studies; Tomography, X-Ray Computed | 2002 |
Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Topics: Animals; Carbon Radioisotopes; Deoxyglucose; Diagnosis, Differential; Disease Models, Animal; Floxuridine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fucose; Lung Neoplasms; Methionine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Thymidine; Tomography, Emission-Computed; Tritium | 1992 |
Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
Topics: Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Tomography, Emission-Computed | 1991 |
Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Topics: Adenocarcinoma; Aged; Carcinoma, Papillary; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radioisotopes; Radionuclide Imaging; Thyroid Neoplasms | 1987 |
Scintigraphy with [18F]2-fluoro-2-deoxy-D-glucose of cancer patients.
Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioisotopes; Radionuclide Imaging | 1986 |